Document and Entity Information
Document and Entity Information - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2020 | Feb. 22, 2021 | Jun. 30, 2020 | |
Entity Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2020 | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Entity File Number | 001-37905 | ||
Entity Central Index Key | 0001685040 | ||
Entity Registrant Name | Brighthouse Financial, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 81-3846992 | ||
Entity Address, Address Line One | 11225 North Community House Road | ||
Entity Address, City or Town | Charlotte | ||
Entity Address, State or Province | NC | ||
Entity Address, Postal Zip Code | 28277 | ||
City Area Code | 980 | ||
Local Phone Number | 365-7100 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 2.6 | ||
Entity Common Stock, Shares Outstanding | 87,378,950 | ||
Common Stock, par value $0.01 per share | |||
Entity Information [Line Items] | |||
Title of 12(b) Security | Common Stock, par value $0.01 per share | ||
Trading Symbol | BHF | ||
Security Exchange Name | NASDAQ | ||
Depositary Shares, each representing a 1/1,000th interest in a share of 6.600% Non-Cumulative Preferred Stock, Series A | |||
Entity Information [Line Items] | |||
Title of 12(b) Security | Depositary Shares, each representing a 1/1,000th interest in a share of 6.600% Non-Cumulative Preferred Stock, Series A | ||
Trading Symbol | BHFAP | ||
Security Exchange Name | NASDAQ | ||
Depositary Shares, each representing a 1/1,000th interest in a share of 6.750% Non-Cumulative Preferred Stock, Series B | |||
Entity Information [Line Items] | |||
Title of 12(b) Security | Depositary Shares, each representing a 1/1,000th interest in a share of 6.750% Non-Cumulative Preferred Stock, Series B | ||
Trading Symbol | BHFAO | ||
Security Exchange Name | NASDAQ | ||
Depositary Shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C | |||
Entity Information [Line Items] | |||
Title of 12(b) Security | Depositary Shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C | ||
Trading Symbol | BHFAN | ||
Security Exchange Name | NASDAQ | ||
6.250% Junior Subordinated Debentures due 2058 | |||
Entity Information [Line Items] | |||
Title of 12(b) Security | 6.250% Junior Subordinated Debentures due 2058 | ||
Trading Symbol | BHFAL | ||
Security Exchange Name | NASDAQ |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Investments: | ||
Debt Securities, Available-for-sale | $ 82,495 | $ 71,036 |
Equity securities, at estimated fair value | 138 | 147 |
Mortgage Loans on Real Estate, Commercial and Consumer, Net | 15,808 | 15,753 |
Policy loans | 1,291 | 1,292 |
Limited partnerships and limited liability companies | 2,810 | 2,380 |
Short-term investments, principally at estimated fair value | 3,242 | 1,958 |
Other invested assets, principally at estimated fair value (net of allowance for credit losses of $13 and $0, respectively) | 3,747 | 3,216 |
Total investments | 109,531 | 95,782 |
Cash and cash equivalents | 4,108 | 2,877 |
Accrued investment income | 676 | 684 |
Premiums, reinsurance and other receivables (net of allowance for credit losses of $10 and $0, respectively) | 16,158 | 14,760 |
Deferred policy acquisition costs and value of business acquired | 4,911 | 5,448 |
Current income tax recoverable | 0 | 17 |
Other assets | 516 | 584 |
Separate account assets | 111,969 | 107,107 |
Total assets | 247,869 | 227,259 |
Liabilities | ||
Liability for Future Policy Benefit, after Reinsurance | 44,448 | 39,686 |
Policyholder account balances | 54,508 | 45,771 |
Other policy-related balances | 3,411 | 3,111 |
Payables for collateral under securities loaned and other transactions | 5,252 | 4,391 |
Long-term debt | 3,436 | 4,365 |
Current income tax payable | 126 | 0 |
Deferred income tax liability | 1,620 | 1,355 |
Other liabilities | 5,011 | 5,236 |
Separate account liabilities | 111,969 | 107,107 |
Total liabilities | 229,781 | 211,022 |
Contingencies, Commitments and Guarantees (Note 15) | ||
Brighthouse Financial, Inc.’s stockholders’ equity: | ||
Preferred Stock, Value, Issued | 0 | 0 |
Common Stock, Value, Issued | 1 | 1 |
Additional paid-in capital | 13,878 | 12,908 |
Retained earnings (deficit) | (534) | 585 |
Treasury Stock, Value | (1,038) | (562) |
Accumulated other comprehensive income (loss) | 5,716 | 3,240 |
Total Brighthouse Financial, Inc.’s stockholders’ equity | 18,023 | 16,172 |
Noncontrolling interests | 65 | 65 |
Total equity | 18,088 | 16,237 |
Total liabilities and equity | $ 247,869 | $ 227,259 |
Preferred stock, par value per share | $ 0.01 | $ 0.01 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Assets | ||
Amortized cost of fixed maturity securities available-for-sale | $ 70,529 | $ 64,079 |
Fixed maturity securities, allowance for credit losses | 2 | 0 |
Mortgage loans valuation allowances | 94 | 64 |
Leveraged leases, allowance for credit losses | 13 | 0 |
Premiums, reinsurance and other, allowance for credit losses | $ 10 | $ 0 |
Equity [Abstract] | ||
Preferred stock, par value | $ 0.01 | $ 0.01 |
Preferred stock, aggregate liquidation preference | $ 1,403 | $ 425 |
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued | 121,002,523 | 120,647,871 |
Common stock, shares outstanding | 88,211,618 | 106,027,301 |
Treasury stock, shares | 32,790,905 | 14,620,570 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Revenues | |||
Premiums | $ 766 | $ 882 | $ 900 |
Universal life and investment-type product policy fees | 3,463 | 3,580 | 3,835 |
Net investment income | 3,601 | 3,579 | 3,338 |
Other revenues | 413 | 389 | 397 |
Net investment gains (losses) | 278 | 112 | (207) |
Net derivative gains (losses) | (18) | (1,988) | 702 |
Total revenues | 8,503 | 6,554 | 8,965 |
Expenses | |||
Policyholder benefits and claims | 5,711 | 3,670 | 3,272 |
Interest credited to policyholder account balances | 1,092 | 1,063 | 1,079 |
Amortization of DAC and VOBA | 766 | 382 | 1,050 |
Other expenses | 2,353 | 2,491 | 2,575 |
Total expenses | 9,922 | 7,606 | 7,976 |
Income (loss) before provision for income tax | (1,419) | (1,052) | 989 |
Provision for income tax expense (benefit) | (363) | (317) | 119 |
Net income (loss) | (1,056) | (735) | 870 |
Less: Net income (loss) attributable to noncontrolling interests | 5 | 5 | 5 |
Net income (loss) attributable to Brighthouse Financial, Inc. | (1,061) | (740) | 865 |
Less: Preferred stock dividends | 44 | 21 | 0 |
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $ (1,105) | $ (761) | $ 865 |
Earnings per common share | |||
Basic | $ (11.58) | $ (6.76) | $ 7.24 |
Diluted | $ (11.58) | $ (6.76) | $ 7.21 |
Consolidated Statements Of Comp
Consolidated Statements Of Comprehensive Income - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ (1,056) | $ (735) | $ 870 |
Other comprehensive income (loss): | |||
Unrealized investment gains (losses), net of related offsets | 3,208 | 3,209 | (1,165) |
Unrealized gains (losses) on derivatives | (72) | (19) | 25 |
Foreign currency translation adjustments | 20 | 12 | (4) |
Defined benefit plans adjustment | (13) | (10) | 7 |
Other comprehensive income (loss), before income tax | 3,143 | 3,192 | (1,137) |
Income tax (expense) benefit related to items of other comprehensive income (loss) | (667) | (668) | 256 |
Other comprehensive income (loss), net of income tax | 2,476 | 2,524 | (881) |
Comprehensive income (loss) | 1,420 | 1,789 | (11) |
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax | 5 | 5 | 5 |
Comprehensive income (loss) attributable to Brighthouse Financial, Inc. | $ 1,415 | $ 1,784 | $ (16) |
Consolidated Statements of Equi
Consolidated Statements of Equity - USD ($) $ in Millions | Total | Cumulative Effect, Adjustment | Cumulative Effect, Adjusted Balance | Preferred Stock [Member] | Preferred Stock [Member]Cumulative Effect, Adjusted Balance | Common Stock | Common StockCumulative Effect, Adjusted Balance | Additional Paid-in Capital | Additional Paid-in CapitalCumulative Effect, Adjusted Balance | Retained Earnings (Deficit) | Retained Earnings (Deficit)Cumulative Effect, Adjustment | Retained Earnings (Deficit)Cumulative Effect, Adjusted Balance | Treasury Stock at Cost | Treasury Stock at CostCumulative Effect, Adjusted Balance | Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss)Cumulative Effect, Adjustment | Accumulated Other Comprehensive Income (Loss)Cumulative Effect, Adjusted Balance | Brighthouse Financial, Inc.’s Stockholders’ Equity | Brighthouse Financial, Inc.’s Stockholders’ EquityCumulative Effect, Adjustment | Brighthouse Financial, Inc.’s Stockholders’ EquityCumulative Effect, Adjusted Balance | Noncontrolling Interests | Noncontrolling InterestsCumulative Effect, Adjusted Balance |
Total Brighthouse Financial, Inc.’s stockholders’ equity | $ 0 | $ 0 | $ 1 | $ 1 | $ 12,432 | $ 12,432 | $ 406 | $ 75 | $ 481 | $ 0 | $ 0 | $ 1,676 | $ (79) | $ 1,597 | $ 14,515 | $ (4) | $ 14,511 | |||||
Beginning Balance at Dec. 31, 2017 | $ 14,580 | $ (4) | $ 14,576 | $ 65 | $ 65 | |||||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | 865 | 865 | 865 | 5 | ||||||||||||||||||
Net income (loss) | 870 | |||||||||||||||||||||
Noncontrolling Interest, Period Increase (Decrease) | (5) | 0 | (5) | |||||||||||||||||||
Other Comprehensive Income (Loss), Net of Tax | (881) | (881) | (881) | |||||||||||||||||||
Treasury Stock, Value, Acquired, Cost Method | (105) | (105) | (105) | |||||||||||||||||||
Share-based compensation | 28 | 41 | (13) | 28 | ||||||||||||||||||
Ending Balance at Dec. 31, 2018 | 14,483 | 65 | ||||||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 0 | 1 | 12,473 | 1,346 | (118) | 716 | 14,418 | |||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | (761) | (740) | (740) | 5 | ||||||||||||||||||
Net income (loss) | (735) | |||||||||||||||||||||
Noncontrolling Interest, Period Increase (Decrease) | (5) | 0 | (5) | |||||||||||||||||||
Other Comprehensive Income (Loss), Net of Tax | 2,524 | 2,524 | 2,524 | |||||||||||||||||||
Treasury Stock, Value, Acquired, Cost Method | (442) | (442) | (442) | |||||||||||||||||||
Share-based compensation | 21 | 23 | (2) | 21 | ||||||||||||||||||
Stock Issued During Period, Value, New Issues | 412 | 0 | 412 | 412 | ||||||||||||||||||
Dividends, Preferred Stock, Cash | (21) | (21) | (21) | |||||||||||||||||||
Ending Balance at Dec. 31, 2019 | 16,237 | $ (11) | $ 16,226 | 65 | $ 65 | |||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 16,172 | 0 | $ 0 | 1 | $ 1 | 12,908 | $ 12,908 | 585 | $ (14) | $ 571 | (562) | $ (562) | 3,240 | $ 3 | $ 3,243 | 16,172 | $ (11) | $ 16,161 | ||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | (1,105) | (1,061) | (1,061) | 5 | ||||||||||||||||||
Net income (loss) | (1,056) | |||||||||||||||||||||
Noncontrolling Interest, Period Increase (Decrease) | (5) | 0 | (5) | |||||||||||||||||||
Other Comprehensive Income (Loss), Net of Tax | 2,473 | 2,473 | 2,473 | |||||||||||||||||||
Treasury Stock, Value, Acquired, Cost Method | (473) | (473) | (473) | |||||||||||||||||||
Share-based compensation | 19 | 0 | 22 | (3) | 19 | |||||||||||||||||
Stock Issued During Period, Value, New Issues | 948 | 0 | 948 | 948 | ||||||||||||||||||
Dividends, Preferred Stock, Cash | (44) | (44) | (44) | |||||||||||||||||||
Ending Balance at Dec. 31, 2020 | 18,088 | $ 65 | ||||||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | $ 18,023 | $ 0 | $ 1 | $ 13,878 | $ (534) | $ (1,038) | $ 5,716 | $ 18,023 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Cash flows from operating activities | |||
Net income (loss) | $ (1,056) | $ (735) | $ 870 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
Amortization of premiums and accretion of discounts associated with investments, net | (260) | (283) | (264) |
(Gains) losses on investments, net | (278) | (112) | 207 |
(Gains) losses on derivatives, net | 424 | 2,547 | (45) |
(Income) loss from equity method investments, net of dividends and distributions | (54) | 70 | (66) |
Interest credited to policyholder account balances | 1,092 | 1,063 | 1,079 |
Universal life and investment-type product policy fees | (3,463) | (3,580) | (3,835) |
Change in accrued investment income | (9) | 84 | (171) |
Change in premiums, reinsurance and other receivables | (1,346) | (629) | (207) |
Change in deferred policy acquisition costs and value of business acquired, net | 358 | 8 | 725 |
Change in income tax | (243) | (316) | 1,082 |
Change in other assets | 1,968 | 1,974 | 2,143 |
Change in future policy benefits and other policy-related balances | 3,395 | 1,688 | 1,358 |
Change in other liabilities | 285 | (26) | 72 |
Other, net | 75 | 75 | 114 |
Net cash provided by (used in) operating activities | 888 | 1,828 | 3,062 |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 8,459 | 14,146 | 15,819 |
Sales, maturities and repayments of equity securities | 68 | 57 | 22 |
Sales, maturities and repayments of mortgage loans | 1,935 | 1,538 | 797 |
Sales, maturities and repayments of limited partnerships and limited liability companies | 177 | 302 | 275 |
Purchases of fixed maturity securities | (14,401) | (16,915) | (16,460) |
Purchases of equity securities | (23) | (22) | (2) |
Purchases of mortgage loans | (2,076) | (3,610) | (3,890) |
Purchases of limited partnerships and limited liability companies | (581) | (463) | (358) |
Cash received in connection with freestanding derivatives | 6,356 | 2,041 | 1,803 |
Cash paid in connection with freestanding derivatives | (4,515) | (2,639) | (2,940) |
Net change in policy loans | 1 | 129 | 103 |
Net change in short-term investments | (1,271) | (1,942) | 312 |
Net change in other invested assets | 28 | 37 | (19) |
Net cash provided by (used in) investing activities | (5,843) | (7,341) | (4,538) |
Cash flows from financing activities | |||
Policyholder account balances: Deposits | 10,095 | 7,672 | 6,480 |
Policyholder account balances: Withdrawals | (3,270) | (2,849) | (3,494) |
Net change in payables for collateral under securities loaned and other transactions | 861 | (666) | 888 |
Long-term debt issued | 615 | 1,000 | 375 |
Long-term debt repaid | (1,552) | (602) | (9) |
Treasury stock acquired in connection with share repurchases | (473) | (442) | (105) |
Preferred stock issued, net of issuance costs | 948 | 412 | 0 |
Dividends on preferred stock | (44) | (21) | 0 |
Financing element on certain derivative instruments and other derivative related transactions, net | (948) | (203) | (303) |
Other, net | (46) | (56) | (68) |
Net cash provided by (used in) financing activities | 6,186 | 4,245 | 3,764 |
Change in cash, cash equivalents and restricted cash | 1,231 | (1,268) | 2,288 |
Cash, cash equivalents and restricted cash, beginning of year | 2,877 | 4,145 | 1,857 |
Cash, cash equivalents and restricted cash, end of year | 4,108 | 2,877 | 4,145 |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 186 | 187 | 159 |
Net cash paid (received) for income tax | $ (100) | $ 16 | $ (895) |
Business, Basis of Presentation
Business, Basis of Presentation and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | Business “Brighthouse Financial” and the “Company” refer to Brighthouse Financial, Inc. and its subsidiaries (formerly, MetLife U.S. Retail Separation Business). Brighthouse Financial, Inc. (“BHF”) is a holding company formed to own the legal entities that historically operated a substantial portion of MetLife, Inc.’s (together with its subsidiaries and affiliates, “MetLife”) former Retail segment. BHF was incorporated in Delaware in 2016 in preparation for MetLife, Inc.’s separation of a substantial portion of its former Retail segment, as well as certain portions of its former Corporate Benefit Funding segment (the “Separation”), which was completed on August 4, 2017. In connection with the Separation, 80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock and MetLife, Inc. retained the remaining 19.2%. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture. Brighthouse Financial is one of the largest providers of annuity and life insurance products in the United States through multiple independent distribution channels and marketing arrangements with a diverse network of distribution partners. The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates. Consolidation The accompanying consolidated financial statements include the accounts of Brighthouse Financial, as well as partnerships and limited liability companies (“LLCs”) that the Company controls. Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in limited partnerships and LLCs when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. When the Company has virtually no influence over the investee’s operations, the investment is carried at fair value. Reclassifications Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as may be discussed when applicable in the Notes to the Consolidated Financial Statements. Summary of Significant Accounting Policies Insurance Future Policy Benefit Liabilities and Policyholder Account Balances The Company establishes liabilities for future amounts payable under insurance policies. Insurance liabilities are generally equal to the present value of future expected benefits to be paid, reduced by the present value of future expected net premiums. Assumptions used to measure the liability are based on the Company’s experience and include a margin for adverse deviation. The most significant assumptions used in the establishment of liabilities for future policy benefits are mortality, benefit election and utilization, withdrawals, policy lapse, and investment returns as appropriate to the respective product type. For traditional long-duration insurance contracts (term, whole life insurance and income annuities), assumptions are determined at issuance of the policy and are not updated unless a premium deficiency exists. A premium deficiency exists when the liability for future policy benefits plus the present value of expected future gross premiums are less than expected future benefits and expenses (based on current assumptions). When a premium deficiency exists, the Company will reduce any deferred acquisition costs and may also establish an additional liability to eliminate the deficiency. To assess whether a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced and measured for profitability. In applying the profitability criteria, groupings are limited by segment. The Company is also required to reflect the effect of investment gains and losses in its premium deficiency testing. When a premium deficiency exists related to unrealized gains and losses, any reductions in deferred acquisition costs or increases in insurance liabilities are recorded to other comprehensive income (loss) (“OCI”). Policyholder account balances relate to customer deposits on universal life insurance and deferred annuity contracts and are equal to the sum of deposits, plus interest credited, less charges and withdrawals. The Company may also hold additional liabilities for certain guaranteed benefits related to these contracts. Liabilities for secondary guarantees on universal life insurance contracts are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. The Company also maintains a liability for profits followed by losses on universal life with secondary guarantees (“ULSG”) determined by projecting future earnings and establishing a liability to offset losses that are expected to occur in later years. Changes in ULSG liabilities are recorded to net income, except for the effects of unrealized gains and losses, which are recorded to OCI. Recognition of Insurance Revenues and Deposits Premiums related to traditional life insurance and annuity contracts are recognized as revenues when due from policyholders. When premiums for income annuities are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to the amount of expected future benefit payments. Deposits related to universal life insurance, deferred annuity contracts and investment contracts are credited to policyholder account balances. Revenues from such contracts consist of asset-based investment management fees, cost of insurance charges, risk charges, policy administration fees and surrender charges. These fees, which are included in universal life and investment-type product policy fees, are recognized when assessed to the contract holder, except for non-level insurance charges which are deferred and amortized over the life of the contracts. Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance. Deferred Policy Acquisition Costs, Value of Business Acquired and Deferred Sales Inducements The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA related to term non-participating whole life insurance over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, in-force or persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. The Company amortizes DAC and VOBA on deferred annuities and universal life insurance contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon investment returns in excess of the amounts credited to policyholders, mortality, in-force or persistency, benefit elections and utilization, and withdrawals. When significant negative gross profits are expected in future periods, the Company substitutes the amount of insurance in-force for expected future gross profits as the amortization basis for DAC. Assumptions for DAC and VOBA are reviewed at least annually, and if they change significantly, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to net income. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. The Company updates expected future gross profits to reflect the actual gross profits for each period, including changes to its nonperformance risk related to embedded derivatives and the actual amount of business remaining in-force. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the actual gross profits are below the previously expected future gross profits. DAC and VOBA balances on deferred annuities and universal life insurance contracts are also adjusted to reflect the effect of investment gains and losses and certain embedded derivatives (including changes in nonperformance risk). These adjustments can create fluctuations in net income from period to period. Changes in DAC and VOBA balances related to unrealized gains and losses are recorded to OCI. DAC and VOBA balances and amortization for variable contracts can be significantly impacted by changes in expected future gross profits related to projected separate account rates of return. The Company’s practice of determining changes in separate account returns assumes that long-term appreciation in equity markets is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately as net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. The Company also has intangible assets representing deferred sales inducements (“DSI”) which are included in other assets. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of DSI is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews DSI to determine whether the assets are impaired. Reinsurance The Company enters into reinsurance arrangements pursuant to which it cedes certain insurance risks to unaffiliated reinsurers. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The accounting for reinsurance arrangements depends on whether the arrangement provides indemnification against loss or liability relating to insurance risk in accordance with GAAP. For ceded reinsurance of existing in-force blocks of insurance contracts that transfer significant insurance risk, premiums, benefits and the amortization of DAC are reported net of reinsurance ceded. Amounts recoverable from reinsurers related to incurred claims and ceded reserves are included in premiums, reinsurance and other receivables and amounts payable to reinsurers included in other liabilities. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. Under certain reinsurance agreements, the Company withholds the funds rather than transferring the underlying investments and, as a result, records a funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Certain funds withheld arrangements may also contain embedded derivatives measured at fair value that are related to the investment return on the assets withheld. The Company accounts for assumed reinsurance similar to directly written business, except for guaranteed minimum income benefits (“GMIB”), where a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. Variable Annuity Guarantees The Company issues certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (the “Benefit Base”) less withdrawals. In some cases, the Benefit Base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups. Certain of the Company’s variable annuity guarantee features are accounted for as insurance liabilities and recorded in future policy benefits while others are accounted for at fair value as embedded derivatives and recorded in policyholder account balances. Generally, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either the occurrence of a specific insurable event, or annuitization. Alternatively, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring the occurrence of specific insurable event, or the policyholder to annuitize, that is, the policyholder can receive the guarantee on a net basis. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Further, changes in assumptions, principally involving policyholder behavior, can result in a change of expected future cash outflows of a guarantee between portions accounted for as insurance liabilities and portions accounted for as embedded derivatives. Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDB”), the life contingent portion of the guaranteed minimum withdrawal benefits (“GMWB”) and the portion of the GMIBs that require annuitization, as well as the life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value. These insurance liabilities are accrued over the accumulation phase of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, the actual amount of business remaining in-force is updated, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings. Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs, guaranteed minimum accumulation benefits (“GMAB”), and for GMIBs the non-life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value, as well as the guaranteed principal option. The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees are considered revenue and are reported in universal life and investment-type product policy fees. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods. The Company updates the estimated fair value of guarantees in subsequent periods by projecting future benefits using capital market and actuarial assumptions including expectations of policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect the Company’s nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value of embedded derivatives, see Note 8. Assumptions for all variable guarantees are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted by a cumulative charge or credit to net income. Index-linked Annuities The Company issues and assumes through reinsurance index-linked annuities. The crediting rate associated with index-linked annuities is accounted for at fair value as an embedded derivative. The estimated fair value is determined using a combination of an option pricing model and an option-budget approach. Under this approach, the company estimates the cost of funding the crediting rate using option pricing and establishes that cost on the balance sheet as a reduction to the initial deposit amount. In subsequent periods, the embedded derivative is remeasured at fair value while the reduction in initial deposit is accreted back up to the initial deposit over the estimated life of the contract. Investments Net Investment Income and Net Investment Gains (Losses) Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein. Fixed Maturity Securities Available-For-Sale The Company’s fixed maturity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of OCI, net of policy-related amounts and deferred income taxes. Publicly-traded security transactions are recorded on a trade date basis, while privately-placed and bank loan security transactions are recorded on a settlement date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”) considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed, and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis. The Company regularly evaluates fixed maturity securities for declines in fair value to determine if a credit loss exists. This evaluation is based on management’s case by case evaluation of the underlying reasons for the decline in fair value including, but not limited to an analysis of the gross unrealized losses by severity and financial condition of the issuer. For fixed maturity securities in an unrealized loss position, when the Company has the intent to sell the security, or it is more likely than not that the Company will be required to sell the security before recovery, the amortized cost basis of the security is written down to fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. If the Company determines the decline in estimated fair value is due to credit losses, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an allowance through net investment gains (losses). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the allowance related to other-than-credit factors is recorded in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Mortgage Loans Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and any deferred fees or expenses, and net of an allowance for credit losses. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. The allowance for credit losses for mortgage loans represents the Company’s best estimate of expected credit losses over the remaining life of the loans and is determined using relevant available information from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Policy Loans Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy. Limited Partnerships and LLCs The Company uses the equity method of accounting for investments when it has more than a minor ownership interest or more than a minor influence over the investee’s operations; when the Company has virtually no influence over the investee’s operations the investment is carried at estimated fair value. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on investments carried at estimated fair value are recognized as earned or received. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Other Invested Assets Other invested assets consist principally of freestanding derivatives with positive estimated fair values which are described in “—Derivatives” below. Securities Lending Program Securities lending transactions whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Derivatives Freestanding Derivatives Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses). The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows. Hedge Accounting The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses). Embedded Derivatives The Company has certain insurance and reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. These host contracts include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; index-linked annuities that are directly written or assumed through reinsurance; and ceded reinsurance of variable annuity GMIBs. Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the consolidate |
Segment Information
Segment Information | 12 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Segment Information | 2. Segment Information The Company is organized into three segments: Annuities; Life; and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Annuities The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security. Life The Life segment consists of insurance products and services, including term, universal, whole and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis. Run-off The Run-off segment consists of products that are no longer actively sold and are separately managed, including structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and ULSG. Corporate & Other Corporate & Other contains the excess capital not allocated to the segments and interest expense related to the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes long-term care and workers’ compensation business reinsured through 100% quota share reinsurance agreements and term life insurance sold direct to consumers, which is no longer being offered for new sales. Financial Measures and Segment Accounting Policies Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by the investor community. Adjusted earnings should not be viewed as a substitute for net income (loss) available to BHF’s common shareholders and excludes net income (loss) attributable to noncontrolling interests and preferred stock dividends. Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends. The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings: • Net investment gains (losses); • Net derivative gains (losses) except earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and • Certain variable annuity GMIB fees (“GMIB Fees”). The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings: • Amounts associated with benefits related to GMIBs (“GMIB Costs”); • Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and • Amortization of DAC and VOBA related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments. The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below. Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital (“RBC”). Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets. Operating results by segment, as well as Corporate & Other, were as follows: Year Ended December 31, 2020 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,433 $ 182 $ (1,655) $ (332) $ (372) Provision for income tax expense (benefit) 266 34 (356) (87) (143) Post-tax adjusted earnings 1,167 148 (1,299) (245) (229) Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — 44 44 Adjusted earnings $ 1,167 $ 148 $ (1,299) $ (294) (278) Adjustments for: Net investment gains (losses) 278 Net derivative gains (losses) (18) Other adjustments to net income (loss) (1,307) Provision for income tax (expense) benefit 220 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (1,105) Interest revenue $ 1,820 $ 460 $ 1,269 $ 70 Interest expense $ — $ — $ — $ 184 Year Ended December 31, 2019 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,263 $ 288 $ (580) $ (301) $ 670 Provision for income tax expense (benefit) 235 57 (126) (121) 45 Post-tax adjusted earnings 1,028 231 (454) (180) 625 Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — 21 21 Adjusted earnings $ 1,028 $ 231 $ (454) $ (206) 599 Adjustments for: Net investment gains (losses) 112 Net derivative gains (losses) (1,988) Other adjustments to net income (loss) 154 Provision for income tax (expense) benefit 362 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (761) Interest revenue $ 1,809 $ 436 $ 1,265 $ 75 Interest expense $ — $ — $ — $ 191 Year Ended December 31, 2018 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,233 $ 285 $ (57) $ (431) $ 1,030 Provision for income tax expense (benefit) 210 57 (14) (120) 133 Post-tax adjusted earnings 1,023 228 (43) (311) 897 Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — — — Adjusted earnings $ 1,023 $ 228 $ (43) $ (316) 892 Adjustments for: Net investment gains (losses) (207) Net derivative gains (losses) 702 Other adjustments to net income (loss) (536) Provision for income tax (expense) benefit 14 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ 865 Interest revenue $ 1,536 $ 449 $ 1,310 $ 57 Interest expense $ — $ — $ — $ 158 Total revenues by segment, as well as Corporate & Other, were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Annuities $ 4,563 $ 4,648 $ 4,567 Life 1,334 1,328 1,389 Run-off 1,938 2,009 2,112 Corporate & Other 156 176 152 Adjustments 512 (1,607) 745 Total $ 8,503 $ 6,554 $ 8,965 Total assets by segment, as well as Corporate & Other, were as follows at: December 31, 2020 2019 (In millions) Annuities $ 172,233 $ 156,965 Life 23,809 21,876 Run-off 38,366 35,112 Corporate & Other 13,461 13,306 Total $ 247,869 $ 227,259 Total premiums, universal life and investment-type product policy fees and other revenues by major product group were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Annuity products $ 3,010 $ 3,106 $ 3,304 Life insurance products 1,619 1,709 1,827 Other products 13 36 1 Total $ 4,642 $ 4,851 $ 5,132 Substantially all of the Company’s premiums, universal life and investment-type product policy fees and other revenues originated in the U.S. Revenues derived from any individual customer did not exceed 10% of premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2020, 2019 and 2018. |
Insurance
Insurance | 12 Months Ended |
Dec. 31, 2020 | |
Insurance [Abstract] | |
Insurance | 3. Insurance Insurance Liabilities Insurance liabilities are comprised of future policy benefits, policyholder account balances and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at: December 31, 2020 2019 (In millions) Annuities $ 54,236 $ 43,843 Life 9,327 8,960 Run-off 31,196 28,064 Corporate & Other 7,608 7,701 Total $ 102,367 $ 88,568 Assumptions for Future Policyholder Benefits and Policyholder Account Balances For term and non-participating whole life insurance, assumptions for mortality and persistency are based upon the Company’s experience. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 9%. The liability for single premium immediate annuities is based on the present value of expected future payments using the Company’s experience for mortality assumptions, with interest rate assumptions used in establishing such liabilities ranging from 0% to 8%. Participating whole life insurance uses an interest assumption based upon non-forfeiture interest rate, ranging from 4% to 5%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts, and also includes a liability for terminal dividends. Participating whole life insurance represented 3% of the Company’s life insurance in-force at both December 31, 2020 and 2019, and 40%, 38% and 38% of gross traditional life insurance premiums for the years ended December 31, 2020, 2019 and 2018, respectively. The liability for future policyholder benefits for long-term care insurance (included in Corporate & Other) includes assumptions for morbidity, withdrawals and interest. Interest rate assumptions used for establishing long-term care claim liabilities range from 3% to 6%. Claim reserves for long-term care insurance include best estimate assumptions for claim terminations, expenses and interest. Policyholder account balances liabilities for fixed deferred annuities and universal life insurance have interest credited rates ranging from 1% to 7%. Guarantees The Company issues variable annuity contracts with guaranteed minimum benefits. GMDBs, the life contingent portion of GMWBs and certain portions of GMIBs are accounted for as insurance liabilities in future policyholder benefits, while other guarantees are accounted for in whole or in part as embedded derivatives in policyholder account balances and are further discussed in Note 7. The most significant assumptions for variable annuity guarantees included in future policyholder benefits are projected general account and separate account investment returns, and policyholder behavior including mortality, benefit election and utilization, and withdrawals. The Company also has secondary guarantees on universal life insurance accounted for as insurance liabilities. The most significant assumptions used in estimating the secondary guarantee liabilities are general account rates of return, premium persistency, mortality and lapses, which are reviewed and updated at least annually. See Note 1 for more information on guarantees accounted for as insurance liabilities. Information regarding the liabilities for guarantees (excluding policyholder account balances and embedded derivatives) relating to variable annuity contracts and universal and variable life insurance contracts was as follows: Variable Annuity Contracts Universal and Variable Life Contracts GMDBs GMIBs Secondary Guarantees Total (In millions) Direct Balance at January 1, 2018 $ 1,439 $ 2,709 $ 4,232 $ 8,380 Incurred guaranteed benefits 186 365 484 1,035 Paid guaranteed benefits (58) — — (58) Balance at December 31, 2018 1,567 3,074 4,716 9,357 Incurred guaranteed benefits 143 163 874 1,180 Paid guaranteed benefits (90) — — (90) Balance at December 31, 2019 1,620 3,237 5,590 10,447 Incurred guaranteed benefits 129 1,133 1,244 2,506 Paid guaranteed benefits (103) — (169) (272) Balance at December 31, 2020 $ 1,646 $ 4,370 $ 6,665 $ 12,681 Net Ceded/(Assumed) Balance at January 1, 2018 $ 18 $ — $ 945 $ 963 Incurred guaranteed benefits 49 — 18 67 Paid guaranteed benefits (56) — — (56) Balance at December 31, 2018 11 — 963 974 Incurred guaranteed benefits 86 — 120 206 Paid guaranteed benefits (88) — — (88) Balance at December 31, 2019 9 — 1,083 1,092 Incurred guaranteed benefits 96 — 102 198 Paid guaranteed benefits (101) — (39) (140) Balance at December 31, 2020 $ 4 $ — $ 1,146 $ 1,150 Net Balance at January 1, 2018 $ 1,421 $ 2,709 $ 3,287 $ 7,417 Incurred guaranteed benefits 137 365 466 968 Paid guaranteed benefits (2) — — (2) Balance at December 31, 2018 1,556 3,074 3,753 8,383 Incurred guaranteed benefits 57 163 754 974 Paid guaranteed benefits (2) — — (2) Balance at December 31, 2019 1,611 3,237 4,507 9,355 Incurred guaranteed benefits 33 1,133 1,142 2,308 Paid guaranteed benefits (2) — (130) (132) Balance at December 31, 2020 $ 1,642 $ 4,370 $ 5,519 $ 11,531 Information regarding the Company’s guarantee exposure was as follows at: December 31, 2020 2019 In the At In the At (Dollars in millions) Annuity Contracts (1), (2) Variable Annuity Guarantees Total account value (3) $ 108,424 $ 60,674 $ 104,271 $ 59,859 Separate account value $ 103,315 $ 59,419 $ 99,385 $ 58,694 Net amount at risk $ 6,438 (4) $ 6,692 (5) $ 6,671 (4) $ 4,750 (5) Average attained age of contract holders 70 years 70 years 68 years 68 years December 31, 2020 2019 Secondary Guarantees (Dollars in millions) Universal Life Contracts Total account value (3) $ 5,772 $ 5,957 Net amount at risk (6) $ 69,083 $ 71,124 Average attained age of policyholders 67 years 66 years Variable Life Contracts Total account value (3) $ 3,926 $ 3,526 Net amount at risk (6) $ 19,909 $ 21,325 Average attained age of policyholders 51 years 50 years _______________ (1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. (2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk presented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 for a discussion of guaranteed minimum benefits which have been reinsured. (3) Includes the contract holder’s investments in the general account and separate account, if applicable. (4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death. (5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved. (6) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date. Account balances of contracts with guarantees were invested in separate account asset classes as follows at: December 31, 2020 2019 (In millions) Fund Groupings: Balanced $ 64,736 $ 64,134 Equity 32,811 29,036 Bond 9,105 8,467 Money Market 16 16 Total $ 106,668 $ 101,653 Obligations Under Funding Agreements Brighthouse Life Insurance Company has issued fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. The Company had obligations outstanding under the funding agreements of $144 million and $134 million at December 31, 2020 and 2019, respectively, which are reported in policyholder account balances. Brighthouse Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Atlanta and holds common stock in certain regional banks in the FHLB system. Holdings of FHLB common stock carried at cost were $39 million at both December 31, 2020 and 2019. Brighthouse Life Insurance Company has an active funding agreement program with FHLB of Atlanta, along with inactive funding agreement programs with certain regional banks in the FHLB system. The Company had obligations outstanding under these funding agreements of $595 million at both December 31, 2020 and 2019, which are reported in policyholder account balances. Funding agreements are issued to FHLBs in exchange for cash, for which the FHLBs have been granted liens on certain assets, some of which are in their custody, including RMBS, to collateralize the Company’s obligations under the funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of the FHLBs as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, the FHLBs’ recovery on the collateral is limited to the amount of the Company’s liabilities to the FHLBs. |
Deferred Policy Acquisition Cos
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles | 12 Months Ended |
Dec. 31, 2020 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |
Intangible Assets Disclosure [Text Block] | 4. Deferred Policy Acquisition Costs, Value of Business Acquired and Deferred Sales Inducements See Note 1 for a description of capitalized acquisition costs. Information regarding DAC and VOBA was as follows: Years Ended December 31, 2020 2019 2018 (In millions) DAC: Balance at January 1, $ 4,946 $ 5,149 $ 5,678 Capitalizations 408 369 322 Amortization related to net investment gains (losses) and net derivative gains (losses) 95 204 (384) All other amortization (833) (577) (560) Total amortization (738) (373) (944) Unrealized investment gains (losses) (209) (199) 93 Balance at December 31, 4,407 4,946 5,149 VOBA: Balance at January 1, 502 568 608 Amortization related to net investment gains (losses) and net derivative gains (losses) — (1) (1) All other amortization (28) (8) (105) Total amortization (28) (9) (106) Unrealized investment gains (losses) 30 (57) 66 Balance at December 31, 504 502 568 Total DAC and VOBA: Balance at December 31, $ 4,911 $ 5,448 $ 5,717 Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at: December 31, 2020 2019 (In millions) Annuities $ 3,829 $ 4,327 Life 971 1,019 Run-off 5 5 Corporate & Other 106 97 Total $ 4,911 $ 5,448 The estimated future VOBA amortization expense to be reported in other expenses for the next five years is $70 million in 2021, $61 million in 2022, $52 million in 2023, $45 million in 2024 and $39 million in 2025. Information regarding DSI was as follows: Years Ended December 31, 2020 2019 2018 (In millions) DSI: Balance at January 1, $ 379 $ 410 $ 431 Capitalization 2 2 2 Amortization (71) (38) (41) Unrealized investment gains (losses) — 5 18 Balance at December 31, $ 310 $ 379 $ 410 |
Reinsurance
Reinsurance | 12 Months Ended |
Dec. 31, 2020 | |
Reinsurance Disclosures [Abstract] | |
Reinsurance | 5. Reinsurance The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by former affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 6. Annuities and Life For annuities, the Company reinsures portions of the living and death benefit guarantees issued in connection with certain variable annuities to unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The value of embedded derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The Company cedes certain fixed rate annuities to unaffiliated third-party reinsurers and assumes certain index-linked annuities from an unaffiliated third-party insurer. These reinsurance arrangements are structured on a coinsurance basis and are reported as deposit accounting. For its life products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. On a case-by-case basis, the Company may retain up to $20 million per life and reinsure 100% of amounts in excess of the amount the Company retains. The Company also reinsures 90% of the risk associated with participating whole life policies to a former affiliate and assumes certain term life policies and universal life policies with secondary death benefit guarantees issued by a former affiliate. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time. Corporate & Other The Company reinsures, through 100% quota share reinsurance agreements certain run-off long-term care and workers’ compensation business written by the Company. At December 31, 2020, the Company had $6.7 billion of reinsurance recoverables associated with its reinsured long-term care business. The reinsurer has established trust accounts for the Company’s benefit to secure their obligations under the reinsurance agreements. Additionally, the Company is indemnified for losses and certain other payment obligations it might incur with respect to such reinsured long-term care insurance business. Catastrophe Coverage Reinsurance Recoverables The Company reinsures its business through a diversified group of highly rated reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers and monitors ratings and the financial strength of its reinsurers. In addition, the reinsurance recoverable balance due from each reinsurer and the recoverability of such balance is evaluated as part of this overall monitoring process. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at both December 31, 2020 and 2019, were not significant. The Company had $5.9 billion and $5.7 billion of unsecured reinsurance recoverable balances with third-party reinsurers at December 31, 2020 and 2019, respectively. The Company records an allowance for credit losses which is a valuation account that reduces reinsurance recoverable balances to present the net amount expected to be collected from reinsurers. When assessing the creditworthiness of the Company’s reinsurance recoverable balances, beyond the analysis of individual claims disputes, the Company considers the financial strength of its reinsurers using public ratings and ratings reports, current existing credit enhancements to reinsurance agreements and the statutory and GAAP financial statements of the reinsurers. Impairments are then determined based on probable and estimable defaults. At December 31, 2020, the Company had an allowance for credit losses of $10 million on its reinsurance recoverable balances. At December 31, 2020, the Company had $15.1 billion of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $12.9 billion, or 85%, were with the Company’s five largest ceded reinsurers, including $4.0 billion of net ceded reinsurance recoverables which were unsecured. At December 31, 2019, the Company had $13.8 billion of net ceded reinsurance recoverables with third-party reinsurers. Of this total, $11.9 billion, or 86%, were with the Company’s five largest ceded reinsurers, including $4.2 billion of net ceded reinsurance recoverables which were unsecured. The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Premiums Direct premiums $ 1,509 $ 1,651 $ 1,699 Reinsurance assumed 10 10 11 Reinsurance ceded (753) (779) (810) Net premiums $ 766 $ 882 $ 900 Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees $ 4,022 $ 4,048 $ 4,296 Reinsurance assumed 48 72 95 Reinsurance ceded (607) (540) (556) Net universal life and investment-type product policy fees $ 3,463 $ 3,580 $ 3,835 Other revenues Direct other revenues $ 351 $ 366 $ 373 Reinsurance assumed 16 1 — Reinsurance ceded 46 22 24 Net other revenues $ 413 $ 389 $ 397 Policyholder benefits and claims Direct policyholder benefits and claims $ 7,545 $ 5,441 $ 4,891 Reinsurance assumed 103 36 32 Reinsurance ceded (1,937) (1,807) (1,651) Net policyholder benefits and claims $ 5,711 $ 3,670 $ 3,272 The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: December 31, 2020 2019 Direct Assumed Ceded Total Direct Assumed Ceded Total (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 728 $ 6 $ 15,424 $ 16,158 $ 631 $ 14 $ 14,115 $ 14,760 Liabilities Future policy benefits $ 44,329 $ 119 $ — $ 44,448 $ 39,581 $ 105 $ — $ 39,686 Policyholder account balances $ 51,451 $ 3,057 $ — $ 54,508 $ 43,154 $ 2,617 $ — $ 45,771 Other policy-related balances $ 1,723 $ 1,688 $ — $ 3,411 $ 1,447 $ 1,664 $ — $ 3,111 Other liabilities $ 3,832 $ 31 $ 1,148 $ 5,011 $ 4,106 $ 32 $ 1,098 $ 5,236 Related Party Reinsurance Transactions The Company has reinsurance agreements with certain MetLife, Inc. subsidiaries, including Metropolitan Life Insurance Company (“MLIC”), Metropolitan Tower Life Insurance Company and MetLife Reinsurance Company of Vermont, all of which were related parties until the completion of the MetLife Divestiture (see Note 1). Information regarding the significant effects of reinsurance with former MetLife affiliates included on the consolidated statements of operations was as follows: Year Ended (In millions) Premiums Reinsurance assumed $ 6 Reinsurance ceded (201) Net premiums $ (195) Universal life and investment-type product policy fees Reinsurance assumed $ 45 Reinsurance ceded 1 Net universal life and investment-type product policy fees $ 46 Other revenues Reinsurance assumed $ — Reinsurance ceded 18 Net other revenues $ 18 Policyholder benefits and claims Reinsurance assumed $ 9 Reinsurance ceded (178) Net policyholder benefits and claims $ (169) The Company cedes risks to MLIC related to guaranteed minimum benefits written directly by the Company. The ceded reinsurance agreement contains embedded derivatives and changes in the estimated fair value are also included within net derivative gains (losses). Net derivative gains (losses) associated with the embedded derivatives were less than ($1) million for the year ended December 31, 2018. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | 6. Investments See Note 8 for information about the fair value hierarchy for investments and the related valuation methodologies. In connection with the adoption of new guidance related to the credit losses (see Note 1), effective January 1, 2020, the Company updated its accounting policies on certain investments. Any accounting policy updates required by the new guidance are described in this footnote. Fixed Maturity Securities Available-for-sale Fixed Maturity Securities by Sector Fixed maturity securities by sector were as follows at: December 31, 2020 December 31, 2019 Amortized Allowance for Credit Losses Gross Unrealized Estimated Allowance for Credit Losses Gross Unrealized Estimated Gains Losses Gains Losses (In millions) U.S. corporate $ 32,608 $ 2 $ 5,370 $ 70 $ 37,906 $ 28,375 $ — $ 2,852 $ 67 $ 31,160 Foreign corporate 10,060 — 1,501 50 11,511 9,177 — 741 74 9,844 U.S. government and agency 6,007 — 2,637 6 8,638 5,529 — 1,869 2 7,396 RMBS 7,653 — 644 3 8,294 8,692 — 438 12 9,118 CMBS 6,207 — 592 9 6,790 5,500 — 264 9 5,755 State and political subdivision 3,673 — 967 — 4,640 3,358 — 701 2 4,057 ABS 2,834 — 60 10 2,884 1,945 — 21 11 1,955 Foreign government 1,487 — 346 1 1,832 1,503 — 250 2 1,751 Total fixed maturity securities $ 70,529 $ 2 $ 12,117 $ 149 $ 82,495 $ 64,079 $ — $ 7,136 $ 179 $ 71,036 The Company held non-income producing fixed maturity securities with an estimated fair value of $5 million at December 31, 2020. The Company did not hold any non-income producing fixed maturity securities at December 31, 2019. Maturities of Fixed Maturity Securities The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2020: Due in One Year or Less Due After One Year Through Five Years Due After Five Years Through Ten Years Due After Ten Years Structured Securities Total Fixed Maturity Securities (In millions) Amortized cost $ 1,504 $ 7,304 $ 14,562 $ 30,465 $ 16,694 $ 70,529 Estimated fair value $ 1,521 $ 7,851 $ 16,339 $ 38,816 $ 17,968 $ 82,495 Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity. Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector The estimated fair value and gross unrealized losses of fixed maturity securities in an unrealized loss position, by sector and by length of time that the securities have been in a continuous unrealized loss position, were as follows at: December 31, 2020 December 31, 2019 Less than 12 Months 12 Months or Greater Less than 12 Months 12 Months or Greater Estimated Gross Estimated Gross Estimated Gross Estimated Gross (Dollars in millions) U.S. corporate $ 1,737 $ 57 $ 185 $ 13 $ 2,017 $ 44 $ 326 $ 23 Foreign corporate 254 8 387 42 576 12 561 62 U.S. government and agency 236 6 — — 40 2 — — RMBS 180 2 22 1 857 8 386 4 CMBS 332 7 44 2 559 7 171 2 State and political subdivision 48 — — — 143 2 8 — ABS 506 3 629 7 362 2 676 9 Foreign government 54 1 — — 65 2 — — Total fixed maturity securities $ 3,347 $ 84 $ 1,267 $ 65 $ 4,619 $ 79 $ 2,128 $ 100 Total number of securities in an unrealized loss position 667 244 720 302 Allowance for Credit Losses for Fixed Maturity Securities Evaluation and Measurement Methodologies For fixed maturity securities in an unrealized loss position, management first assesses whether the Company intends to sell, or whether it is more likely than not it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to estimated fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the allowance for credit loss evaluation process include, but are not limited to: (i) the extent to which estimated fair value is less than amortized cost; (ii) any changes to the rating of the security by a rating agency; (iii) adverse conditions specifically related to the security, industry or geographic area; and (iv) payment structure of the fixed maturity security and the likelihood of the issuer being able to make payments in the future or the issuer’s failure to make scheduled interest and principal payments. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss is deemed to exist and an allowance for credit losses is recorded, limited by the amount that the estimated fair value is less than the amortized cost basis, with a corresponding charge to net investment gains (losses). Any unrealized losses that have not been recorded through an allowance for credit losses are recognized in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Accrued interest receivables are presented separate from the amortized cost basis of fixed maturity securities. An allowance for credit losses is not estimated on an accrued interest receivable, rather receivable balances 90-days past due are deemed uncollectible and are written off with a corresponding reduction to net investment income. The accrued interest receivable on fixed maturity securities totaled $514 million at December 31, 2020 and is included in accrued investment income. Fixed maturity securities are also evaluated to determine if they qualify as purchased financial assets with credit deterioration (“PCD”). To determine if the credit deterioration experienced since origination is more than insignificant, both (i) the extent of the credit deterioration and (ii) any rating agency downgrades are evaluated. For securities categorized as PCD assets, the present value of cash flows expected to be collected from the security are compared to the par value of the security. If the present value of cash flows expected to be collected is less than the par value, credit losses are embedded in the purchase price of the PCD asset. In this situation, both an allowance for credit losses and amortized cost gross-up is recorded, limited by the amount that the estimated fair value is less than the grossed-up amortized cost basis. Any difference between the purchase price and the present value of cash flows is amortized or accreted into net investment income over the life of the PCD asset. Any subsequent PCD asset allowance for credit losses is evaluated in a manner similar to the process described above for fixed maturity securities. Current Period Evaluation Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector The changes in the allowance for credit losses by sector were as follows: U.S. Corporate Foreign Corporate Total (In millions) Balance at January 1, 2020 $ 3 $ 1 $ 4 Allowance on securities where credit losses were not previously recorded 3 1 4 Reductions for securities sold (1) — (1) Change in allowance on securities with an allowance recorded in a previous period — (1) (1) Write-offs charged against allowance (1) (3) (1) (4) Balance at December 31, 2020 $ 2 $ — $ 2 _______________ (1) The Company recorded total write-offs of $13 million for the year ended December 31, 2020. Mortgage Loans Mortgage Loans by Portfolio Segment Mortgage loans are summarized as follows at: December 31, 2020 2019 Carrying % of Carrying % of (Dollars in millions) Commercial $ 9,714 61.4 % $ 9,721 61.7 % Agricultural 3,538 22.4 3,388 21.5 Residential 2,650 16.8 2,708 17.2 Total mortgage loans (1) 15,902 100.6 15,817 100.4 Allowance for credit losses (94) (0.6) (64) (0.4) Total mortgage loans, net $ 15,808 100.0 % $ 15,753 100.0 % _______________ (1) Purchases of mortgage loans from third parties were $815 million and $962 million for the years ended December 31, 2020 and 2019, respectively, and were primarily comprised of residential mortgage loans. Allowance for Credit Losses for Mortgage Loans Evaluation and Measurement Methodologies The allowance for credit losses is a valuation account that is deducted from the mortgage loan’s amortized cost basis to present the net amount expected to be collected on the mortgage loan. The loan balance, or a portion of the loan balance, is written-off against the allowance when management believes this amount is uncollectible. Accrued interest receivables are presented separate from the amortized cost basis of mortgage loans. An allowance for credit losses is generally not estimated on an accrued interest receivable, rather when a loan is placed in nonaccrual status the associated accrued interest receivable balance is written off with a corresponding reduction to net investment income. For mortgage loans that are granted payment deferrals due to the worldwide pandemic sparked by the novel coronavirus (“COVID-19 pandemic”), interest continues to be accrued during the deferral period if the loan was less than 30 days past due at December 31, 2019 and performing at the onset of the pandemic. Accrued interest on COVID-19 pandemic impacted loans was not significant at December 31, 2020. The accrued interest receivable on mortgage loans is included in accrued investment income and totaled $89 million at December 31, 2020. The allowance for credit losses is estimated using relevant available information, from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Historical credit loss experience provides the basis for estimating expected credit losses. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics and environmental conditions. A reasonable and supportable forecast period of two-years is used with an input reversion period of one-year. Mortgage loans are evaluated in each of the three portfolio segments to determine the allowance for credit losses. The loan-level loss rates are determined using individual loan terms and characteristics, risk pools/internal ratings, national economic forecasts, prepayment speeds, and estimated default and loss severity. The resulting loss rates are applied to the mortgage loan’s amortized cost to generate an allowance for credit losses. In certain situations, the allowance for credit losses is measured as the difference between the loan’s amortized cost and liquidation value of the collateral. These situations include collateral dependent loans, expected troubled debt restructurings (“TDR”), foreclosure probable loans, and loans with dissimilar risk characteristics. Mortgage loans are also evaluated to determine if they qualify as PCD assets. To determine if the credit deterioration experienced since origination is more than insignificant, the extent of credit deterioration is evaluated. All re-performing/modified loan (“RPL”) pools purchased after December 31, 2019 are determined to have been acquired with evidence of more than insignificant credit deterioration since origination and are classified as PCD assets. RPLs are pools of residential mortgage loans acquired at a discount or premium which have both credit and non-credit components. For PCD mortgage loans, the allowance for credit losses is determined using a similar methodology described above, except the loss-rate is determined at the pool level instead of the individual loan level. The initial allowance for credit losses, determined on a collective basis, is then allocated to the individual loans. The initial amortized cost of the loan is grossed-up to reflect the sum of the loan’s purchase price and allowance for credit losses. The difference between the grossed-up amortized cost basis and the par value of the loan is a noncredit discount or premium, which is accreted or amortized into net investment income over the remaining life of the loan. Any subsequent PCD mortgage loan allowance for credit losses is evaluated in a manner similar to the process described above for each of the three portfolio segments. Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment The changes in the allowance for credit losses by portfolio segment were as follows: Commercial Agricultural Residential Total (In millions) Balance at December 31, 2019 $ 47 $ 10 $ 7 $ 64 Cumulative effect of change in accounting principle (20) 7 15 2 Balance at January 1, 2020 27 17 22 66 Current period provision 17 (2) 13 28 Balance at December 31, 2020 $ 44 $ 15 $ 35 $ 94 PCD Mortgage Loans Purchases of PCD mortgage loans are summarized as follows: Year Ended December 31, 2020 (In millions) Purchase price $ 159 Allowance at acquisition date 3 Discount or premium attributable to other factors (2) Par value $ 160 Credit Quality of Mortgage Loans by Portfolio Segment The amortized cost of mortgage loans by year of origination and credit quality indicator was as follows at: 2020 2019 2018 2017 2016 Prior Total (In millions) December 31, 2020 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 317 $ 1,527 $ 1,004 $ 515 $ 1,109 $ 2,808 $ 7,280 65% to 75% 200 450 482 322 59 521 2,034 76% to 80% — — — 44 79 8 131 Greater than 80% — — 29 — 6 234 269 Total commercial mortgage loans 517 1,977 1,515 881 1,253 3,571 9,714 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 569 526 749 391 417 663 3,315 65% to 75% 81 81 10 33 — 18 223 Total agricultural mortgage loans 650 607 759 424 417 681 3,538 Residential mortgage loans Performing 214 381 413 131 70 1,375 2,584 Nonperforming 2 6 4 — 1 53 66 Total residential mortgage loans 216 387 417 131 71 1,428 2,650 Total $ 1,383 $ 2,971 $ 2,691 $ 1,436 $ 1,741 $ 5,680 $ 15,902 The loan-to-value ratio is a measure commonly used to assess the quality of commercial and agricultural mortgage loans. The loan-to-value ratio compares the amount of the loan to the estimated fair value of the underlying property collateralizing the loan and is commonly expressed as a percentage. A loan-to-value ratio less than 100% indicates an excess of collateral value over the loan amount. Loan-to-value ratios greater than 100% indicate that the loan amount exceeds the collateral value. Performing status is a measure commonly used to assess the quality of residential mortgage loans. A loan is considered performing when the borrower makes consistent and timely payments. The amortized cost of commercial mortgage loans by debt-service coverage ratio was as follows at: December 31, 2020 2019 Amortized Cost % of Amortized Cost % of (Dollars in millions) Debt-service coverage ratios: Greater than 1.20x $ 9,450 97.3 % $ 9,257 95.2 % 1.00x - 1.20x 204 2.1 298 3.1 Less than 1.00x 60 0.6 166 1.7 Total $ 9,714 100.0 % $ 9,721 100.0 % The debt-service coverage ratio compares a property’s net operating income to its debt-service payments. Debt-service coverage ratios less than 1.00 times indicate that property operations do not generate enough income to cover the loan’s current debt payments. A debt-service coverage ratio greater than 1.00 times indicates an excess of net operating income over the debt-service payments. Past Due Mortgage Loans by Portfolio Segment The Company has a high-quality, well-performing mortgage loan portfolio, with over 99% of all mortgage loans classified as performing at both December 31, 2020 and 2019. Delinquency is defined consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. To the extent a payment deferral is agreed to with a borrower, in response to the COVID-19 pandemic, the past due status of the impacted loans during the forbearance period is locked-in as of March 1, 2020, which reflects the date on which the COVID-19 pandemic began to affect the borrower’s ability to make payments. At December 31, 2020, $38 million of the COVID-19 pandemic modified loans were classified as delinquent. The aging of the amortized cost of past due mortgage loans by portfolio segment was as follows at: December 31, 2020 Commercial Agricultural Residential Total (In millions) Current $ 9,714 $ 3,538 $ 2,575 $ 15,827 30-59 days past due — — 9 9 60-89 days past due — — 24 24 90-179 days past due — — 27 27 180+ days past due — — 15 15 Total $ 9,714 $ 3,538 $ 2,650 $ 15,902 Mortgage Loans in Nonaccrual Status by Portfolio Segment Mortgage loans are placed in a nonaccrual status if there are concerns regarding collectability of future payments or the loan is past due, unless the past due loan is well collateralized and in the process of foreclosure. To the extent a payment deferral is agreed to with a borrower, in response to the COVID-19 pandemic, the impacted loans generally will not be reported as in a nonaccrual status during the period of deferral. A COVID-19 pandemic modified loan is only reported as a nonaccrual asset in the event a borrower declares bankruptcy, the borrower experiences significant credit deterioration such that the Company does not expect to collect all principal and interest due, or the loan was 90 days past due at the onset of the pandemic. At December 31, 2020, $38 million of the COVID-19 pandemic modified loans were in nonaccrual status. The amortized cost of mortgage loans in a nonaccrual status by portfolio segment were as follows at: Commercial Agricultural Residential Total (In millions) December 31, 2019 $ — $ 21 $ 37 $ 58 December 31, 2020 (1) $ — $ — $ 66 $ 66 _______________ (1) The Company had $7 million of residential mortgage loans in nonaccrual status for which there was no related allowance for credit losses for the year ended December 31, 2020. Modified Mortgage Loans by Portfolio Segment Under certain circumstances, modifications are granted to nonperforming mortgage loans. Each modification is evaluated to determine if a TDR has occurred. A modification is a TDR when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include reducing the amount of debt owed, reducing the contractual interest rate, extending the maturity date at an interest rate lower than current market interest rates and/or reducing accrued interest. The Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring during the year ended December 31, 2020. Short-term modifications made on a good faith basis to borrowers who were not more than 30 days past due at December 31, 2019 and in response to the COVID-19 pandemic are not considered TDRs. Other Invested Assets Over 95% of other invested assets is comprised of freestanding derivatives with positive estimated fair values. See Note 7 for information about freestanding derivatives with positive estimated fair values. Other invested assets also includes tax credit and renewable energy partnerships, leveraged leases and FHLB stock. Leveraged Leases The carrying value of leveraged leases at December 31, 2020 and 2019 was $50 million and $64 million, respectively, net of allowance for credit losses of $13 million and $0, respectively. Rental receivables are generally due in periodic installments. The payment periods for leveraged leases generally range from one to 12 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. Nonperforming rental receivables are generally defined as those that are 90 days or more past due. At both December 31, 2020 and 2019, all leveraged leases were performing. Net Unrealized Investment Gains (Losses) Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, VOBA, DSI and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI. The components of net unrealized investment gains (losses), included in AOCI, were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Fixed maturity securities $ 11,968 $ 6,957 $ 1,691 Derivatives 173 245 264 Other (16) (13) (13) Subtotal 12,125 7,189 1,942 Amounts allocated from: Future policy benefits (4,313) (2,692) (886) DAC, VOBA and DSI (520) (341) (90) Subtotal (4,833) (3,033) (976) Deferred income tax benefit (expense) (1,531) (873) (203) Net unrealized investment gains (losses) $ 5,761 $ 3,283 $ 763 The changes in net unrealized investment gains (losses) were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Balance at December 31, $ 3,283 $ 763 $ 1,726 Unrealized investment gains (losses) change due to cumulative effect, net of income tax — — (79) Balance at January 1, 3,283 763 1,647 Unrealized investment gains (losses) during the year 4,936 5,247 (3,057) Unrealized investment gains (losses) relating to: Future policy benefits (1,621) (1,806) 1,740 DAC, VOBA and DSI (179) (251) 177 Deferred income tax benefit (expense) (658) (670) 256 Balance at December 31, $ 5,761 $ 3,283 $ 763 Change in net unrealized investment gains (losses) $ 2,478 $ 2,520 $ (884) Concentrations of Credit Risk There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both December 31, 2020 and 2019. Securities Lending Elements of the securities lending program are presented below at: December 31, 2020 2019 (In millions) Securities on loan: (1) Amortized cost $ 2,373 $ 2,031 Estimated fair value $ 3,603 $ 2,996 Cash collateral received from counterparties (2) $ 3,674 $ 3,074 Reinvestment portfolio — estimated fair value $ 3,830 $ 3,174 _______________ (1) Included within fixed maturity securities. (2) Included within payables for collateral under securities loaned and other transactions. The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at: December 31, 2020 December 31, 2019 Open (1) 1 Month or Less 1 to 6 Months Total Open (1) 1 Month or Less 1 to 6 Months Total (In millions) U.S. government and agency $ 937 $ 2,300 $ 437 $ 3,674 $ 1,279 $ 1,094 $ 701 $ 3,074 _______________ (1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral. If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized in normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at December 31, 2020 was $920 million, primarily comprised of U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement. The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including agency RMBS, ABS, U.S. and foreign corporate securities, non-agency RMBS and U.S. government and agency securities) with 63% invested in agency RMBS, cash and cash equivalents and U.S. government and agency securities at December 31, 2020. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company. Invested Assets on Deposit, Held in Trust and Pledged as Collateral Invested assets on deposit, held in trust and pledged as collateral at estimated fair value were as follows at: December 31, 2020 2019 (In millions) Invested assets on deposit (regulatory deposits) (1) $ 10,135 $ 9,349 Invested assets held in trust (reinsurance agreements) (2) 5,717 4,561 Invested assets pledged as collateral (3) 5,595 3,641 Total invested assets on deposit, held in trust and pledged as collateral $ 21,447 $ 17,551 _______________ (1) The Company has assets, primarily fixed maturity securities, on deposit with governmental authorities relating to certain policyholder liabilities, of which $60 million and $69 million of the assets on deposit represents restricted cash and cash equivalents at December 31, 2020 and 2019, respectively. (2) The Company has assets, primarily fixed maturity securities, held in trust relating to certain reinsurance transactions, of which $101 million and $124 million of the assets held in trust balance represents restricted cash and cash equivalents at December 31, 2020 and 2019, respectively. (3) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 3) and derivative transactions (see Note 7). See “— Securities Lending” for information regarding securities on loan. Collectively Significant Equity Method Investments The Company holds investments in limited partnerships and LLCs consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $2.8 billion at December 31, 2020. The Company’s maximum exposure to loss related to these equity method investments is the carrying value of these investments plus unfunded commitments of $1.5 billion at December 31, 2020. The Company’s investments in limited partnerships and LLCs are generally of a passive nature in that the Company does not participate in the management of the entities. As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company’s consolidated pre-tax income (loss) for each of the years ended December 31, 2020, 2019 and 2018. This aggregated summarized financial data does not represent the Company’s proportionate share of the assets, liabilities or earnings of such entities. The aggregated summarized financial data presented below reflects the latest available financial information and is as of and for the years ended December 31, 2020, 2019 and 2018. Aggregate total assets of these entities totaled $504.0 billion and $404.0 billion at December 31, 2020 and 2019, respectively. Aggregate total liabilities of these entities totaled $63.0 billion and $52.8 billion at December 31, 2020 and 2019, respectively. Aggregate net income (loss) of these entities totaled $37.7 billion, $33.3 billion and $33.3 billion for the years ended December 31, 2020, 2019 and 2018, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses). Variable Interest Entities The Company has invested in legal entities that are variable interest entities (“VIE”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to (i) direct the activities of the VIE that most significantly impact the economic performance of the VIE and (ii) the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. There were no material VIEs for which the Company has concluded that it is the primary beneficiary at either December 31, 2020 or 2019. The carrying amount and maximum exposure to loss related to the VIEs for which the Company has concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at: December 31, 2020 2019 Carrying Maximum Carrying Maximum (In millions) Fixed maturity securities $ 13,665 $ 12,581 $ 13,094 $ 12,454 Limited partnerships and LLCs 2,319 3,578 1,907 3,080 Total $ 15,984 $ 16,159 $ 15,001 $ 15,534 The Company’s investments in unconsolidated VIEs are described below. Fixed Maturity Securities The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities, issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities Available-for-sale” for information on these securities. Limited Partnerships and LLCs The Company holds investments in certain limited partnerships and LLCs which are VIEs. These ventures include limited partnerships, LLCs, private equity funds, hedge funds, and to a lesser extent tax credit and renewable energy partnerships. The Company is not considered the primary beneficiary, or consolidator, when its involvement takes the form of a limited partner interest and is restricted to a role of a passive investor, as a limited partner’s interest does not provide the Company with any substantive kick-out or participating rights, nor does it provide the Company with the power to direct the activities of the fund. The Company’s maximum exposure to loss on these investments is limited to: (i) the amount invested in debt or equity of the VIE and (ii) commitments to the VIE, as described in Note 15. Net Investment Income The components of net investment income were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Investment income: Fixed maturity securities $ 2,700 $ 2,673 $ 2,565 Equity securities 6 8 7 Mortgage loans 666 680 543 Policy loans 56 67 85 Limited partnerships and LLCs (1) 240 220 258 Cash, cash equivalents and short-term investments 49 93 35 Other 54 41 41 Total investment income 3,771 3,782 3,534 Less: Investment expenses 170 203 196 Net investment income $ 3,601 $ 3,579 $ 3,338 _______________ (1) Includes net investment income pertaining to other limited partnership interests of $225 million, $181 million and $211 million for the years ended December 31, 2020, 2019, and 2018, respectively. See “— Related Party Investment Transactions” for discussion of related party investment expenses. Net Investment Gains (Losses) Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Fixed maturity securities $ 297 $ 106 $ (180) Equity securities — 17 (16) Mortgage loans (27) (10) (13) Limited partnerships and LLCs (3) 7 40 Other 11 (8) (38) Total net investment gains (losses) $ 278 $ 112 $ (207) Sales or Disposals of Fixed Maturity Securities Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales o |
Derivatives
Derivatives | 12 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments and Hedging Activities Disclosure [Text Block] | 7. Derivatives Accounting for Derivatives See Note 1 for a description of the Company’s accounting policies for derivatives and Note 8 for information about the fair value hierarchy for derivatives. Derivative Strategies The Company maintains an overall risk management strategy that incorporates the use of derivative instruments to minimize its exposure to various market risks, including interest rate, foreign currency exchange rate, credit and equity market. Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). Interest Rate Derivatives Interest rate swaps: The Company uses interest rate swaps to manage the collective interest rate risks primarily in variable annuity products and ULSG. Interest rate swaps are used in non-qualifying hedging relationships. Interest rate caps: The Company uses interest rate caps to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities. Interest rate caps are used in non-qualifying hedging relationships. Interest rate swaptions: The Company uses interest rate swaptions to manage the collective interest rate risks primarily in variable annuity products and ULSG. Interest rate swaptions are used in non-qualifying hedging relationships. Interest rate swaptions are included in interest rate options. Interest rate forwards: The Company uses interest rate forwards to manage the collective interest rate risks primarily in variable annuity products and ULSG. Interest rate forwards are used in cash flow and non-qualifying hedging relationships. Foreign Currency Exchange Rate Derivatives Foreign currency swaps: The Company uses foreign currency swaps to convert foreign currency denominated cash flows to U.S. dollars to reduce cash flow fluctuations due to changes in currency exchange rates. Foreign currency swaps are used in cash flow and non-qualifying hedging relationships. Foreign currency forwards: The Company uses foreign currency forwards to hedge currency exposure on its invested assets. Foreign currency forwards are used in non-qualifying hedging relationships. Credit Derivatives Credit default swaps: The Company uses credit default swaps to create synthetic credit investments to replicate credit exposure that is more economically attractive than what is available in the market or otherwise unavailable (written credit protection), or to reduce credit loss exposure on certain assets that the Company owns (purchased credit protection). Credit default swaps are used in non-qualifying hedging relationships. Credit default swaptions: The Company uses credit default swaptions to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. Swaptions are used to create callable bonds from replication synthetic asset transaction (“RSAT”) positions. This enhances the income of the RSAT program through earned premiums while not changing the credit profile of the RSATs. Credit default swaptions are used in non-qualifying hedging relationships. Equity Derivatives Equity index options: The Company uses equity index options primarily to hedge minimum guarantees embedded in certain variable annuity products against adverse changes in equity markets. Additionally, the Company uses equity index options to hedge index-linked annuity products against adverse changes in equity markets. Equity index options are used in non-qualifying hedging relationships. Equity total return swaps: The Company uses equity total return swaps to hedge minimum guarantees embedded in certain variable annuity products against adverse changes equity markets. Equity total return swaps are used in non-qualifying hedging relationships. Equity variance swaps: The Company uses equity variance swaps to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. Equity variance swaps are used in non-qualifying hedging relationships. Primary Risks Managed by Derivatives The primary underlying risk exposure, gross notional amount and estimated fair value of derivatives held were as follows at: December 31, 2020 2019 Primary Underlying Risk Exposure Gross Notional Amount Estimated Fair Value Gross Notional Amount Estimated Fair Value Assets Liabilities Assets Liabilities (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate forwards Interest rate $ 290 $ 66 $ — $ 420 $ 22 $ — Foreign currency swaps Foreign currency exchange rate 2,812 134 112 2,765 190 27 Total qualifying hedges 3,102 200 112 3,185 212 27 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate swaps Interest rate 2,295 463 — 7,559 878 29 Interest rate caps Interest rate 2,350 2 — 3,350 2 — Interest rate options Interest rate 25,980 712 122 29,750 782 187 Interest rate forwards Interest rate 8,086 851 78 5,418 94 114 Foreign currency swaps Foreign currency exchange rate 1,000 86 32 1,051 96 15 Foreign currency forwards Foreign currency exchange rate 201 — — 138 — 1 Credit default swaps — purchased Credit 18 — — 18 — — Credit default swaps — written Credit 1,755 41 — 1,635 36 — Credit default options Credit 100 — — — — — Equity index options Equity market 31,576 1,071 838 51,509 850 1,728 Equity variance swaps Equity market 1,098 13 20 2,136 69 69 Equity total return swaps Equity market 15,056 143 822 7,723 2 367 Total non-designated or non-qualifying derivatives 89,515 3,382 1,912 110,287 2,809 2,510 Embedded derivatives: Ceded guaranteed minimum income benefits Other N/A 283 — N/A 217 — Direct index-linked annuities Other N/A — 3,855 N/A — 2,253 Direct guaranteed minimum benefits Other N/A — 2,920 N/A — 1,656 Assumed index-linked annuities Other N/A — 382 N/A — 339 Total embedded derivatives N/A 283 7,157 N/A 217 4,248 Total $ 92,617 $ 3,865 $ 9,181 $ 113,472 $ 3,238 $ 6,785 The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses) were as follows: Year Ended December 31, 2020 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 2 $ — $ 3 $ — $ 77 Foreign currency exchange rate derivatives 15 (7) 37 — (129) Total cash flow hedges 17 (7) 40 — (52) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 3,565 — — — — Foreign currency exchange rate derivatives (16) (7) — — — Credit derivatives 18 — — — — Equity derivatives (1,367) — — — — Embedded derivatives (2,221) — — — — Total non-qualifying hedges (21) (7) — — — Total $ (4) $ (14) $ 40 $ — $ (52) Year Ended December 31, 2019 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 32 $ — $ 2 $ — $ 25 Foreign currency exchange rate derivatives 25 (29) 34 — 15 Total cash flow hedges 57 (29) 36 — 40 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 1,589 — — — — Foreign currency exchange rate derivatives 22 (3) — — — Credit derivatives 44 — — — — Equity derivatives (2,476) — — — — Embedded derivatives (1,192) — — — — Total non-qualifying hedges (2,013) (3) — — — Total $ (1,956) $ (32) $ 36 $ — $ 40 Year Ended December 31, 2018 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Fair value hedges: Interest rate derivatives $ (12) $ 12 $ 1 $ — $ — Total fair value hedges (12) 12 1 — — Cash flow hedges: Interest rate derivatives 129 (1) 5 — (5) Foreign currency exchange rate derivatives — (1) 27 — 164 Total cash flow hedges 129 (2) 32 — 159 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives (658) — — — — Foreign currency exchange rate derivatives 82 (8) — — — Credit derivatives (7) — — — — Equity derivatives 632 — — — — Embedded derivatives 534 — — (8) — Total non-qualifying hedges 583 (8) — (8) — Total $ 700 $ 2 $ 33 $ (8) $ 159 At December 31, 2020 and 2019, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions was three four At December 31, 2020 and 2019, the balance in AOCI associated with cash flow hedges was $173 million and $245 million, respectively. Credit Derivatives In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps were as follows at: December 31, 2020 2019 Rating Agency Designation of Referenced Estimated Maximum Weighted Average Years to Maturity (2) Estimated Maximum Weighted Average Years to Maturity (2) (Dollars in millions) Aaa/Aa/A $ 15 $ 683 2.9 $ 11 $ 615 2.5 Baa 26 1,072 5.2 25 1,020 5.1 Total $ 41 $ 1,755 4.3 $ 36 $ 1,635 4.1 _______________ (1) The Company has written credit protection on both single name and index references. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. (2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts. Counterparty Credit Risk The Company may be exposed to credit-related losses in the event of counterparty nonperformance on derivative instruments. Generally, the credit exposure is the fair value at the reporting date less any collateral received from the counterparty. The Company manages its credit risk by: (i) entering into derivative transactions with creditworthy counterparties governed by master netting agreements; (ii) trading through regulated exchanges and central clearing counterparties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review. See Note 8 for a description of the impact of credit risk on the valuation of derivatives. The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2020 Derivative assets $ 3,588 $ (1,342) $ (1,340) $ 906 $ (840) $ 66 Derivative liabilities $ 2,010 $ (1,342) $ — $ 668 $ (630) $ 38 December 31, 2019 Derivative assets $ 3,062 $ (1,458) $ (1,115) $ 489 $ (488) $ 1 Derivative liabilities $ 2,522 $ (1,458) $ — $ 1,064 $ (1,061) $ 3 _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. The Company’s collateral arrangements generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. Certain of these arrangements also include credit-contingent provisions which permit the party with positive fair value to terminate the derivative at the current fair value or demand immediate full collateralization from the party in a net liability position, in the event that the financial strength or credit rating of the party in a net liability position falls below a certain level. The aggregate estimated fair values of derivatives in a net liability position containing such credit-contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments were as follows at: December 31, 2020 2019 (In millions) Estimated fair value of derivatives in a net liability position (1) $ 668 $ 1,064 Estimated Fair Value of Collateral Provided (2): Fixed maturity securities $ 1,205 $ 1,473 _______________ (1) After taking into consideration the existence of netting agreements. (2) Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit-contingent provisions of derivative contracts in a net liability position were triggered minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately. |
Fair Value
Fair Value | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value | 8. Fair Value When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Recurring Fair Value Measurements The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy. December 31, 2020 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated Fair Value (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 37,415 $ 491 $ 37,906 Foreign corporate — 11,314 197 11,511 U.S. government and agency 2,217 6,421 — 8,638 RMBS — 8,272 22 8,294 CMBS — 6,785 5 6,790 State and political subdivision — 4,640 — 4,640 ABS — 2,844 40 2,884 Foreign government — 1,832 — 1,832 Total fixed maturity securities 2,217 79,523 755 82,495 Equity securities 36 99 3 138 Short-term investments 2,782 460 — 3,242 Derivative assets: (1) Interest rate — 2,094 — 2,094 Foreign currency exchange rate — 219 1 220 Credit — 27 14 41 Equity market — 1,213 14 1,227 Total derivative assets — 3,553 29 3,582 Embedded derivatives within asset host contracts (2) — — 283 283 Separate account assets 86 111,880 3 111,969 Total assets $ 5,121 $ 195,515 $ 1,073 $ 201,709 Liabilities Derivative liabilities: (1) Interest rate $ — $ 200 $ — $ 200 Foreign currency exchange rate — 137 7 144 Equity market — 1,660 20 1,680 Total derivative liabilities — 1,997 27 2,024 Embedded derivatives within liability host contracts (2) — — 7,157 7,157 Total liabilities $ — $ 1,997 $ 7,184 $ 9,181 December 31, 2019 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 30,831 $ 329 $ 31,160 Foreign corporate — 9,712 132 9,844 U.S. government and agency 1,636 5,760 — 7,396 RMBS — 9,074 44 9,118 CMBS — 5,755 — 5,755 State and political subdivision — 3,984 73 4,057 ABS — 1,882 73 1,955 Foreign government — 1,751 — 1,751 Total fixed maturity securities 1,636 68,749 651 71,036 Equity securities 14 125 8 147 Short-term investments 1,271 682 5 1,958 Derivative assets: (1) Interest rate — 1,778 — 1,778 Foreign currency exchange rate — 281 5 286 Credit — 25 11 36 Equity market — 850 71 921 Total derivative assets — 2,934 87 3,021 Embedded derivatives within asset host contracts (2) — — 217 217 Separate account assets 180 106,924 3 107,107 Total assets $ 3,101 $ 179,414 $ 971 $ 183,486 Liabilities Derivative liabilities: (1) Interest rate $ — $ 330 $ — $ 330 Foreign currency exchange rate — 43 — 43 Equity market — 2,093 71 2,164 Total derivative liabilities — 2,466 71 2,537 Embedded derivatives within liability host contracts (2) — — 4,248 4,248 Total liabilities $ — $ 2,466 $ 4,319 $ 6,785 _______________ (1) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets. (2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the consolidated balance sheets. Valuation Controls and Procedures The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards. The fair value of financial assets and financial liabilities is based on quoted market prices, where available. Prices received are assessed to determine if they represent a reasonable estimate of fair value. Several controls are performed, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for a non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments. A formal process is also applied to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, the last available price will be used. Additional controls are performed, such as, balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the year ended December 31, 2020. Determination of Fair Value Fixed Maturity Securities The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below. U.S. corporate and foreign corporate securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues. U.S. government and agency, state and political subdivision and foreign government securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker-dealer quotes, and comparable securities that are actively traded. Structured Securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance. Equity Securities and Short-term Investments The fair value for actively traded equity securities and short-term investments are determined using quoted market prices and are classified as Level 1 assets. For financial instruments classified as Level 2 assets, fair values are determined using a market approach and are valued based on a variety of observable inputs as described below. Equity securities and short-term investments: Fair value is determined using third-party commercial pricing services, with the primary input being quoted prices in markets that are not active. Derivatives The fair values for exchange-traded derivatives are determined using the quoted market prices and are classified as Level 1 assets. For OTC-bilateral derivatives and OTC-cleared derivatives classified as Level 2 assets or liabilities, fair values are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs. The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. Embedded Derivatives Embedded derivatives principally include certain direct and ceded variable annuity guarantees and equity crediting rates within index-linked annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The Company issues certain variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and certain portions of GMIBs are accounted for as embedded derivatives and measured at estimated fair value separately from the host variable annuity contract. These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets, with changes in estimated fair value reported in net derivative gains (losses). The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods. Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly-traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims-paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. The Company issues and assumes through reinsurance index-linked annuities which allow the policyholder to participate in returns from equity indices. The crediting rates associated with these features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets. The estimated fair value of crediting rates associated with index-linked annuities is determined using a combination of an option pricing model and an option-budget approach. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk. Transfers Into or Out of Level 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) Certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) were as follows at: December 31, 2020 December 31, 2019 Impact of Valuation Techniques Significant Range Range Embedded derivatives Direct, assumed and ceded guaranteed minimum benefits • Option pricing techniques • Mortality rates 0.03 % - 12.13 % 0.02 % - 11.31 % Decrease (1) • Lapse rates 0.25 % - 15.00 % 0.25 % - 16.00 % Decrease (2) • Utilization rates 0.00 % - 25.00 % 0.00 % - 25.00 % Increase (3) • Withdrawal rates 0.25 % - 10.00 % 0.25 % - 10.00 % (4) • Long-term equity volatilities 16.66 % - 22.21 % 16.24 % - 21.65 % Increase (5) • Nonperformance risk spread 0.47 % - 1.97 % 0.54 % - 1.99 % Decrease (6) _______________ (1) Mortality rates vary by age and by demographic characteristics such as gender. The range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement. (2) The range shown reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. (3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. (4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value. The changes in assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3) were summarized as follows: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Fixed Maturity Securities Corporate (1) Structured Securities State and Equity Short-term Investments Net Derivatives (2) Net Embedded Derivatives (3) Separate Account Assets (4) (In millions) Balance, January 1, 2019 $ 732 $ 173 $ 74 $ 3 $ — $ (122) $ (1,998) $ 1 Total realized/unrealized gains (losses) included in net income (loss) (5) (6) — 1 1 — — (12) (1,192) — Total realized/unrealized gains (losses) included in AOCI 15 2 (1) — — (1) — — Purchases (7) 342 69 — 5 5 — — 3 Sales (7) (150) (25) (1) — — — — — Issuances (7) — — — — — — — — Settlements (7) — — — — — 155 (841) — Transfers into Level 3 (8) 24 42 — — — — — — Transfers out of Level 3 (8) (502) (145) — — — (4) — (1) Balance, December 31, 2019 461 117 73 8 5 16 (4,031) 3 Total realized/unrealized gains (losses) included in net income (loss) (5) (6) (6) — — — — 9 (2,221) — Total realized/unrealized gains (losses) included in AOCI (3) 1 — — — (9) — — Purchases (7) 409 58 — — — — — — Sales (7) (117) (5) — — (5) (14) — — Issuances (7) — — — — — — — — Settlements (7) — — — — — — (622) — Transfers into Level 3 (8) 186 11 — — — — — — Transfers out of Level 3 (8) (242) (115) (73) (5) — — — — Balance, December 31, 2020 $ 688 $ 67 $ — $ 3 $ — $ 2 $ (6,874) $ 3 Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2018 (9) $ (2) $ — $ 1 $ 1 $ — $ 148 $ 395 $ — Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2019 (9) $ — $ — $ 1 $ — $ — $ (10) $ (1,450) $ — Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2020 (9) $ (5) $ — $ — $ — $ — $ (4) $ (2,297) $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2020 $ (3) $ 1 $ — $ — $ — $ (9) $ — $ — Gains (Losses) Data for the year ended December 31, 2018: Total realized/unrealized gains (losses) included in net income (loss) (5) (6) $ 1 $ 2 $ 1 $ — $ — $ 152 $ 526 $ — Total realized/unrealized gains (losses) included in AOCI $ (33) $ (6) $ (1) $ — $ — $ 9 $ — $ — _______________ (1) Comprised of U.S. and foreign corporate securities. (2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward. (3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward. (4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses). (5) Amortization of premium/accretion of discount is included within net investment income. Changes in the allowance for credit losses and direct write-offs are charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). (6) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (7) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (8) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (9) Changes in unrealized gains (losses) included in net income (loss) for fixed maturities are reported in either net investment income or net investment gains (losses). Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). Fair Value of Financial Instruments Carried at Other Than Fair Value The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure. The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: December 31, 2020 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 15,808 $ — $ — $ 16,926 $ 16,926 Policy loans $ 1,291 $ — $ 512 $ 1,530 $ 2,042 Other invested assets $ 51 $ — $ 39 $ 12 $ 51 Premiums, reinsurance and other receivables $ 3,277 $ — $ 90 $ 3,975 $ 4,065 Liabilities Policyholder account balances $ 17,497 $ — $ — $ 19,100 $ 19,100 Long-term debt $ 3,436 $ — $ 3,858 $ — $ 3,858 Other liabilities $ 807 $ — $ 163 $ 644 $ 807 Separate account liabilities $ 1,334 $ — $ 1,334 $ — $ 1,334 December 31, 2019 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 15,753 $ — $ — $ 16,383 $ 16,383 Policy loans $ 1,292 $ — $ 516 $ 1,062 $ 1,578 Other invested assets $ 51 $ — $ 39 $ 12 $ 51 Premiums, reinsurance and other receivables $ 2,224 $ — $ 41 $ 2,593 $ 2,634 Liabilities Policyholder account balances $ 15,614 $ — $ — $ 15,710 $ 15,710 Long-term debt $ 4,365 $ — $ 3,334 $ 1,000 $ 4,334 Other liabilities $ 846 $ — $ 191 $ 655 $ 846 Separate account liabilities $ 1,189 $ — $ 1,189 $ — $ 1,189 |
Long-term Debt
Long-term Debt | 12 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Long-term Debt | 9. Long-term Debt Long-term debt outstanding was as follows at: December 31, 2020 2019 Stated Interest Rate Maturity Face Value Carrying Value Face Value Carrying Value (In millions) Senior notes (1) 3.700% 2027 $ 1,300 $ 1,294 $ 1,500 $ 1,492 Senior notes (1) 5.625% 2030 615 614 — — Senior notes (1) 4.700% 2047 1,150 1,134 1,500 1,478 Term loan LIBOR plus 1.5% 2024 — — 1,000 1,000 Junior subordinated debentures (1) 6.250% 2058 375 363 375 363 Other long-term debt (2) 7.028% 2030 31 31 32 32 Total long-term debt (3) $ 3,471 $ 3,436 $ 4,407 $ 4,365 _______________ (1) Interest on senior notes is payable semi-annually. Interest on junior subordinated debentures is payable quarterly subject to BHF’s right to defer interest payments in accordance with the terms of the debentures. (2) Represents non-recourse debt for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment companies. (3) Includes unamortized debt issuance costs, discounts and premiums, as applicable, totaling net $35 million and $42 million for the senior notes and junior subordinated debentures on a combined basis at December 31, 2020 and 2019, respectively. The aggregate maturities of long-term debt at December 31, 2020 were $2 million in each of 2021, 2022, 2023 and 2024, $3 million in 2025 and $3.5 billion thereafter. Unsecured senior notes rank highest in priority, followed by subordinated debt consisting of junior subordinated debentures. Interest expense related to long-term debt of $184 million, $191 million and $158 million for the years ended December 31, 2020, 2019 and 2018, respectively, is included in other expenses. The Company’s debt instruments and credit and committed facilities contain certain administrative, reporting and legal covenants. Additionally, the 2019 Revolving Credit Facility (as defined below) contain financial covenants, including requirements to maintain a specified minimum adjusted consolidated net worth, to maintain a ratio of total indebtedness to total capitalization not in excess of a specified percentage and that place limitations on the dollar amount of indebtedness that may be incurred by the Company’ subsidiaries. At December 31, 2020, the Company was in compliance with these financial covenants. Senior Notes During the second quarter of 2020, BHF issued $615 million aggregate principal amount of senior notes due May 2030 (the “2030 Senior Notes”) for aggregate net cash proceeds of $614 million. The 2030 Senior Notes bear interest at a fixed rate of 5.625%, payable semi-annually. During the fourth quarter of 2020, BHF used the net proceeds from the issuance of the Series C Depositary Shares (as defined in Note 10) to repurchase $200 million principal amount of senior notes due 2027 and $350 million principal amount of senior notes due 2047. In connection with this repurchase, BHF recorded a premium of $37 million paid in excess of the debt principal and wrote off $6 million of unamortized debt issuance costs, which is included in other expenses. Junior Subordinated Debentures During the third quarter of 2018, BHF issued $375 million of junior subordinated debentures (the “Junior Debentures”) due September 2058, which bear interest at a fixed rate of 6.25%, payable quarterly, subject to BHF’s right to defer interest payments in accordance with the terms of the debentures. In connection with the issuance of the Junior Debentures, BHF capitalized $14 million of debt issuance costs. Credit Facilities Revolving Credit Facility On May 7, 2019, BHF entered into an amended and restated revolving credit agreement with respect to a new $1.0 billion senior unsecured revolving credit facility maturing May 7, 2024 (the “2019 Revolving Credit Facility”), all of which may be used for revolving loans or letters of credit. The 2019 Revolving Credit Facility replaced a $2.0 billion senior unsecured revolving credit facility maturing December 2, 2021. At December 31, 2020, there were no borrowings or letters of credit outstanding under the 2019 Revolving Credit Facility. Term Loan Facility On February 1, 2019, BHF entered into a new term loan agreement with respect to a new $1.0 billion unsecured term loan facility maturing February 1, 2024 (the “2019 Term Loan Facility”), borrowed $1.0 billion under the 2019 Term Loan Facility, terminated its then-existing $600 million unsecured delayed draw term loan facility (the “2017 Term Loan Facility”) without penalty and repaid $600 million of borrowings outstanding under the 2017 Term Loan Facility. Debt issuance costs incurred related to the 2019 Term Loan Facility were not significant. During the second quarter of 2020, BHF used the aggregate net proceeds from the issuances of the 2030 Senior Notes and the Series B Depositary Shares (as defined in Note 10) to repay all outstanding borrowings under the 2019 Term Loan Facility. On June 2, 2020, BHF terminated the 2019 Term Loan Facility without penalty. For the years ended December 31, 2020, 2019 and 2018, fees associated with these credit facilities were not significant. Committed Facilities Reinsurance Financing Arrangement On April 28, 2017, Brighthouse Reinsurance Company of Delaware (“BRCD”) entered into a $10.0 billion financing arrangement with a pool of highly rated third-party reinsurers consisting of credit-linked notes. On June 11, 2020, BRCD amended its financing arrangement to increase the maximum amount to $12.0 billion and extend the term by two years to 2039. At December 31, 2020, there were no borrowings and there was $10.9 billion of funding available under this financing arrangement. For the years ended December 31, 2020, 2019 and 2018, the Company recognized commitment fees of $30 million, $41 million and $44 million, respectively, in other expenses associated with this financing arrangement. Repurchase Facilities On November 20, 2020, Brighthouse Life Insurance Company terminated without penalty its existing $2.0 billion secured committed repurchase facility with a financial institution and concurrently entered into new secured committed repurchase facilities (the “2020 Repurchase Facilities”) under which Brighthouse Life Insurance Company may continue to enter into repurchase transactions in an aggregate amount up to $2.0 billion for a term of up to three years. Under the 2020 Repurchase Facilities, Brighthouse Life Insurance Company may sell certain eligible securities at a purchase price based on the market value of the securities less an applicable margin based on the types of securities sold, with a concurrent agreement to repurchase such securities at a predetermined future date (up to three months) and at a price which represents the original purchase price plus interest. At December 31, 2020, there were no borrowings under the 2020 Repurchase Facilities. For the years ended December 31, 2020, 2019 and 2018, fees associated with this committed facility were not significant. |
Equity
Equity | 12 Months Ended |
Dec. 31, 2020 | |
Equity [Abstract] | |
Equity | 10. Equity Preferred Stock Preferred stock shares authorized, issued and outstanding were as follows at: December 31, 2020 2019 Shares Authorized Shares Issued Shares Outstanding Shares Authorized Shares Issued Shares Outstanding 6.600% Non-Cumulative Preferred Stock, Series A 17,000 17,000 17,000 17,000 17,000 17,000 6.750% Non-Cumulative Preferred Stock, Series B 16,100 16,100 16,100 — — — 5.375% Non-Cumulative Preferred Stock, Series C 23,000 23,000 23,000 — — — Not designated 99,943,900 — — 99,983,000 — — Total 100,000,000 56,100 56,100 100,000,000 17,000 17,000 In November 2020, BHF issued depositary shares (the “Series C Depositary Shares”), each representing a 1/1,000th ownership interest in a share of BHF’s perpetual 5.375% Series C non-cumulative preferred stock (the “Series C Preferred Stock”) and in the aggregate representing 23,000 shares of Series C Preferred Stock, with a stated amount of $25,000 per share, for aggregate net cash proceeds of $558 million. Dividends, if declared, will be payable commencing on March 25, 2021 and will accrue and be payable quarterly, in arrears, at an annual rate of 5.375% on the stated amount per share. In connection with the issuance of the Series C Depositary Shares and the underlying Series C Preferred Stock, BHF incurred $17 million of issuance costs, which have been recorded as a reduction of additional paid-in capital. In May 2020, BHF issued depositary shares (the “Series B Depositary Shares”), each representing a 1/1,000th ownership interest in a share of its perpetual 6.750% non-cumulative preferred stock, Series B (the “Series B Preferred Stock”) and in the aggregate representing 16,100 shares of Series B Preferred Stock, with a stated amount of $25,000 per share, for aggregate net cash proceeds of $390 million. Dividends, if declared, will accrue and be payable quarterly, in arrears, at an annual rate of 6.750% on the stated amount per share. In connection with the issuance of the Series B Depositary Shares and the underlying Series B Preferred Stock, BHF incurred $13 million of issuance costs, which have been recorded as a reduction of additional paid-in capital. In March 2019, BHF issued depositary shares, each representing a 1/1,000th ownership interest in a share of BHF’s perpetual 6.600% Series A non-cumulative preferred stock (the “Series A Preferred Stock”) and in the aggregate representing 17,000 shares of Series A Preferred Stock, with a stated amount of $25,000 per share, for aggregate net cash proceeds of $412 million. Dividends, if declared, will accrue and be payable quarterly, in arrears, at an annual rate of 6.600% on the stated amount per share. In connection with the issuance of the depositary shares and the underlying Series A Preferred Stock, BHF incurred $13 million of issuance costs, which have been recorded as a reduction of additional paid-in capital. The Series A Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (together, the “Preferred Stock”) rank equally with each other. The Preferred Stock ranks senior to common stock with respect to the payment of dividends and distributions of assets upon liquidation, dissolution or winding-up of the Company. Holders of the Preferred Stock are not entitled to any other amounts from the Company after they have received their full liquidation preference and do not have voting rights except in certain limited circumstances, including where dividends have not been paid in full for at least six dividend payment periods, whether or not such periods are consecutive. In such circumstances, the holders of the Preferred Stock, and, in turn, the underlying depositary shares, will have certain voting rights with respect to the election of additional directors to the BHF Board of Directors, as provided in the Certificate of Designations for each series of Preferred Stock. Each series of Preferred Stock has a stated amount of $25,000 per share, is perpetual and has no maturity date. Dividends are payable, if declared, quarterly in arrears on the 25th day of March, June, September and December of each year at a specified annual rate on the stated amount per share applicable to each particular series. Dividends are recorded when declared. No dividends may be paid or declared on BHF’s common stock and BHF may not purchase, redeem, or otherwise acquire its common stock unless the full dividends for the latest completed dividend period on all outstanding Preferred Stock have been declared and either paid or a sum sufficient for the payment thereof has been set aside. The Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company or its subsidiaries and is not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. Each series of the Preferred Stock is redeemable at the Company’s option in whole or in part on or after a specified optional redemption date applicable to that series (March 25, 2024 for the Series A Preferred Stock, June 25, 2025 for the Series B Preferred Stock and December 25, 2025 for the Series C Preferred Stock) at a redemption price equal to $25,000 per share, plus any accrued but unpaid dividends. Prior to the optional redemption date applicable to each series of Preferred Stock, the Preferred Stock is redeemable at the Company’s option in whole but not in part within 90 days of the occurrence of (i) a specified rating agency event or (ii) a specified regulatory capital event, in each case at a specified redemption price. The declaration, record and payment dates, as well as per share and aggregate dividend amounts for BHF’s preferred stock by series for the years ended December 31, 2020 and 2019 were as follows: Series A Series B Declaration Date Record Date Payment Date Per Share Aggregate Per Share Aggregate (In millions, except per share data) November 16, 2020 December 10, 2020 December 28, 2020 $ 412.50 $ 7 $ 421.88 $ 6 August 17, 2020 September 10, 2020 September 25, 2020 412.50 7 595.31 10 May 15, 2020 June 10, 2020 June 25, 2020 412.50 7 — — February 14, 2020 March 10, 2020 March 25, 2020 412.50 7 — — $ 1,650.00 $ 28 $ 1,017.19 $ 16 November 15, 2019 December 10, 2019 December 26, 2019 $ 412.50 $ 7 $ — $ — August 15, 2019 September 10, 2019 September 25, 2019 412.50 7 — — May 15, 2019 June 10, 2019 June 25, 2019 412.50 7 — — $ 1,237.50 $ 21 $ — $ — See Note 17 for information relating to preferred dividends declared subsequent to December 31, 2020. Common Stock Changes in common shares outstanding were as follows: Years Ended December 31, 2020 2019 2018 Shares outstanding at beginning of year 106,027,301 117,532,336 119,773,106 Shares issued 354,652 199,853 674,912 Shares repurchased (1) (18,170,335) (11,704,888) (2,915,682) Shares outstanding at end of year 88,211,618 106,027,301 117,532,336 _______________ (1) Includes shares of common stock withheld with respect to tax withholding obligations associated with the vesting of share-based compensation awards under the Company’s publicly announced benefit plans or programs. On August 5, 2018, BHF authorized the repurchase of up to $200 million of its common stock. On May 3, 2019, BHF authorized the repurchase of up to an additional $400 million of its common stock. On February 6, 2020, BHF authorized the repurchase of up to an additional $500 million of its common stock. Future repurchases may be made through open market purchases, including pursuant to 10b5-1 plans or pursuant to accelerated stock repurchase plans, or through privately negotiated transactions, from time to time at management’s discretion in accordance with applicable legal requirements. On May 11, 2020, the Company announced that it had temporarily suspended repurchases of its common stock. On August 24, 2020, the Company resumed repurchases of its common stock, as was announced on August 21, 2020. See Note 17 for information relating to the authorization of share repurchases subsequent to December 31, 2020. During the years ended December 31, 2020, 2019 and 2018, BHF repurchased 18,097,084 shares, 11,658,208 shares and 2,628,167 shares, respectively, of its common stock through open market purchases pursuant to 10b5-1 plans for $473 million, $442 million and $105 million, respectively. At December 31, 2020, BHF had $80 million remaining under its common stock repurchase program. Share-Based Compensation Plans The Company’s share-based compensation plans provide awards to employees and non-employee directors and may be in the form of non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, or other share-based awards. Additionally, employees may purchase shares at a discount under an employee stock purchase plan (the “ESPP”). The Company also granted restricted stock units to certain employees and non-employee directors on September 8, 2017, shortly following the Separation (the “Founders’ Grant”). The employee stock incentive plan and the non-employee director stock compensation plan were each approved at the BHF annual meeting of stockholders held on May 23, 2018. The aggregate number of authorized shares available for issuance at December 31, 2020 under the Company’s various share-based compensation plans was 6,747,990. All share-based compensation is measured at fair value as of the grant date. The Company recognizes compensation expense related to share-based awards based on the number of awards expected to vest, which for some award types represent the awards granted less expected forfeitures over the life of the award, as estimated at the date of grant and actual forfeitures for other award types. Unless a material deviation from the assumed forfeiture rate is observed during the term in which the awards are expensed, the Company recognizes any adjustment necessary to reflect differences in actual experience in the period the award becomes payable or exercisable. Compensation expense related to share-based awards, which is included in other expenses, is principally related to the issuance of restricted stock units and performance units with other costs incurred relating to stock options. The Company grants the majority of each year’s awards in the first quarter of the year. Compensation Expense Related to Share-Based Compensation The following table presents total share-based compensation expense: Years Ended December 31, 2020 2019 2018 (In millions) Restricted stock units, Founders’ Grant $ — $ — $ 31 Restricted stock units $ 15 $ 15 $ 7 Stock options $ — $ 1 $ 1 Performance share units $ 5 $ 4 $ — Employee stock purchase plan $ 1 $ 1 $ 1 The share-based compensation cost for the Founders’ Grant was fully recognized by September 30, 2018. Unrecognized share-based compensation for other grants related to restricted stock units, stock options and performance share units was $17 million , $24 million and $13 million at December 31, 2020, 2019 and 2018, respectively, with a weighted average remaining recognition period of four quarters. Equity Awards Restricted Stock Units (“RSU”) RSUs are units that, if vested, are payable in shares of BHF common stock. The Company does not credit RSUs with dividend-equivalents as RSUs do not accrue dividends. Accordingly, the estimated fair value of RSUs is based upon the closing price of shares on the date of grant, less a forfeiture rate. With the exception of the Founders’ Grant, most RSUs use graded vesting and vest in thirds on, or shortly after, the first three anniversaries of their grant date, while other RSUs vest in their entirety on the specified anniversary of their grant date. Vesting is subject to continued service, except for employees who meet specified age and service criteria, and in certain other limited circumstances. Performance Share Units (“PSU”) PSUs are units that, if vested, are multiplied by a performance factor to produce a final number of BHF common stock shares. PSUs cliff vest at the end of a three-year performance period. Vesting is subject to continued service, except for employees who meet specified age and service criteria, and in certain other limited circumstances. The performance factors are based on the achievement of corporate expense reductions, capital return targets and statutory expense ratio over the respective performance period depending on year of issue. For awards granted for performance periods in progress through December 31, 2020, the vested PSUs will be multiplied by a performance factor up to a maximum payout of 150%. Assuming the Company has met certain threshold performance goals, the Compensation Committee of BHF’s Board of Directors will determine the performance factor in its discretion. The Company estimates the fair value of performance shares semi-annually until they become payable. The following table presents a summary of PSU and RSU activity: RSUs PSUs Units Weighted Average Grant-Date Fair Value Units Weighted Average Grant-Date Fair Value Outstanding at January 1, 2020 588,729 $ 41.27 253,180 $ 41.21 Granted 494,596 $ 35.68 223,003 $ 35.84 Forfeited (50,251) $ 38.21 (22,212) $ 39.85 Paid (241,974) $ 41.90 — $ — Outstanding at December 31, 2020 791,100 $ 37.80 453,971 $ 38.64 Vested at December 31, 2020 — $ — — $ — Stock Options Stock options represent the contingent right of award holders to purchase shares of BHF common stock at a stated price for a limited time. All stock options have an exercise price equal to the closing price of a share on the date of grant and have a maximum term of ten years. Stock options granted are exercisable at a rate of one-third of each award on each of the first three anniversaries of the grant date. Vesting is subject to continued service, except for employees who meet specified age and service criteria, and in certain other limited circumstances. In May 2018, the Company granted 242,560 options at a weighted average exercise price of $53.47 for aggregate intrinsic value of $0. During the year ended December 31, 2020, no stock options were granted or exercised, and 9,121 options were forfeited or expired. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes model. The significant assumptions the Company uses in its model include: expected volatility of the price of shares; risk-free rate of return; graded three-year vesting; and expected option life. The following table presents the weighted average assumptions used to determine the grant-date fair value of stock options that BHF has granted: Year Ended December 31, 2018 (1) Risk-free rate of return 2.93% Expected volatility 25.00% Expected option life, years 5.8 years Weighted average exercise price of stock options granted $53.47 Weighted average fair value of stock options granted $12.54 _______________ (1) There were no stock options granted during the years ended December 31, 2020 and 2019. Employee Stock Purchase Plan Shares Statutory Equity and Income The states of domicile of the Company’s insurance subsidiaries impose RBC requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). Regulatory compliance is determined by a ratio of a company’s total adjusted capital (“TAC”), calculated in the manner prescribed by the NAIC to its authorized control level RBC (“ACL RBC”), calculated in the manner prescribed by the NAIC, based on the statutory-based filed financial statements. Companies below specific trigger levels or ratios are classified by their respective levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC. The RBC ratios for the Company’s insurance subsidiaries were each in excess of 400% for all periods presented. The Company’s insurance subsidiaries prepare statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting of reinsurance agreements and valuing investments and deferred tax assets on a different basis. The tables below present amounts from certain of the Company’s insurance subsidiaries, which are derived from the statutory-basis financial statements as filed with the insurance regulators. Statutory net income (loss) was as follows: Years Ended December 31, Company State of Domicile 2020 2019 2018 (In millions) Brighthouse Life Insurance Company Delaware $ (979) $ 1,074 $ (1,104) New England Life Insurance Company Massachusetts $ 105 $ 61 $ 130 Statutory capital and surplus was as follows at: December 31, Company 2020 2019 (In millions) Brighthouse Life Insurance Company $ 7,410 $ 8,746 New England Life Insurance Company $ 150 $ 116 The Company has a reinsurance subsidiary, BRCD which reinsures risks including level premium term life and ULSG assumed from other Brighthouse Financial life insurance subsidiaries. BRCD, with the explicit permission of the Delaware Insurance Commissioner (“Delaware Commissioner”), has included, as admitted assets, the value of credit-linked notes, serving as collateral, which resulted in higher statutory capital and surplus of $8.0 billion and $9.0 billion for the years ended December 31, 2020 and 2019, respectively. The statutory net income (loss) of BRCD was $145 million, ($316) million and ($1.1) billion for the years ended December 31, 2020, 2019 and 2018, respectively, and the combined statutory capital and surplus, including the aforementioned prescribed practices, were $624 million and $572 million at December 31, 2020 and 2019, respectively. Dividend Restrictions The table below sets forth the dividends permitted to be paid by certain of the Company’s insurance companies without insurance regulatory approval and dividends paid: 2021 2020 2019 2018 Company Permitted Paid (2) Paid (2) Paid (2) (In millions) Brighthouse Life Insurance Company $ 733 $ 1,250 $ — $ — New England Life Insurance Company (3) $ 105 $ 61 $ 131 $ 400 ______________ (1) Reflects dividend amounts that may be paid during 2021 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2021, some or all of such dividends may require regulatory approval. (2) Reflects all amounts paid, including those requiring regulatory approval. (3) Dividends paid by NELICO in 2018, including a $65 million ordinary cash dividend and a $335 million extraordinary dividend comprised of $135 million of cash and a $200 million surplus note, were paid to its parent, BH Holdings, LLC. Under the Delaware Insurance Law, Brighthouse Life Insurance Company is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not including pro rata distributions of Brighthouse Life Insurance Company’s own securities. Brighthouse Life Insurance Company will be permitted to pay a stockholder dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the immediately preceding calendar year requires insurance regulatory approval. Under the Delaware Insurance Law, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. Under the Massachusetts State Insurance Law, NELICO is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the aggregate amount of the dividend, when aggregated with all other dividends paid in the preceding 12 months, does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net gain from operations for the immediately preceding calendar year, not including pro rata distributions of NELICO’s own securities. NELICO will be permitted to pay a dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Massachusetts Commissioner of Insurance (the “Massachusetts Commissioner”) and the Massachusetts Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the last filed annual statutory statement requires insurance regulatory approval. Under the Massachusetts State Insurance Law, the Massachusetts Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI was as follows: Unrealized Unrealized Foreign Defined Benefit Plans Adjustment Total (In millions) Balance at December 31, 2017 $ 1,572 $ 154 $ (24) $ (26) $ 1,676 Cumulative effect of change in accounting principle and other, net of income tax (79) — — — (79) Balance, January 1, 2018 1,493 154 (24) (26) 1,597 OCI before reclassifications (1,346) 159 (4) 6 (1,185) Deferred income tax benefit (expense) 287 48 1 (1) 335 AOCI before reclassifications, net of income tax 434 361 (27) (21) 747 Amounts reclassified from AOCI 181 (134) — 1 48 Deferred income tax benefit (expense) (39) (40) — — (79) Amounts reclassified from AOCI, net of income tax 142 (174) — 1 (31) Balance at December 31, 2018 576 187 (27) (20) 716 OCI before reclassifications 3,285 40 12 (10) 3,327 Deferred income tax benefit (expense) (690) (8) — 2 (696) AOCI before reclassifications, net of income tax 3,171 219 (15) (28) 3,347 Amounts reclassified from AOCI (76) (59) — — (135) Deferred income tax benefit (expense) 16 12 — — 28 Amounts reclassified from AOCI, net of income tax (60) (47) — — (107) Balance at December 31, 2019 3,111 172 (15) (28) 3,240 OCI before reclassifications (2) 3,511 (52) 20 (14) 3,465 Deferred income tax benefit (expense) (737) 11 (13) 4 (735) AOCI before reclassifications, net of income tax 5,885 131 (8) (38) 5,970 Amounts reclassified from AOCI (303) (20) — 1 (322) Deferred income tax benefit (expense) 64 4 — — 68 Amounts reclassified from AOCI, net of income tax (239) (16) — 1 (254) Balance at December 31, 2020 $ 5,646 $ 115 $ (8) $ (37) $ 5,716 _______________ (1) See Note 6 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI. (2) Includes $3 million related to the adoption of ASU 2016-13 (see Note 1). Information regarding amounts reclassified out of each component of AOCI was as follows: AOCI Components Amounts Reclassified from AOCI Consolidated Statements of Operations Locations Years Ended December 31, 2020 2019 2018 (In millions) Net unrealized investment gains (losses): Net unrealized investment gains (losses) $ 318 $ 113 $ (180) Net investment gains (losses) Net unrealized investment gains (losses) — — 1 Net investment income Net unrealized investment gains (losses) (15) (37) (2) Net derivative gains (losses) Net unrealized investment gains (losses), before income tax 303 76 (181) Income tax (expense) benefit (64) (16) 39 Net unrealized investment gains (losses), net of income tax 239 60 (142) Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps 2 32 98 Net derivative gains (losses) Interest rate swaps 3 2 3 Net investment income Interest rate forwards — — 31 Net derivative gains (losses) Interest rate forwards — — 2 Net investment income Foreign currency swaps 15 25 — Net derivative gains (losses) Gains (losses) on cash flow hedges, before income tax 20 59 134 Income tax (expense) benefit (4) (12) 40 Gains (losses) on cash flow hedges, net of income tax 16 47 174 Defined benefit plans adjustment: Amortization of net actuarial gains (losses) (1) — (1) Amortization of defined benefit plan items, before income tax (1) — (1) Income tax (expense) benefit — — — Amortization of defined benefit plan items, net of income tax (1) — (1) Total reclassifications, net of income tax $ 254 $ 107 $ 31 |
Other Revenues and Other Expens
Other Revenues and Other Expenses | 12 Months Ended |
Dec. 31, 2020 | |
Other Income and Expenses [Abstract] | |
Other Revenues and Other Expenses | 11. Other Revenues and Other Expenses Other Revenues The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees. To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees. Other revenues consisted primarily of 12b-1 fees of $325 million, $336 million and $360 million for the years ended December 31, 2020, 2019 and 2018, respectively, of which substantially all were reported in the Annuities segment. Other Expenses Information on other expenses was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Compensation $ 346 $ 333 $ 289 Contracted services and other labor costs 281 287 245 Transition services agreements 127 245 279 Establishment costs 112 118 239 Premium and other taxes, licenses and fees 44 48 68 Separate account fees 466 488 524 Volume related costs, excluding compensation, net of DAC capitalization 662 636 628 Interest expense on debt 184 191 158 Other 131 145 145 Total other expenses $ 2,353 $ 2,491 $ 2,575 Capitalization of DAC See Note 4 for additional information on the capitalization of DAC. Interest Expense on Debt See Note 9 for attribution of interest expense by debt issuance. Related Party Expenses See Note 16 for a discussion of related party expenses included in the table above. |
Employee Benefit Plan
Employee Benefit Plan | 12 Months Ended |
Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |
Retirement Benefits [Text Block] | 12. Employee Benefit Plans BHF Active Defined Contribution Plans Brighthouse Services sponsors qualified and non-qualified defined contribution plans. For the years ended December 31, 2020, 2019 and 2018, the total employer contributions for the qualified defined contribution plan were $17 million, $15 million and $14 million, respectively, and the total expense recognition for the non-qualified defined contribution plans were $7 million, $6 million and $3 million, respectively, all of which are reported in other expenses. NELICO Legacy Pension and Other Unfunded Benefit Plans NELICO sponsors both a qualified and a non-qualified defined benefit pension plan, a postretirement plan and other unfunded benefit plans. These pension and other unfunded benefit plans were amended to cease benefit accruals and are closed to new entrants. The qualified defined benefit pension plan had an accumulated benefit obligation of $182 million and $164 million at December 31, 2020 and 2019, respectively. This plan was fully funded at December 31, 2020 and 2019 with assets in excess of the accumulated benefit obligation of $8 million and $7 million, respectively. The Company did not make any employer contributions to this qualified plan during 2020 or 2019. The non-qualified defined benefit pension plan and the postretirement plan had a combined accumulated benefit obligation totaling $111 million and $106 million at December 31, 2020 and 2019, respectively. These amounts are unfunded. The other unfunded benefit plans consist primarily of deferred compensation due to former agents which represent general unsecured liabilities of NELICO. The amounts due under these other unfunded benefit plans were $65 million and $72 million at December 31, 2020 and 2019, respectively. |
Income Tax
Income Tax | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Tax | 13. Income Tax The provision for income tax was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Current: Federal $ 30 $ (36) $ (166) State and local 6 4 — Subtotal 36 (32) (166) Deferred: Federal (399) (285) 285 Provision for income tax expense (benefit) $ (363) $ (317) $ 119 The reconciliation of the income tax provision at the statutory tax rate to the provision for income tax as reported was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Tax provision at statutory rate $ (298) $ (221) $ 207 Tax effect of: Excess loss account - Separation from MetLife — — (2) Dividends received deduction (42) (42) (44) Tax credits (25) (31) (25) Release of valuation allowance — — (11) Other, net 2 (23) (6) Provision for income tax expense (benefit) $ (363) $ (317) $ 119 Effective tax rate 26 % 30 % 12 % Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: December 31, 2020 2019 (In millions) Deferred income tax assets: Tax credit carryforwards $ 133 $ 106 Net operating loss carryforwards 1,486 1,087 Employee benefits 15 17 Intangibles 58 93 Investments, including derivatives — 260 Other — 15 Total deferred income tax assets 1,692 1,578 Deferred income tax liabilities: Policyholder liabilities and receivables 905 1,277 Net unrealized investment gains 1,532 871 DAC 720 785 Investments, including derivatives 154 — Other 1 — Total deferred income tax liabilities 3,312 2,933 Net deferred income tax asset (liability) $ (1,620) $ (1,355) The following table sets forth the net operating loss carryforwards for tax purposes at December 31, 2020. Net Operating Loss Carryforwards (In millions) Expiration 2032-2037 $ 3,011 Indefinite 4,064 $ 7,075 The following table sets forth the general business credits and foreign tax credits available for carryforward for tax purposes at December 31, 2020. Tax Credit Carryforwards General Business Credits Foreign Tax Credits (In millions) Expiration 2020-2024 $ — $ 18 2025-2029 — 70 2030-2034 — 28 2035-2039 17 — Indefinite — — $ 17 $ 116 The Company’s liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its consolidated financial statements, although the resolution of income tax matters could impact the Company’s effective tax rate in the future. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Balance at January 1, $ 35 $ 35 $ 23 Additions for tax positions of prior years — — 12 Reductions for tax positions of prior years — — — Additions for tax positions of current year — — — Reductions for tax positions of current year — — — Settlements with tax authorities — — — Balance at December 31, $ 35 $ 35 $ 35 Unrecognized tax benefits that, if recognized would impact the effective rate $ 35 $ 35 $ 35 The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense. Interest related to unrecognized tax benefits was not significant. The Company had no penalties for each of the years ended December 31, 2020, 2019 and 2018. The Company is under continuous examination by the Internal Revenue Service and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to federal, state or local income tax examinations for years prior to 2007. Management believes it has established adequate tax liabilities, and final resolution of the audit for the years 2007 and forward is not expected to have a material impact on the Company’s consolidated financial statements. Tax Sharing Agreements For the periods prior to the Separation, Brighthouse Financial filed a consolidated federal life and non-life income tax return in accordance with the provisions of the Tax Code. Current taxes (and the benefits of tax attributes such as losses) are allocated to Brighthouse Financial, Inc., and its includable subsidiaries, under the consolidated tax return regulations and a tax sharing agreement with MetLife. This tax sharing agreement states that federal taxes will be computed on a modified separate return basis with benefits for losses. For periods after the Separation, Brighthouse Financial entered into two separate tax sharing agreements. Brighthouse Life Insurance Company and any directly owned life insurance and reinsurance subsidiaries (including BHNY and BRCD) entered in a tax sharing agreement to join a life consolidated federal income tax return. Brighthouse Financial, Inc. and its includable subsidiaries entered into a tax sharing agreement to join a non-life consolidated federal income tax return. NELICO and the non-life subsidiaries of Brighthouse Life Insurance Company will file their own federal income tax returns. The tax sharing agreements state that federal taxes are computed on a modified separate return basis with benefit for losses. Income Tax Transactions with Former Parent In connection with the Separation, the Company entered into a tax receivables agreement (the “Tax Receivables Agreement”) with MetLife that provides MetLife with the right to receive as partial consideration for its contribution of assets to BHF future payments from BHF, equal to 86% of the amount of cash savings, if any, in federal income tax that Brighthouse Financial actually, or are deemed to, realize as a result of the utilization of Brighthouse Financial, Inc. and its subsidiaries’ net operating losses, capital losses, tax basis and amortization or depreciation deductions in respect of certain tax benefits it may realize as a result of certain transactions involved in the Separation. In connection with the Tax Receivables Agreement, the Company has a payable to MetLife of $328 million at both December 31, 2020 and 2019, included in other liabilities. |
Earnings Per Common Share
Earnings Per Common Share | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Earnings Per Common Share | 14. Earnings Per Common Share The calculation of earnings per common share was as follows: Years Ended December 31, 2020 2019 2018 (In millions, except share and per share data) Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (1,105) $ (761) $ 865 Weighted average common shares outstanding — basic 95,350,822 112,508,650 119,386,280 Dilutive effect of share-based awards — — 441,198 Weighted average common shares outstanding — diluted 95,350,822 112,508,650 119,827,478 Earnings per common share: Basic $ (11.58) $ (6.76) $ 7.24 Diluted $ (11.58) $ (6.76) $ 7.21 For the years ended December 31, 2020 and 2019, basic loss per common share equaled diluted loss per common share. The diluted shares were not utilized in the per share calculation for these periods as the inclusion of such shares would have an antidilutive effect. For the year ended December 31, 2018, weighted average shares used for calculating diluted earnings per common share excludes 217,990 of out-of-the-money stock options, as the inclusion of these shares would be antidilutive to the earnings per common share calculation due to the average share price for the periods presented. See Note 10 for further information on share-based compensation plans. |
Contingencies, Commitments and
Contingencies, Commitments and Guarantees | 12 Months Ended |
Dec. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies, Commitments and Guarantees | 15. Contingencies, Commitments and Guarantees Contingencies Litigation The Company is a defendant in a number of litigation matters. In some of the matters, large or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at December 31, 2020. Matters as to Which an Estimate Can Be Made For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. In addition to amounts accrued for probable and reasonably estimable losses, as of December 31, 2020, the Company estimates the aggregate range of reasonably possible losses to be up to approximately $10 million. Matters as to Which an Estimate Cannot Be Made For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. Sales Practices Claims Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters. Cost of Insurance Class Action Richard A. Newton v. Brighthouse Life Insurance Company (U.S. District Court, Northern District of Georgia, Atlanta Division, filed May 8, 2020). Plaintiff has filed a purported class action lawsuit against Brighthouse Life Insurance Company. Plaintiff was the owner of a universal life insurance policy issued by Travelers Insurance Company, a predecessor to Brighthouse Life Insurance Company. Plaintiff seeks to certify a class of all persons who own or owned life insurance policies issued where the terms of the life insurance policy provide or provided, among other things, a guarantee that the cost of insurance rates would not be increased by more than a specified percentage in any contract year. Plaintiff alleges, among other things, causes of action for breach of contract, fraud, suppression and concealment, and violation of the Georgia Racketeer Influenced and Corrupt Organizations Act. Plaintiff seeks to recover damages, including punitive damages, interest and treble damages, attorneys’ fees, and injunctive and declaratory relief. Brighthouse Life Insurance Company filed a motion to dismiss in June 2020 and intends to vigorously defend this matter. Summary Various litigations, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations, it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods. Other Contingencies As with litigation and regulatory loss contingencies, the Company considers establishing liabilities for certain non-litigation loss contingencies when assertions are made involving disputes or other matters with counterparties to contractual arrangements entered into by the Company, including with third-party vendors. The Company establishes liabilities for such non-litigation loss contingencies when it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. In matters where it is not probable, but is reasonably possible that a loss will be incurred and the amount of loss can be reasonably estimated, such losses or range of losses are disclosed, and no accrual is made. In the absence of sufficient information to support an assessment of the reasonably possible loss or range of loss, no accrual is made and no loss or range of loss is disclosed. Disputes have arisen with counterparties in connection with reinsurance arrangements where the Company’s subsidiaries are acting as either the reinsured or the reinsurer. These disputes involve assertions by third parties primarily related to rates, fees or reinsured benefit calculations, and in certain of such disputes the counterparty has made a request to arbitrate the dispute. As of December 31, 2020, the Company estimates the amount of reasonably possible losses in excess of the amounts accrued for certain non-litigation loss contingencies to be up to approximately $125 million, which are primarily associated with reinsurance-related matters. For certain other reinsurance-related matters, the Company is not currently able to estimate the reasonably possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of such loss. On a quarterly and annual basis, the Company reviews relevant information with respect to non-litigation contingencies and, when applicable, updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. Commitments Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $210 million and $206 million at December 31, 2020 and 2019, respectively. Commitments to Fund Partnership Investments, Bank Credit Facilities and Private Corporate Bond Investments The Company commits to fund partnership investments and to lend funds under bank credit facilities and private corporate bond investments. The amounts of these unfunded commitments were $1.7 billion and $1.8 billion at December 31, 2020 and 2019, respectively. Guarantees In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $112 million, with a cumulative maximum of $118 million, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments. In addition, the Company indemnifies its directors and officers as provided in its charters and bylaws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future. The Company’s recorded liabilities were $1 million at both December 31, 2020 and 2019 for indemnities, guarantees and commitments. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2020 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | 16. Related Party Transactions The Company has various existing arrangements with its Brighthouse affiliates and had previous arrangements with MetLife for services necessary to conduct its activities. Certain of the MetLife services have continued, however, MetLife ceased to be a related party in June 2018. See Note 11 for amounts related to continuing transition services. Non-Broker-Dealer Transactions The Company had income and expenses from transactions with MetLife (excluding broker-dealer transactions) of ($182) million and $133 million, respectively, for the year ended December 31, 2018. The material arrangements between the Company and MetLife are as follows: Reinsurance Agreements The Company has reinsurance agreements with certain of MetLife subsidiaries. See Note 5 for further discussion of the related party reinsurance agreements. Investment Transactions In the ordinary course of business, the Company had previously transferred invested assets, primarily consisting of fixed maturity securities, to and from former affiliates. See Note 6 for further discussion of the related party investment transactions. Shared Services and Overhead Allocations MetLife provides the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. The Company is charged for these services through a transition services agreement and the costs are allocated to the legal entities and products within the Company. When specific identification to a particular legal entity and/or product is not practicable, an allocation methodology based on various performance measures or activity-based costing, such as sales, new policies/contracts issued, reserves, and in-force policy counts is used. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Management believes that the methods used to allocate expenses under these arrangements are reasonable. Costs incurred with MetLife prior to the MetLife Divestiture (see Note 1) under these arrangements, that were considered related party expenses, were $186 million for the year ended December 31, 2018 and were recorded in other expenses. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events | 17. Subsequent Events Common Stock Repurchase Authorization On February 10, 2021, BHF authorized the repurchase of up to an additional $200 million of common stock. No common stock repurchases have been made under the February 10, 2021 authorization as of February 24, 2021. Future repurchases may be made through open market purchases, including pursuant to 10b5-1 plans or pursuant to accelerated stock repurchase plans, or through privately negotiated transactions, from time to time at management’s discretion in accordance with applicable legal requirements. Preferred Stock Dividend On February 16, 2021, BHF declared a dividend of $412.50 per share on its Series A Preferred Stock, $421.88 per share on its Series B Preferred Stock and $466.58 per share on its Series C Preferred Stock for a total of $25 million, which will be paid on March 25, 2021 to stockholders of record as of March 10, 2021. |
Consolidated Summary of Investm
Consolidated Summary of Investments - Other Than Investments in Related Parties | 12 Months Ended |
Dec. 31, 2020 | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block] | Schedule I Consolidated Summary of Investments — Other Than Investments in Related Parties December 31, 2020 (In millions) Types of Investments Cost or Estimated Fair Value Amount at Fixed maturity securities: Bonds: U.S. government and agency $ 6,007 $ 8,638 $ 8,638 State and political subdivision 3,673 4,640 4,640 Public utilities 3,699 4,489 4,489 Foreign government 1,487 1,832 1,832 All other corporate bonds 38,696 44,630 44,630 Total bonds 53,562 64,229 64,229 Mortgage-backed and asset-backed securities 16,694 17,968 17,968 Redeemable preferred stock 273 298 298 Total fixed maturity securities 70,529 82,495 82,495 Equity securities: Non-redeemable preferred stock 98 99 99 Common stock: Industrial, miscellaneous and all other 34 37 37 Public utilities — 2 2 Total equity securities 132 138 138 Mortgage loans 15,808 15,808 Policy loans 1,291 1,291 Limited partnerships and LLCs 2,810 2,810 Short-term investments 3,242 3,242 Other invested assets 3,747 3,747 Total investments $ 97,559 $ 109,531 _______________ (1) Cost or amortized cost for fixed maturity securities represents original cost reduced by impairments that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for mortgage loans, cost represents original cost reduced by repayments and valuation allowances and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost; for limited partnerships and LLCs, cost represents original cost adjusted for equity in earnings and distributions. |
Condensed Financial Information
Condensed Financial Information (Parent Company) | 12 Months Ended |
Dec. 31, 2020 | |
Condensed Financial Information Disclosure [Abstract] | |
Condensed Financial Information of Parent Company Only Disclosure [Text Block] | Brighthouse Financial, Inc. Schedule II Condensed Financial Information (Parent Company Only) December 31, 2020 and 2019 (In millions, except share and per share data) 2020 2019 Condensed Balance Sheets Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $45 and $44, respectively; allowance for credit losses of $0 and $0, respectively) $ 47 $ 44 Short-term investments, principally at estimated fair value 1,333 459 Investment in subsidiary 20,326 20,222 Total investments 21,706 20,725 Cash and cash equivalents 262 212 Premiums and other receivables 197 199 Current income tax recoverable 62 36 Deferred income tax receivable 1 8 Other assets 4 7 Total assets $ 22,232 $ 21,187 Liabilities and Stockholders’ Equity Liabilities Long-term and short-term debt $ 3,858 $ 4,676 Other liabilities 351 339 Total liabilities 4,209 5,015 Stockholders’ Equity Preferred stock, par value $0.01 per share; $1,403 and $425, respectively, aggregate liquidation preference — — Common stock, par value $0.01 per share; 1,000,000,000 shares authorized; 121,002,523 and 120,647,871 shares issued, respectively; 88,211,618 and 106,027,301 shares outstanding, respectively 1 1 Additional paid-in capital 13,878 12,908 Retained earnings (deficit) (534) 585 Treasury stock, at cost; 32,790,905 and 14,620,570 shares, respectively (1,038) (562) Accumulated other comprehensive income (loss) 5,716 3,240 Total stockholders’ equity 18,023 16,172 Total liabilities and stockholders’ equity $ 22,232 $ 21,187 See accompanying notes to the condensed financial information. Brighthouse Financial, Inc. Schedule II Condensed Financial Information (continued) (Parent Company Only) For the Years Ended December 31, 2020, 2019 and 2018 (In millions) 2020 2019 2018 Condensed Statements of Operations Revenues Net investment income $ 7 $ 20 $ 10 Other revenues 19 24 5 Net derivative gains (losses) 8 — — Total revenues 34 44 15 Expenses Debt repayment costs 43 — — Other expenses 211 219 183 Total expenses 254 219 183 Income (loss) before provision for income tax and equity in earnings (losses) of subsidiaries (220) (175) (168) Provision for income tax expense (benefit) (45) (37) (30) Income (loss) before equity in earnings (losses) of subsidiaries (175) (138) (138) Equity in earnings (losses) of subsidiaries (886) (602) 1,003 Net income (loss) (1,061) (740) 865 Less: Preferred stock dividends 44 21 — Net income (loss) available to common shareholders $ (1,105) $ (761) $ 865 Comprehensive income (loss) $ 1,415 $ 1,784 $ (16) See accompanying notes to the condensed financial information. Brighthouse Financial, Inc. Schedule II Condensed Financial Information (continued) (Parent Company Only) For the Years Ended December 31, 2020, 2019 and 2018 (In millions) 2020 2019 2018 Condensed Statements of Cash Flows Cash flows from operating activities Net income (loss) $ (1,061) $ (740) $ 865 Equity in (earnings) losses of subsidiaries 886 602 (1,003) Distributions from subsidiary 1,468 195 52 Other, net 68 (16) 7 Net cash provided by (used in) operating activities 1,361 41 (79) Cash flows from investing activities Sales, maturities and repayments of fixed maturity securities 11 194 3 Purchases of fixed maturity securities (12) (4) — Capital contributions to subsidiary — (412) (208) Net change in short-term investments (873) (455) — Net cash provided by (used in) investing activities (874) (677) (205) Cash flows from financing activities Long-term and short-term debt issued 1,764 2,156 893 Long-term and short-term debt repaid (2,590) (1,716) (351) Treasury stock acquired in connection with share repurchases (473) (442) (105) Preferred stock issued, net of issuance costs 948 412 — Dividends on preferred stock (44) (21) — Other, net (42) (2) (18) Net cash provided by (used in) financing activities (437) 387 419 Change in cash and cash equivalents 50 (249) 135 Cash and cash equivalents, beginning of year 212 461 326 Cash and cash equivalents, end of year $ 262 $ 212 $ 461 Supplemental disclosures of cash flow information Net cash paid (received) for: Interest $ 184 $ 187 $ 158 Income tax: Cash received from MetLife, Inc. for income tax $ — $ — $ (7) Income tax paid (received) by Brighthouse Financial, Inc. (25) (4) 1 Net cash paid (received) for income tax $ (25) $ (4) $ (6) The condensed financial information of Brighthouse Financial, Inc. (the “Parent Company”) should be read in conjunction with the consolidated financial statements of Brighthouse Financial, Inc. and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for Brighthouse Financial, Inc. Investments in subsidiaries are accounted for using the equity method of accounting. Beginning in 2020, the Parent Company elected to change the presentation of equity in earnings (losses) of subsidiaries, including it as a separate component on net income in the Condensed Statement of Operations. This presentation was applied to all periods presented in the condensed financial information of the Parent Company. Previously, this activity was presented as a component of total revenues. The preparation of these condensed unconsolidated financial statements in conformity with GAAP requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates. Long-term and short-term debt outstanding was as follows at: December 31, Stated Interest Rate Maturity 2020 2019 (In millions) Senior notes — unaffiliated 3.700% 2027 $ 1,294 $ 1,492 Senior notes — unaffiliated 5.625% 2030 614 — Senior notes — unaffiliated 4.700% 2047 1,134 1,478 Term loan — unaffiliated LIBOR plus 1.5% 2024 — 1,000 Junior subordinated debentures — unaffiliated 6.250% 2058 363 363 Total long-term debt (1) 3,405 4,333 Short-term intercompany loans 453 343 Total long-term and short-term debt (1) $ 3,858 $ 4,676 _______________ (1) Includes unamortized debt issuance costs, discounts and premiums, as applicable, totaling net $35 million and $42 million for the senior notes and junior subordinated debentures on a combined basis at December 31, 2020 and 2019, respectively. The aggregate maturities of long-term and short-term debt at December 31, 2020 were $453 million in 2021, $0 in each of 2022, 2023, 2024 and 2025 and $3.4 billion thereafter. Interest expense related to long-term and short-term debt of $183 million, $191 million and $157 million for the years ended December 31, 2020, 2019 and 2018, respectively, is included in other expenses. Senior Notes and Junior Subordinated Debentures See Note 9 of the Notes to the Consolidated Financial Statements for information regarding the unaffiliated senior notes and junior subordinated debentures. Credit Facilities See Note 9 of the Notes to the Consolidated Financial Statements for information regarding BHF’s credit facilities, including the unaffiliated term loan. Short-term Intercompany Loans BHF, as borrower, has a short-term intercompany loan agreement with certain of its non-insurance subsidiaries, as lenders, for the purposes of facilitating the management of the available cash of the borrower and the lenders on a short-term and consolidated basis. Such intercompany loan agreement allows management to optimize the efficient use of and maximize the yield on cash between BHF and its subsidiary lenders. Each loan entered into under this intercompany loan agreement has a term not more than 364 days and bears interest on the unpaid principal amount at a variable rate, payable monthly. During the years ended December 31, 2020, 2019 and 2018, BHF borrowed $1.2 billion, $1.2 billion and $478 million, respectively, from certain of its non-insurance subsidiaries and repaid $1.0 billion, $1.1 billion and $311 million of such borrowings during the years ended December 31, 2020, 2019 and 2018, respectively. The weighted average interest rate on short-term intercompany loans outstanding at December 31, 2020, 2019 and 2018 was 0.05%, 0.95% and 1.80%, respectively. Intercompany Liquidity Facilities BHF has established intercompany liquidity facilities with certain of its insurance and non-insurance subsidiaries to provide short-term liquidity within and across the combined group of companies. Under these facilities, which are comprised of a series of revolving loan agreements among BHF and its participating subsidiaries, each company may lend to or borrow from each other, subject to certain maximum limits for a term not more than 364 days. During the years ended December 31, 2020 and 2019, there were no borrowings or repayments by BHF under these facilities. In the second quarter of 2018, BHF borrowed $40 million from NELICO under this facility and repaid such borrowing in the third quarter of 2018. |
Consolidated Supplementary Insu
Consolidated Supplementary Insurance Information | 12 Months Ended |
Dec. 31, 2020 | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Disclosure [Text Block] | Brighthouse Financial, Inc. Schedule III Consolidated Supplementary Insurance Information December 31, 2020 and 2019 (In millions) Segment DAC Future Policy Benefits and Other Policy-Related Balances Policyholder Account Balances Unearned Premiums (1)(2) Unearned Revenue (1) 2020 Annuities $ 3,829 $ 10,452 $ 43,784 $ — $ 86 Life 971 6,242 3,085 10 350 Run-off 5 23,558 7,638 — 184 Corporate & Other 106 7,607 1 5 — Total $ 4,911 $ 47,859 $ 54,508 $ 15 $ 620 2019 Annuities $ 4,327 $ 9,073 $ 34,770 $ — $ 88 Life 1,019 5,832 3,128 13 335 Run-off 5 20,192 7,872 — 151 Corporate & Other 97 7,700 1 6 — Total $ 5,448 $ 42,797 $ 45,771 $ 19 $ 574 _______________ (1) Amounts are included within the future policy benefits and other policy-related balances column. (2) Includes premiums received in advance. Brighthouse Financial, Inc. Schedule III Consolidated Supplementary Insurance Information (continued) December 31, 2020, 2019 and 2018 (In millions) Segment Premiums and Net Policyholder Benefits and Claims and Amortization of Other 2020 Annuities $ 2,656 $ 1,809 $ 2,452 $ 668 $ 1,554 Life 848 459 869 107 176 Run-off 641 1,263 3,422 — 186 Corporate & Other 84 70 60 (9) 437 Total $ 4,229 $ 3,601 $ 6,803 $ 766 $ 2,353 2019 Annuities $ 2,788 $ 1,797 $ 1,414 $ 363 $ 1,676 Life 871 434 824 5 211 Run-off 718 1,273 2,436 — 200 Corporate & Other 85 75 59 14 404 Total $ 4,462 $ 3,579 $ 4,733 $ 382 $ 2,491 2018 Annuities $ 2,947 $ 1,522 $ 1,597 $ 944 $ 1,629 Life 927 447 768 90 241 Run-off 776 1,312 1,922 — 202 Corporate & Other 85 57 64 16 503 Total $ 4,735 $ 3,338 $ 4,351 $ 1,050 $ 2,575 _______________ (1) See Note 2 of the Notes to the Consolidated Financial Statements for the basis of allocation of net investment income. |
Consolidated Reinsurance
Consolidated Reinsurance | 12 Months Ended |
Dec. 31, 2020 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] | |
Consolidated Reinsurance | Brighthouse Financial, Inc. Schedule IV Consolidated Reinsurance December 31, 2020, 2019 and 2018 (Dollars in millions) Gross Amount Ceded Assumed Net Amount % Amount Assumed to Net 2020 Life insurance in-force $ 541,463 $ 164,336 $ 7,293 $ 384,420 1.9% Insurance premium Life insurance (1) $ 1,289 $ 538 $ 10 $ 761 1.3% Accident & health insurance 220 215 — 5 —% Total insurance premium $ 1,509 $ 753 $ 10 $ 766 1.3% 2019 Life insurance in-force $ 568,120 $ 175,728 $ 7,153 $ 399,545 1.8% Insurance premium Life insurance (1) $ 1,424 $ 556 $ 10 $ 878 1.1% Accident & health insurance 227 223 — 4 —% Total insurance premium $ 1,651 $ 779 $ 10 $ 882 1.1% 2018 Life insurance in-force $ 597,694 $ 191,083 $ 7,458 $ 414,069 1.8% Insurance premium Life insurance (1) $ 1,468 $ 580 $ 11 $ 899 1.2% Accident & health insurance 231 230 — 1 —% Total insurance premium $ 1,699 $ 810 $ 11 $ 900 1.2% _______________ (1) Includes annuities with life contingencies. |
Business, Basis of Presentati_2
Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Use of Estimates, Policy [Policy Text Block] | Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates. |
Consolidation, Policy [Policy Text Block] | Consolidation The accompanying consolidated financial statements include the accounts of Brighthouse Financial, as well as partnerships and limited liability companies (“LLCs”) that the Company controls. Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in limited partnerships and LLCs when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. When the Company has virtually no influence over the investee’s operations, the investment is carried at fair value. Reclassifications |
Future Policy Benefit Liability [Policy Text Block] | Future Policy Benefit Liabilities and Policyholder Account Balances The Company establishes liabilities for future amounts payable under insurance policies. Insurance liabilities are generally equal to the present value of future expected benefits to be paid, reduced by the present value of future expected net premiums. Assumptions used to measure the liability are based on the Company’s experience and include a margin for adverse deviation. The most significant assumptions used in the establishment of liabilities for future policy benefits are mortality, benefit election and utilization, withdrawals, policy lapse, and investment returns as appropriate to the respective product type. For traditional long-duration insurance contracts (term, whole life insurance and income annuities), assumptions are determined at issuance of the policy and are not updated unless a premium deficiency exists. A premium deficiency exists when the liability for future policy benefits plus the present value of expected future gross premiums are less than expected future benefits and expenses (based on current assumptions). When a premium deficiency exists, the Company will reduce any deferred acquisition costs and may also establish an additional liability to eliminate the deficiency. To assess whether a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced and measured for profitability. In applying the profitability criteria, groupings are limited by segment. The Company is also required to reflect the effect of investment gains and losses in its premium deficiency testing. When a premium deficiency exists related to unrealized gains and losses, any reductions in deferred acquisition costs or increases in insurance liabilities are recorded to other comprehensive income (loss) (“OCI”). Policyholder account balances relate to customer deposits on universal life insurance and deferred annuity contracts and are equal to the sum of deposits, plus interest credited, less charges and withdrawals. The Company may also hold additional liabilities for certain guaranteed benefits related to these contracts. Liabilities for secondary guarantees on universal life insurance contracts are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. The Company also maintains a liability for profits followed by losses on universal life with secondary guarantees (“ULSG”) determined by projecting future earnings and establishing a liability to offset losses that are expected to occur in later years. Changes in ULSG liabilities are recorded to net income, except for the effects of unrealized gains and losses, which are recorded to OCI. |
Insurance Premiums Revenue Recognition, Policy [Policy Text Block] | Recognition of Insurance Revenues and Deposits Premiums related to traditional life insurance and annuity contracts are recognized as revenues when due from policyholders. When premiums for income annuities are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to the amount of expected future benefit payments. Deposits related to universal life insurance, deferred annuity contracts and investment contracts are credited to policyholder account balances. Revenues from such contracts consist of asset-based investment management fees, cost of insurance charges, risk charges, policy administration fees and surrender charges. These fees, which are included in universal life and investment-type product policy fees, are recognized when assessed to the contract holder, except for non-level insurance charges which are deferred and amortized over the life of the contracts. Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance. |
Deferred Policy Acquisition Costs, Policy [Policy Text Block] | Deferred Policy Acquisition Costs, Value of Business Acquired and Deferred Sales Inducements The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA related to term non-participating whole life insurance over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, in-force or persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. The Company amortizes DAC and VOBA on deferred annuities and universal life insurance contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon investment returns in excess of the amounts credited to policyholders, mortality, in-force or persistency, benefit elections and utilization, and withdrawals. When significant negative gross profits are expected in future periods, the Company substitutes the amount of insurance in-force for expected future gross profits as the amortization basis for DAC. Assumptions for DAC and VOBA are reviewed at least annually, and if they change significantly, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to net income. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. The Company updates expected future gross profits to reflect the actual gross profits for each period, including changes to its nonperformance risk related to embedded derivatives and the actual amount of business remaining in-force. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the actual gross profits are below the previously expected future gross profits. DAC and VOBA balances on deferred annuities and universal life insurance contracts are also adjusted to reflect the effect of investment gains and losses and certain embedded derivatives (including changes in nonperformance risk). These adjustments can create fluctuations in net income from period to period. Changes in DAC and VOBA balances related to unrealized gains and losses are recorded to OCI. DAC and VOBA balances and amortization for variable contracts can be significantly impacted by changes in expected future gross profits related to projected separate account rates of return. The Company’s practice of determining changes in separate account returns assumes that long-term appreciation in equity markets is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately as net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. |
Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Policy [Policy Text Block] | Deferred Policy Acquisition Costs, Value of Business Acquired and Deferred Sales Inducements The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. These costs mainly consist of commissions and include the portion of employees’ compensation and benefits related to time spent selling, underwriting or processing the issuance of new insurance contracts. All other acquisition-related costs are expensed as incurred. Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity and investment-type contracts in-force as of the acquisition date. The Company amortizes DAC and VOBA related to term non-participating whole life insurance over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, in-force or persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. The Company amortizes DAC and VOBA on deferred annuities and universal life insurance contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon investment returns in excess of the amounts credited to policyholders, mortality, in-force or persistency, benefit elections and utilization, and withdrawals. When significant negative gross profits are expected in future periods, the Company substitutes the amount of insurance in-force for expected future gross profits as the amortization basis for DAC. Assumptions for DAC and VOBA are reviewed at least annually, and if they change significantly, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to net income. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. The Company updates expected future gross profits to reflect the actual gross profits for each period, including changes to its nonperformance risk related to embedded derivatives and the actual amount of business remaining in-force. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to net income. The opposite result occurs when the actual gross profits are below the previously expected future gross profits. DAC and VOBA balances on deferred annuities and universal life insurance contracts are also adjusted to reflect the effect of investment gains and losses and certain embedded derivatives (including changes in nonperformance risk). These adjustments can create fluctuations in net income from period to period. Changes in DAC and VOBA balances related to unrealized gains and losses are recorded to OCI. DAC and VOBA balances and amortization for variable contracts can be significantly impacted by changes in expected future gross profits related to projected separate account rates of return. The Company’s practice of determining changes in separate account returns assumes that long-term appreciation in equity markets is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of an existing contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If a modification is considered to have substantially changed the contract, the associated DAC or VOBA is written off immediately as net income and any new acquisition costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. |
Sales Inducements to Contract Holders, Policy [Policy Text Block] | The Company also has intangible assets representing deferred sales inducements (“DSI”) which are included in other assets. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of DSI is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews DSI to determine whether the assets are impaired. |
Reinsurance Accounting Policy [Policy Text Block] | Reinsurance The Company enters into reinsurance arrangements pursuant to which it cedes certain insurance risks to unaffiliated reinsurers. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The accounting for reinsurance arrangements depends on whether the arrangement provides indemnification against loss or liability relating to insurance risk in accordance with GAAP. For ceded reinsurance of existing in-force blocks of insurance contracts that transfer significant insurance risk, premiums, benefits and the amortization of DAC are reported net of reinsurance ceded. Amounts recoverable from reinsurers related to incurred claims and ceded reserves are included in premiums, reinsurance and other receivables and amounts payable to reinsurers included in other liabilities. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. Under certain reinsurance agreements, the Company withholds the funds rather than transferring the underlying investments and, as a result, records a funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Certain funds withheld arrangements may also contain embedded derivatives measured at fair value that are related to the investment return on the assets withheld. The Company accounts for assumed reinsurance similar to directly written business, except for guaranteed minimum income benefits (“GMIB”), where a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. |
Minimum Guarantees, Policy [Policy Text Block] | Variable Annuity Guarantees The Company issues certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (the “Benefit Base”) less withdrawals. In some cases, the Benefit Base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups. Certain of the Company’s variable annuity guarantee features are accounted for as insurance liabilities and recorded in future policy benefits while others are accounted for at fair value as embedded derivatives and recorded in policyholder account balances. Generally, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either the occurrence of a specific insurable event, or annuitization. Alternatively, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring the occurrence of specific insurable event, or the policyholder to annuitize, that is, the policyholder can receive the guarantee on a net basis. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Further, changes in assumptions, principally involving policyholder behavior, can result in a change of expected future cash outflows of a guarantee between portions accounted for as insurance liabilities and portions accounted for as embedded derivatives. Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDB”), the life contingent portion of the guaranteed minimum withdrawal benefits (“GMWB”) and the portion of the GMIBs that require annuitization, as well as the life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value. These insurance liabilities are accrued over the accumulation phase of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, the actual amount of business remaining in-force is updated, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings. Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs, guaranteed minimum accumulation benefits (“GMAB”), and for GMIBs the non-life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value, as well as the guaranteed principal option. The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees are considered revenue and are reported in universal life and investment-type product policy fees. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods. The Company updates the estimated fair value of guarantees in subsequent periods by projecting future benefits using capital market and actuarial assumptions including expectations of policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect the Company’s nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value of embedded derivatives, see Note 8. Assumptions for all variable guarantees are reviewed at least annually, and if they change significantly, the estimated fair value is adjusted by a cumulative charge or credit to net income. Index-linked Annuities The Company issues and assumes through reinsurance index-linked annuities. The crediting rate associated with index-linked annuities is accounted for at fair value as an embedded derivative. The estimated fair value is determined using a combination of an option pricing model and an option-budget approach. Under this approach, the company estimates the cost of funding the crediting rate using option pricing and establishes that cost on the balance sheet as a reduction to the initial deposit amount. In subsequent periods, the embedded derivative is remeasured at fair value while the reduction in initial deposit is accreted back up to the initial deposit over the estimated life of the contract. Embedded Derivatives Embedded derivatives principally include certain direct and ceded variable annuity guarantees and equity crediting rates within index-linked annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The Company issues certain variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and certain portions of GMIBs are accounted for as embedded derivatives and measured at estimated fair value separately from the host variable annuity contract. These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets, with changes in estimated fair value reported in net derivative gains (losses). The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods. Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly-traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims-paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. |
Investments, Policy [Policy Text Block] | Investments Net Investment Income and Net Investment Gains (Losses) Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein. Fixed Maturity Securities Available-For-Sale The Company’s fixed maturity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of OCI, net of policy-related amounts and deferred income taxes. Publicly-traded security transactions are recorded on a trade date basis, while privately-placed and bank loan security transactions are recorded on a settlement date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”) considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed, and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis. The Company regularly evaluates fixed maturity securities for declines in fair value to determine if a credit loss exists. This evaluation is based on management’s case by case evaluation of the underlying reasons for the decline in fair value including, but not limited to an analysis of the gross unrealized losses by severity and financial condition of the issuer. For fixed maturity securities in an unrealized loss position, when the Company has the intent to sell the security, or it is more likely than not that the Company will be required to sell the security before recovery, the amortized cost basis of the security is written down to fair value through net investment gains (losses). For fixed maturity securities that do not meet the aforementioned criteria, management evaluates whether the decline in estimated fair value has resulted from credit losses or other factors. If the Company determines the decline in estimated fair value is due to credit losses, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an allowance through net investment gains (losses). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the allowance related to other-than-credit factors is recorded in OCI. Once a security specific allowance for credit losses is established, the present value of cash flows expected to be collected from the security continues to be reassessed. Any changes in the security specific allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in net investment gains (losses). Fixed maturity securities are also evaluated to determine whether any amounts have become uncollectible. When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses. Mortgage Loans Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and any deferred fees or expenses, and net of an allowance for credit losses. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. The allowance for credit losses for mortgage loans represents the Company’s best estimate of expected credit losses over the remaining life of the loans and is determined using relevant available information from internal and external sources, relating to past events, current conditions, and a reasonable and supportable forecast. Policy Loans Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy. Limited Partnerships and LLCs The Company uses the equity method of accounting for investments when it has more than a minor ownership interest or more than a minor influence over the investee’s operations; when the Company has virtually no influence over the investee’s operations the investment is carried at estimated fair value. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on investments carried at estimated fair value are recognized as earned or received. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Other Invested Assets Other invested assets consist principally of freestanding derivatives with positive estimated fair values which are described in “—Derivatives” below. Securities Lending Program Securities lending transactions whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. |
Derivatives, Policy [Policy Text Block] | Derivatives Freestanding Derivatives Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses). The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows. Hedge Accounting The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses). Embedded Derivatives The Company has certain insurance and reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. These host contracts include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; index-linked annuities that are directly written or assumed through reinsurance; and ceded reinsurance of variable annuity GMIBs. Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the consolidated balance sheets. Changes in the estimated fair value of the embedded derivative are reported in net derivative gains (losses). See “— Variable Annuity Guarantees,” “— Index-Linked Annuities” and “— Reinsurance” for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts. Accounting for Derivatives See Note 1 for a description of the Company’s accounting policies for derivatives and Note 8 for information about the fair value hierarchy for derivatives. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. In determining the estimated fair value of the Company’s investments, fair values are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical investments, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of investments. When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. |
Policyholder Accounts, Policy [Policy Text Block] | Separate Accounts Separate accounts underlying the Company’s variable life and annuity contracts are reported at fair value. Assets in separate accounts supporting the contract liabilities are legally insulated from the Company’s general account liabilities. Investments in these separate accounts are directed by the contract holder and all investment performance, net of contract fees and assessments, is passed through to the contract holder. Investment performance and the corresponding amounts credited to contract holders of such separate accounts are offset within the same line on the statements of operations. Separate accounts that do not pass all investment performance to the contract holder, including those underlying certain index-linked annuities, are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. The accounting for investments in these separate accounts is consistent with the methodologies described herein for similar financial instruments held within the general account. The Company receives asset-based distribution and service fees from mutual funds available to the variable life and annuity contract holders as investment options in its separate accounts. These fees are recognized in the period in which the related services are performed and are included in other revenues in the statement of operations. |
Income Tax, Policy [Policy Text Block] | Income Tax Income taxes as presented herein attribute current and deferred income taxes of MetLife, Inc., for periods up until the Separation, to Brighthouse Financial in a manner that is systematic, rational and consistent with the asset and liability method prescribed by the Financial Accounting Standards Board (“FASB”) guidance Accounting Standards Codification 740 — Income Taxes (“ASC 740”). The Company’s income tax provision was prepared following the modified separate return method. The modified separate return method applies ASC 740 to the standalone financial statements of each member of the consolidated group as if the group member were a separate taxpayer and a standalone enterprise, after providing benefits for losses. The Company’s accounting for income taxes represents management’s best estimate of various events and transactions. Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, the Company considers many factors, including the jurisdiction in which the deferred tax asset was generated, the length of time that carryforward can be utilized in the various taxing jurisdictions, future taxable income exclusive of reversing temporary differences and carryforwards, future reversals of existing taxable temporary differences, taxable income in prior carryback years, tax planning strategies and the nature, frequency, and amount of cumulative financial reporting income and losses in recent years. The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made. |
Commitments and Contingencies, Policy [Policy Text Block] | Litigation ContingenciesThe Company is a party to a number of legal actions and may be involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected on the Company’s financial statements. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at estimated fair value or amortized cost, which approximates estimated fair value. |
Pension and Other Postretirement Plans, Policy [Policy Text Block] | Employee Benefit Plans Brighthouse Services, LLC (“Brighthouse Services”), sponsors qualified and non-qualified defined contribution plans, and New England Life Insurance Company (“NELICO”) sponsors certain frozen defined benefit pension and postretirement plans. NELICO recognizes the funded status of each of its pension plans, measured as the difference between the fair value of plan assets and the benefit obligation, which is the projected benefit obligation (“PBO”) for pension benefits in other assets or other liabilities. Brighthouse Services and NELICO are both indirect wholly-owned subsidiaries. Actuarial gains and losses result from differences between the actual experience and the assumed experience on plan assets or PBO during a particular period and are recorded in accumulated other comprehensive income (loss) (“AOCI”). To the extent such gains and losses exceed 10% of the greater of the PBO or the estimated fair value of plan assets, the excess is amortized into net periodic benefit costs over the average projected future lifetime of all plan participants or projected future working lifetime, as appropriate. Prior service costs (credit) are recognized in AOCI at the time of the amendment and then amortized into net periodic benefit costs over the average projected future lifetime of all plan participants or projected future working lifetime, as appropriate. |
New Accounting Pronouncements, Policy [Policy Text Block] | Adoption of New Accounting Pronouncements Changes to GAAP are established by the FASB in the form of accounting standards updates (“ASU”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s consolidated financial statements. Effective January 1, 2020, using the modified retrospective method, the Company adopted ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than-temporary impairment on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses. The Company recorded an after tax net decrease to retained earnings of $14 million and a net increase to AOCI of $3 million for the cumulative effect of adoption. The adjustment included establishing or updating the allowance for credit losses on fixed maturity securities, mortgage loans, and other invested assets. Future Adoption of New Accounting Pronouncements In August 2018, the FASB issued new guidance on long-duration contracts (ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts ). This new guidance is effective for fiscal years beginning after January 1, 2023. The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (i) require all guarantees that qualify as market risk benefits to be measured at fair value, (ii) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (iii) modify the methods of amortization for deferred policy acquisition costs (“DAC”), and (iv) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances. The market risk benefit guidance is required to be applied on a retrospective basis, while the changes to guidance for insurance liabilities and DAC may be applied to existing carrying amounts on the effective date or on a retrospective basis. The Company continues to evaluate the new guidance and therefore is unable to estimate the impact on its financial statements. The most significant impact from the ASU is the requirement that all variable annuity guarantees will be considered market risk benefits and measured at fair value, whereas today a significant amount of variable annuity guarantees are classified as insurance liabilities. |
Share-based Payment Arrangement [Policy Text Block] | The Company’s share-based compensation plans provide awards to employees and non-employee directors and may be in the form of non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, or other share-based awards. Additionally, employees may purchase shares at a discount under an employee stock purchase plan (the “ESPP”).All share-based compensation is measured at fair value as of the grant date. The Company recognizes compensation expense related to share-based awards based on the number of awards expected to vest, which for some award types represent the awards granted less expected forfeitures over the life of the award, as estimated at the date of grant and actual forfeitures for other award types. Unless a material deviation from the assumed forfeiture rate is observed during the term in which the awards are expensed, the Company recognizes any adjustment necessary to reflect differences in actual experience in the period the award becomes payable or exercisable. Compensation expense related to share-based awards, which is included in other expenses, is principally related to the issuance of restricted stock units and performance units with other costs incurred relating to stock options. The Company grants the majority of each year’s awards in the first quarter of the year. Restricted Stock Units (“RSU”) RSUs are units that, if vested, are payable in shares of BHF common stock. The Company does not credit RSUs with dividend-equivalents as RSUs do not accrue dividends. Accordingly, the estimated fair value of RSUs is based upon the closing price of shares on the date of grant, less a forfeiture rate. With the exception of the Founders’ Grant, most RSUs use graded vesting and vest in thirds on, or shortly after, the first three anniversaries of their grant date, while other RSUs vest in their entirety on the specified anniversary of their grant date. Vesting is subject to continued service, except for employees who meet specified age and service criteria, and in certain other limited circumstances. Performance Share Units (“PSU”) |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Segment Reporting [Abstract] | |
Segment Reporting Information, by Segment | Operating results by segment, as well as Corporate & Other, were as follows: Year Ended December 31, 2020 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,433 $ 182 $ (1,655) $ (332) $ (372) Provision for income tax expense (benefit) 266 34 (356) (87) (143) Post-tax adjusted earnings 1,167 148 (1,299) (245) (229) Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — 44 44 Adjusted earnings $ 1,167 $ 148 $ (1,299) $ (294) (278) Adjustments for: Net investment gains (losses) 278 Net derivative gains (losses) (18) Other adjustments to net income (loss) (1,307) Provision for income tax (expense) benefit 220 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (1,105) Interest revenue $ 1,820 $ 460 $ 1,269 $ 70 Interest expense $ — $ — $ — $ 184 Year Ended December 31, 2019 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,263 $ 288 $ (580) $ (301) $ 670 Provision for income tax expense (benefit) 235 57 (126) (121) 45 Post-tax adjusted earnings 1,028 231 (454) (180) 625 Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — 21 21 Adjusted earnings $ 1,028 $ 231 $ (454) $ (206) 599 Adjustments for: Net investment gains (losses) 112 Net derivative gains (losses) (1,988) Other adjustments to net income (loss) 154 Provision for income tax (expense) benefit 362 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (761) Interest revenue $ 1,809 $ 436 $ 1,265 $ 75 Interest expense $ — $ — $ — $ 191 Year Ended December 31, 2018 Annuities Life Run-off Corporate & Other Total (In millions) Pre-tax adjusted earnings $ 1,233 $ 285 $ (57) $ (431) $ 1,030 Provision for income tax expense (benefit) 210 57 (14) (120) 133 Post-tax adjusted earnings 1,023 228 (43) (311) 897 Less: Net income (loss) attributable to noncontrolling interests — — — 5 5 Less: Preferred stock dividends — — — — — Adjusted earnings $ 1,023 $ 228 $ (43) $ (316) 892 Adjustments for: Net investment gains (losses) (207) Net derivative gains (losses) 702 Other adjustments to net income (loss) (536) Provision for income tax (expense) benefit 14 Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ 865 Interest revenue $ 1,536 $ 449 $ 1,310 $ 57 Interest expense $ — $ — $ — $ 158 Total assets by segment, as well as Corporate & Other, were as follows at: December 31, 2020 2019 (In millions) Annuities $ 172,233 $ 156,965 Life 23,809 21,876 Run-off 38,366 35,112 Corporate & Other 13,461 13,306 Total $ 247,869 $ 227,259 |
Reconciliation of Revenue from Segments to Consolidated | Total revenues by segment, as well as Corporate & Other, were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Annuities $ 4,563 $ 4,648 $ 4,567 Life 1,334 1,328 1,389 Run-off 1,938 2,009 2,112 Corporate & Other 156 176 152 Adjustments 512 (1,607) 745 Total $ 8,503 $ 6,554 $ 8,965 |
Premiums, Universal Life and Investment-Type Product Policy Fees and Other Revenues by Product Groups | Total premiums, universal life and investment-type product policy fees and other revenues by major product group were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Annuity products $ 3,010 $ 3,106 $ 3,304 Life insurance products 1,619 1,709 1,827 Other products 13 36 1 Total $ 4,642 $ 4,851 $ 5,132 |
Insurance (Tables)
Insurance (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Insurance [Abstract] | |
Insurance Liabilities | Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at: December 31, 2020 2019 (In millions) Annuities $ 54,236 $ 43,843 Life 9,327 8,960 Run-off 31,196 28,064 Corporate & Other 7,608 7,701 Total $ 102,367 $ 88,568 |
Liabilities for Guarantees | Information regarding the liabilities for guarantees (excluding policyholder account balances and embedded derivatives) relating to variable annuity contracts and universal and variable life insurance contracts was as follows: Variable Annuity Contracts Universal and Variable Life Contracts GMDBs GMIBs Secondary Guarantees Total (In millions) Direct Balance at January 1, 2018 $ 1,439 $ 2,709 $ 4,232 $ 8,380 Incurred guaranteed benefits 186 365 484 1,035 Paid guaranteed benefits (58) — — (58) Balance at December 31, 2018 1,567 3,074 4,716 9,357 Incurred guaranteed benefits 143 163 874 1,180 Paid guaranteed benefits (90) — — (90) Balance at December 31, 2019 1,620 3,237 5,590 10,447 Incurred guaranteed benefits 129 1,133 1,244 2,506 Paid guaranteed benefits (103) — (169) (272) Balance at December 31, 2020 $ 1,646 $ 4,370 $ 6,665 $ 12,681 Net Ceded/(Assumed) Balance at January 1, 2018 $ 18 $ — $ 945 $ 963 Incurred guaranteed benefits 49 — 18 67 Paid guaranteed benefits (56) — — (56) Balance at December 31, 2018 11 — 963 974 Incurred guaranteed benefits 86 — 120 206 Paid guaranteed benefits (88) — — (88) Balance at December 31, 2019 9 — 1,083 1,092 Incurred guaranteed benefits 96 — 102 198 Paid guaranteed benefits (101) — (39) (140) Balance at December 31, 2020 $ 4 $ — $ 1,146 $ 1,150 Net Balance at January 1, 2018 $ 1,421 $ 2,709 $ 3,287 $ 7,417 Incurred guaranteed benefits 137 365 466 968 Paid guaranteed benefits (2) — — (2) Balance at December 31, 2018 1,556 3,074 3,753 8,383 Incurred guaranteed benefits 57 163 754 974 Paid guaranteed benefits (2) — — (2) Balance at December 31, 2019 1,611 3,237 4,507 9,355 Incurred guaranteed benefits 33 1,133 1,142 2,308 Paid guaranteed benefits (2) — (130) (132) Balance at December 31, 2020 $ 1,642 $ 4,370 $ 5,519 $ 11,531 |
Fund Groupings | Account balances of contracts with guarantees were invested in separate account asset classes as follows at: December 31, 2020 2019 (In millions) Fund Groupings: Balanced $ 64,736 $ 64,134 Equity 32,811 29,036 Bond 9,105 8,467 Money Market 16 16 Total $ 106,668 $ 101,653 |
Guarantees related to Annuity, Universal and Variable Life Contracts | Information regarding the Company’s guarantee exposure was as follows at: December 31, 2020 2019 In the At In the At (Dollars in millions) Annuity Contracts (1), (2) Variable Annuity Guarantees Total account value (3) $ 108,424 $ 60,674 $ 104,271 $ 59,859 Separate account value $ 103,315 $ 59,419 $ 99,385 $ 58,694 Net amount at risk $ 6,438 (4) $ 6,692 (5) $ 6,671 (4) $ 4,750 (5) Average attained age of contract holders 70 years 70 years 68 years 68 years December 31, 2020 2019 Secondary Guarantees (Dollars in millions) Universal Life Contracts Total account value (3) $ 5,772 $ 5,957 Net amount at risk (6) $ 69,083 $ 71,124 Average attained age of policyholders 67 years 66 years Variable Life Contracts Total account value (3) $ 3,926 $ 3,526 Net amount at risk (6) $ 19,909 $ 21,325 Average attained age of policyholders 51 years 50 years _______________ (1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. (2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk presented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 for a discussion of guaranteed minimum benefits which have been reinsured. (3) Includes the contract holder’s investments in the general account and separate account, if applicable. (4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death. (5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved. (6) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date. |
Deferred Policy Acquisition C_2
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |
Schedule of Deferred Policy Acquisition Costs and Value of Business Acquired | Information regarding DAC and VOBA was as follows: Years Ended December 31, 2020 2019 2018 (In millions) DAC: Balance at January 1, $ 4,946 $ 5,149 $ 5,678 Capitalizations 408 369 322 Amortization related to net investment gains (losses) and net derivative gains (losses) 95 204 (384) All other amortization (833) (577) (560) Total amortization (738) (373) (944) Unrealized investment gains (losses) (209) (199) 93 Balance at December 31, 4,407 4,946 5,149 VOBA: Balance at January 1, 502 568 608 Amortization related to net investment gains (losses) and net derivative gains (losses) — (1) (1) All other amortization (28) (8) (105) Total amortization (28) (9) (106) Unrealized investment gains (losses) 30 (57) 66 Balance at December 31, 504 502 568 Total DAC and VOBA: Balance at December 31, $ 4,911 $ 5,448 $ 5,717 |
Deferred Policy Acquisition Costs | Information regarding DAC and VOBA was as follows: Years Ended December 31, 2020 2019 2018 (In millions) DAC: Balance at January 1, $ 4,946 $ 5,149 $ 5,678 Capitalizations 408 369 322 Amortization related to net investment gains (losses) and net derivative gains (losses) 95 204 (384) All other amortization (833) (577) (560) Total amortization (738) (373) (944) Unrealized investment gains (losses) (209) (199) 93 Balance at December 31, 4,407 4,946 5,149 VOBA: Balance at January 1, 502 568 608 Amortization related to net investment gains (losses) and net derivative gains (losses) — (1) (1) All other amortization (28) (8) (105) Total amortization (28) (9) (106) Unrealized investment gains (losses) 30 (57) 66 Balance at December 31, 504 502 568 Total DAC and VOBA: Balance at December 31, $ 4,911 $ 5,448 $ 5,717 |
Information Regarding Deferred Policy Acquisition Costs and Value of Business Acquired by Segment | Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at: December 31, 2020 2019 (In millions) Annuities $ 3,829 $ 4,327 Life 971 1,019 Run-off 5 5 Corporate & Other 106 97 Total $ 4,911 $ 5,448 |
Deferred Sales Inducements | Information regarding DSI was as follows: Years Ended December 31, 2020 2019 2018 (In millions) DSI: Balance at January 1, $ 379 $ 410 $ 431 Capitalization 2 2 2 Amortization (71) (38) (41) Unrealized investment gains (losses) — 5 18 Balance at December 31, $ 310 $ 379 $ 410 |
Reinsurance (Tables)
Reinsurance (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Effects of Reinsurance [Line Items] | |
Effect of reinsurance | The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Premiums Direct premiums $ 1,509 $ 1,651 $ 1,699 Reinsurance assumed 10 10 11 Reinsurance ceded (753) (779) (810) Net premiums $ 766 $ 882 $ 900 Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees $ 4,022 $ 4,048 $ 4,296 Reinsurance assumed 48 72 95 Reinsurance ceded (607) (540) (556) Net universal life and investment-type product policy fees $ 3,463 $ 3,580 $ 3,835 Other revenues Direct other revenues $ 351 $ 366 $ 373 Reinsurance assumed 16 1 — Reinsurance ceded 46 22 24 Net other revenues $ 413 $ 389 $ 397 Policyholder benefits and claims Direct policyholder benefits and claims $ 7,545 $ 5,441 $ 4,891 Reinsurance assumed 103 36 32 Reinsurance ceded (1,937) (1,807) (1,651) Net policyholder benefits and claims $ 5,711 $ 3,670 $ 3,272 The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: December 31, 2020 2019 Direct Assumed Ceded Total Direct Assumed Ceded Total (In millions) Assets Premiums, reinsurance and other receivables (net of allowance for credit losses) $ 728 $ 6 $ 15,424 $ 16,158 $ 631 $ 14 $ 14,115 $ 14,760 Liabilities Future policy benefits $ 44,329 $ 119 $ — $ 44,448 $ 39,581 $ 105 $ — $ 39,686 Policyholder account balances $ 51,451 $ 3,057 $ — $ 54,508 $ 43,154 $ 2,617 $ — $ 45,771 Other policy-related balances $ 1,723 $ 1,688 $ — $ 3,411 $ 1,447 $ 1,664 $ — $ 3,111 Other liabilities $ 3,832 $ 31 $ 1,148 $ 5,011 $ 4,106 $ 32 $ 1,098 $ 5,236 Information regarding the significant effects of reinsurance with former MetLife affiliates included on the consolidated statements of operations was as follows: Year Ended (In millions) Premiums Reinsurance assumed $ 6 Reinsurance ceded (201) Net premiums $ (195) Universal life and investment-type product policy fees Reinsurance assumed $ 45 Reinsurance ceded 1 Net universal life and investment-type product policy fees $ 46 Other revenues Reinsurance assumed $ — Reinsurance ceded 18 Net other revenues $ 18 Policyholder benefits and claims Reinsurance assumed $ 9 Reinsurance ceded (178) Net policyholder benefits and claims $ (169) |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
Fixed Maturity Securities by Sector | Fixed maturity securities by sector were as follows at: December 31, 2020 December 31, 2019 Amortized Allowance for Credit Losses Gross Unrealized Estimated Allowance for Credit Losses Gross Unrealized Estimated Gains Losses Gains Losses (In millions) U.S. corporate $ 32,608 $ 2 $ 5,370 $ 70 $ 37,906 $ 28,375 $ — $ 2,852 $ 67 $ 31,160 Foreign corporate 10,060 — 1,501 50 11,511 9,177 — 741 74 9,844 U.S. government and agency 6,007 — 2,637 6 8,638 5,529 — 1,869 2 7,396 RMBS 7,653 — 644 3 8,294 8,692 — 438 12 9,118 CMBS 6,207 — 592 9 6,790 5,500 — 264 9 5,755 State and political subdivision 3,673 — 967 — 4,640 3,358 — 701 2 4,057 ABS 2,834 — 60 10 2,884 1,945 — 21 11 1,955 Foreign government 1,487 — 346 1 1,832 1,503 — 250 2 1,751 Total fixed maturity securities $ 70,529 $ 2 $ 12,117 $ 149 $ 82,495 $ 64,079 $ — $ 7,136 $ 179 $ 71,036 |
Maturities of Fixed Maturity Securities | The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2020: Due in One Year or Less Due After One Year Through Five Years Due After Five Years Through Ten Years Due After Ten Years Structured Securities Total Fixed Maturity Securities (In millions) Amortized cost $ 1,504 $ 7,304 $ 14,562 $ 30,465 $ 16,694 $ 70,529 Estimated fair value $ 1,521 $ 7,851 $ 16,339 $ 38,816 $ 17,968 $ 82,495 |
Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector | The estimated fair value and gross unrealized losses of fixed maturity securities in an unrealized loss position, by sector and by length of time that the securities have been in a continuous unrealized loss position, were as follows at: December 31, 2020 December 31, 2019 Less than 12 Months 12 Months or Greater Less than 12 Months 12 Months or Greater Estimated Gross Estimated Gross Estimated Gross Estimated Gross (Dollars in millions) U.S. corporate $ 1,737 $ 57 $ 185 $ 13 $ 2,017 $ 44 $ 326 $ 23 Foreign corporate 254 8 387 42 576 12 561 62 U.S. government and agency 236 6 — — 40 2 — — RMBS 180 2 22 1 857 8 386 4 CMBS 332 7 44 2 559 7 171 2 State and political subdivision 48 — — — 143 2 8 — ABS 506 3 629 7 362 2 676 9 Foreign government 54 1 — — 65 2 — — Total fixed maturity securities $ 3,347 $ 84 $ 1,267 $ 65 $ 4,619 $ 79 $ 2,128 $ 100 Total number of securities in an unrealized loss position 667 244 720 302 |
Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector | The changes in the allowance for credit losses by sector were as follows: U.S. Corporate Foreign Corporate Total (In millions) Balance at January 1, 2020 $ 3 $ 1 $ 4 Allowance on securities where credit losses were not previously recorded 3 1 4 Reductions for securities sold (1) — (1) Change in allowance on securities with an allowance recorded in a previous period — (1) (1) Write-offs charged against allowance (1) (3) (1) (4) Balance at December 31, 2020 $ 2 $ — $ 2 _______________ (1) The Company recorded total write-offs of $13 million for the year ended December 31, 2020. |
Mortgage Loans by Portfolio Segment | Mortgage loans are summarized as follows at: December 31, 2020 2019 Carrying % of Carrying % of (Dollars in millions) Commercial $ 9,714 61.4 % $ 9,721 61.7 % Agricultural 3,538 22.4 3,388 21.5 Residential 2,650 16.8 2,708 17.2 Total mortgage loans (1) 15,902 100.6 15,817 100.4 Allowance for credit losses (94) (0.6) (64) (0.4) Total mortgage loans, net $ 15,808 100.0 % $ 15,753 100.0 % _______________ (1) Purchases of mortgage loans from third parties were $815 million and $962 million for the years ended December 31, 2020 and 2019, respectively, and were primarily comprised of residential mortgage loans. |
Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment | The changes in the allowance for credit losses by portfolio segment were as follows: Commercial Agricultural Residential Total (In millions) Balance at December 31, 2019 $ 47 $ 10 $ 7 $ 64 Cumulative effect of change in accounting principle (20) 7 15 2 Balance at January 1, 2020 27 17 22 66 Current period provision 17 (2) 13 28 Balance at December 31, 2020 $ 44 $ 15 $ 35 $ 94 |
Purchases of PCD Mortgage Loans | Purchases of PCD mortgage loans are summarized as follows: Year Ended December 31, 2020 (In millions) Purchase price $ 159 Allowance at acquisition date 3 Discount or premium attributable to other factors (2) Par value $ 160 |
Credit Quality of Mortgage Loans by Portfolio Segment | The amortized cost of mortgage loans by year of origination and credit quality indicator was as follows at: 2020 2019 2018 2017 2016 Prior Total (In millions) December 31, 2020 Commercial mortgage loans Loan-to-value ratios: Less than 65% $ 317 $ 1,527 $ 1,004 $ 515 $ 1,109 $ 2,808 $ 7,280 65% to 75% 200 450 482 322 59 521 2,034 76% to 80% — — — 44 79 8 131 Greater than 80% — — 29 — 6 234 269 Total commercial mortgage loans 517 1,977 1,515 881 1,253 3,571 9,714 Agricultural mortgage loans Loan-to-value ratios: Less than 65% 569 526 749 391 417 663 3,315 65% to 75% 81 81 10 33 — 18 223 Total agricultural mortgage loans 650 607 759 424 417 681 3,538 Residential mortgage loans Performing 214 381 413 131 70 1,375 2,584 Nonperforming 2 6 4 — 1 53 66 Total residential mortgage loans 216 387 417 131 71 1,428 2,650 Total $ 1,383 $ 2,971 $ 2,691 $ 1,436 $ 1,741 $ 5,680 $ 15,902 The amortized cost of commercial mortgage loans by debt-service coverage ratio was as follows at: December 31, 2020 2019 Amortized Cost % of Amortized Cost % of (Dollars in millions) Debt-service coverage ratios: Greater than 1.20x $ 9,450 97.3 % $ 9,257 95.2 % 1.00x - 1.20x 204 2.1 298 3.1 Less than 1.00x 60 0.6 166 1.7 Total $ 9,714 100.0 % $ 9,721 100.0 % |
Past Due Mortgage Loans by Portfolio Segment | The aging of the amortized cost of past due mortgage loans by portfolio segment was as follows at: December 31, 2020 Commercial Agricultural Residential Total (In millions) Current $ 9,714 $ 3,538 $ 2,575 $ 15,827 30-59 days past due — — 9 9 60-89 days past due — — 24 24 90-179 days past due — — 27 27 180+ days past due — — 15 15 Total $ 9,714 $ 3,538 $ 2,650 $ 15,902 |
Mortgage Loans in Nonaccrual Status by Portfolio Segment | The amortized cost of mortgage loans in a nonaccrual status by portfolio segment were as follows at: Commercial Agricultural Residential Total (In millions) December 31, 2019 $ — $ 21 $ 37 $ 58 December 31, 2020 (1) $ — $ — $ 66 $ 66 _______________ (1) The Company had $7 million of residential mortgage loans in nonaccrual status for which there was no related allowance for credit losses for the year ended December 31, 2020. |
Net Unrealized Investment Gains (Losses) | The components of net unrealized investment gains (losses), included in AOCI, were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Fixed maturity securities $ 11,968 $ 6,957 $ 1,691 Derivatives 173 245 264 Other (16) (13) (13) Subtotal 12,125 7,189 1,942 Amounts allocated from: Future policy benefits (4,313) (2,692) (886) DAC, VOBA and DSI (520) (341) (90) Subtotal (4,833) (3,033) (976) Deferred income tax benefit (expense) (1,531) (873) (203) Net unrealized investment gains (losses) $ 5,761 $ 3,283 $ 763 The changes in net unrealized investment gains (losses) were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Balance at December 31, $ 3,283 $ 763 $ 1,726 Unrealized investment gains (losses) change due to cumulative effect, net of income tax — — (79) Balance at January 1, 3,283 763 1,647 Unrealized investment gains (losses) during the year 4,936 5,247 (3,057) Unrealized investment gains (losses) relating to: Future policy benefits (1,621) (1,806) 1,740 DAC, VOBA and DSI (179) (251) 177 Deferred income tax benefit (expense) (658) (670) 256 Balance at December 31, $ 5,761 $ 3,283 $ 763 Change in net unrealized investment gains (losses) $ 2,478 $ 2,520 $ (884) |
Securities Lending | Elements of the securities lending program are presented below at: December 31, 2020 2019 (In millions) Securities on loan: (1) Amortized cost $ 2,373 $ 2,031 Estimated fair value $ 3,603 $ 2,996 Cash collateral received from counterparties (2) $ 3,674 $ 3,074 Reinvestment portfolio — estimated fair value $ 3,830 $ 3,174 _______________ (1) Included within fixed maturity securities. (2) Included within payables for collateral under securities loaned and other transactions. The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at: December 31, 2020 December 31, 2019 Open (1) 1 Month or Less 1 to 6 Months Total Open (1) 1 Month or Less 1 to 6 Months Total (In millions) U.S. government and agency $ 937 $ 2,300 $ 437 $ 3,674 $ 1,279 $ 1,094 $ 701 $ 3,074 _______________ (1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral. |
Invested Assets on Deposit, Held in Trust and Pledged as Collateral | Invested assets on deposit, held in trust and pledged as collateral at estimated fair value were as follows at: December 31, 2020 2019 (In millions) Invested assets on deposit (regulatory deposits) (1) $ 10,135 $ 9,349 Invested assets held in trust (reinsurance agreements) (2) 5,717 4,561 Invested assets pledged as collateral (3) 5,595 3,641 Total invested assets on deposit, held in trust and pledged as collateral $ 21,447 $ 17,551 _______________ (1) The Company has assets, primarily fixed maturity securities, on deposit with governmental authorities relating to certain policyholder liabilities, of which $60 million and $69 million of the assets on deposit represents restricted cash and cash equivalents at December 31, 2020 and 2019, respectively. (2) The Company has assets, primarily fixed maturity securities, held in trust relating to certain reinsurance transactions, of which $101 million and $124 million of the assets held in trust balance represents restricted cash and cash equivalents at December 31, 2020 and 2019, respectively. (3) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 3) and derivative transactions (see Note 7). |
Variable Interest Entities | The carrying amount and maximum exposure to loss related to the VIEs for which the Company has concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at: December 31, 2020 2019 Carrying Maximum Carrying Maximum (In millions) Fixed maturity securities $ 13,665 $ 12,581 $ 13,094 $ 12,454 Limited partnerships and LLCs 2,319 3,578 1,907 3,080 Total $ 15,984 $ 16,159 $ 15,001 $ 15,534 |
Components of Net Investment Income | The components of net investment income were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Investment income: Fixed maturity securities $ 2,700 $ 2,673 $ 2,565 Equity securities 6 8 7 Mortgage loans 666 680 543 Policy loans 56 67 85 Limited partnerships and LLCs (1) 240 220 258 Cash, cash equivalents and short-term investments 49 93 35 Other 54 41 41 Total investment income 3,771 3,782 3,534 Less: Investment expenses 170 203 196 Net investment income $ 3,601 $ 3,579 $ 3,338 _______________ (1) Includes net investment income pertaining to other limited partnership interests of $225 million, $181 million and $211 million for the years ended December 31, 2020, 2019, and 2018, respectively. |
Components of Net Investment Gains (Losses) | The components of net investment gains (losses) were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Fixed maturity securities $ 297 $ 106 $ (180) Equity securities — 17 (16) Mortgage loans (27) (10) (13) Limited partnerships and LLCs (3) 7 40 Other 11 (8) (38) Total net investment gains (losses) $ 278 $ 112 $ (207) |
Sales or Disposals of Fixed Maturity Securities | Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as follows: Years Ended December 31, 2020 2019 2018 (In millions) Proceeds $ 3,218 $ 9,259 $ 11,251 Gross investment gains $ 390 $ 257 $ 102 Gross investment losses (78) (151) (282) Net investment gains (losses) $ 312 $ 106 $ (180) |
Derivatives (Tables)
Derivatives (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivatives Instruments in Statement of Financial Position, Fair Value | The primary underlying risk exposure, gross notional amount and estimated fair value of derivatives held were as follows at: December 31, 2020 2019 Primary Underlying Risk Exposure Gross Notional Amount Estimated Fair Value Gross Notional Amount Estimated Fair Value Assets Liabilities Assets Liabilities (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate forwards Interest rate $ 290 $ 66 $ — $ 420 $ 22 $ — Foreign currency swaps Foreign currency exchange rate 2,812 134 112 2,765 190 27 Total qualifying hedges 3,102 200 112 3,185 212 27 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate swaps Interest rate 2,295 463 — 7,559 878 29 Interest rate caps Interest rate 2,350 2 — 3,350 2 — Interest rate options Interest rate 25,980 712 122 29,750 782 187 Interest rate forwards Interest rate 8,086 851 78 5,418 94 114 Foreign currency swaps Foreign currency exchange rate 1,000 86 32 1,051 96 15 Foreign currency forwards Foreign currency exchange rate 201 — — 138 — 1 Credit default swaps — purchased Credit 18 — — 18 — — Credit default swaps — written Credit 1,755 41 — 1,635 36 — Credit default options Credit 100 — — — — — Equity index options Equity market 31,576 1,071 838 51,509 850 1,728 Equity variance swaps Equity market 1,098 13 20 2,136 69 69 Equity total return swaps Equity market 15,056 143 822 7,723 2 367 Total non-designated or non-qualifying derivatives 89,515 3,382 1,912 110,287 2,809 2,510 Embedded derivatives: Ceded guaranteed minimum income benefits Other N/A 283 — N/A 217 — Direct index-linked annuities Other N/A — 3,855 N/A — 2,253 Direct guaranteed minimum benefits Other N/A — 2,920 N/A — 1,656 Assumed index-linked annuities Other N/A — 382 N/A — 339 Total embedded derivatives N/A 283 7,157 N/A 217 4,248 Total $ 92,617 $ 3,865 $ 9,181 $ 113,472 $ 3,238 $ 6,785 |
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses) were as follows: Year Ended December 31, 2020 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 2 $ — $ 3 $ — $ 77 Foreign currency exchange rate derivatives 15 (7) 37 — (129) Total cash flow hedges 17 (7) 40 — (52) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 3,565 — — — — Foreign currency exchange rate derivatives (16) (7) — — — Credit derivatives 18 — — — — Equity derivatives (1,367) — — — — Embedded derivatives (2,221) — — — — Total non-qualifying hedges (21) (7) — — — Total $ (4) $ (14) $ 40 $ — $ (52) Year Ended December 31, 2019 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 32 $ — $ 2 $ — $ 25 Foreign currency exchange rate derivatives 25 (29) 34 — 15 Total cash flow hedges 57 (29) 36 — 40 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 1,589 — — — — Foreign currency exchange rate derivatives 22 (3) — — — Credit derivatives 44 — — — — Equity derivatives (2,476) — — — — Embedded derivatives (1,192) — — — — Total non-qualifying hedges (2,013) (3) — — — Total $ (1,956) $ (32) $ 36 $ — $ 40 Year Ended December 31, 2018 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Fair value hedges: Interest rate derivatives $ (12) $ 12 $ 1 $ — $ — Total fair value hedges (12) 12 1 — — Cash flow hedges: Interest rate derivatives 129 (1) 5 — (5) Foreign currency exchange rate derivatives — (1) 27 — 164 Total cash flow hedges 129 (2) 32 — 159 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives (658) — — — — Foreign currency exchange rate derivatives 82 (8) — — — Credit derivatives (7) — — — — Equity derivatives 632 — — — — Embedded derivatives 534 — — (8) — Total non-qualifying hedges 583 (8) — (8) — Total $ 700 $ 2 $ 33 $ (8) $ 159 |
Derivative Instruments, Gain (Loss) | The amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses) were as follows: Year Ended December 31, 2020 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 2 $ — $ 3 $ — $ 77 Foreign currency exchange rate derivatives 15 (7) 37 — (129) Total cash flow hedges 17 (7) 40 — (52) Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 3,565 — — — — Foreign currency exchange rate derivatives (16) (7) — — — Credit derivatives 18 — — — — Equity derivatives (1,367) — — — — Embedded derivatives (2,221) — — — — Total non-qualifying hedges (21) (7) — — — Total $ (4) $ (14) $ 40 $ — $ (52) Year Ended December 31, 2019 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Cash flow hedges: Interest rate derivatives $ 32 $ — $ 2 $ — $ 25 Foreign currency exchange rate derivatives 25 (29) 34 — 15 Total cash flow hedges 57 (29) 36 — 40 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives 1,589 — — — — Foreign currency exchange rate derivatives 22 (3) — — — Credit derivatives 44 — — — — Equity derivatives (2,476) — — — — Embedded derivatives (1,192) — — — — Total non-qualifying hedges (2,013) (3) — — — Total $ (1,956) $ (32) $ 36 $ — $ 40 Year Ended December 31, 2018 Net Derivative Gains (Losses) Recognized for Derivatives Net Derivative Gains (Losses) Recognized for Hedged Items Net Investment Income Policyholder Benefits and Claims Amount of Gains (Losses) Deferred in AOCI (In millions) Derivatives Designated as Hedging Instruments: Fair value hedges: Interest rate derivatives $ (12) $ 12 $ 1 $ — $ — Total fair value hedges (12) 12 1 — — Cash flow hedges: Interest rate derivatives 129 (1) 5 — (5) Foreign currency exchange rate derivatives — (1) 27 — 164 Total cash flow hedges 129 (2) 32 — 159 Derivatives Not Designated or Not Qualifying as Hedging Instruments: Interest rate derivatives (658) — — — — Foreign currency exchange rate derivatives 82 (8) — — — Credit derivatives (7) — — — — Equity derivatives 632 — — — — Embedded derivatives 534 — — (8) — Total non-qualifying hedges 583 (8) — (8) — Total $ 700 $ 2 $ 33 $ (8) $ 159 |
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps | In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps were as follows at: December 31, 2020 2019 Rating Agency Designation of Referenced Estimated Maximum Weighted Average Years to Maturity (2) Estimated Maximum Weighted Average Years to Maturity (2) (Dollars in millions) Aaa/Aa/A $ 15 $ 683 2.9 $ 11 $ 615 2.5 Baa 26 1,072 5.2 25 1,020 5.1 Total $ 41 $ 1,755 4.3 $ 36 $ 1,635 4.1 _______________ (1) The Company has written credit protection on both single name and index references. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. (2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts. |
Offsetting Assets | The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2020 Derivative assets $ 3,588 $ (1,342) $ (1,340) $ 906 $ (840) $ 66 Derivative liabilities $ 2,010 $ (1,342) $ — $ 668 $ (630) $ 38 December 31, 2019 Derivative assets $ 3,062 $ (1,458) $ (1,115) $ 489 $ (488) $ 1 Derivative liabilities $ 2,522 $ (1,458) $ — $ 1,064 $ (1,061) $ 3 _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. |
Offsetting Liabilities | The estimated fair values of net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: Gross Amounts Not Offset on the Consolidated Balance Sheets Gross Amount Recognized Financial Instruments (1) Collateral Received/Pledged (2) Net Amount Securities Collateral Received/Pledged (3) Net Amount After Securities Collateral (In millions) December 31, 2020 Derivative assets $ 3,588 $ (1,342) $ (1,340) $ 906 $ (840) $ 66 Derivative liabilities $ 2,010 $ (1,342) $ — $ 668 $ (630) $ 38 December 31, 2019 Derivative assets $ 3,062 $ (1,458) $ (1,115) $ 489 $ (488) $ 1 Derivative liabilities $ 2,522 $ (1,458) $ — $ 1,064 $ (1,061) $ 3 _______________ (1) Represents amounts subject to an enforceable master netting agreement or similar agreement. (2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement. (3) Securities collateral received from counterparties is not reported on the consolidated balance sheets and may not be sold or re-pledged unless the counterparty is in default. Amounts do not include excess of collateral pledged or received. |
Schedule of Derivative Instruments | The aggregate estimated fair values of derivatives in a net liability position containing such credit-contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments were as follows at: December 31, 2020 2019 (In millions) Estimated fair value of derivatives in a net liability position (1) $ 668 $ 1,064 Estimated Fair Value of Collateral Provided (2): Fixed maturity securities $ 1,205 $ 1,473 _______________ (1) After taking into consideration the existence of netting agreements. (2) Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit-contingent provisions of derivative contracts in a net liability position were triggered minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately. |
Fair Value (Tables)
Fair Value (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Recurring Fair Value Measurements | The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy. December 31, 2020 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated Fair Value (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 37,415 $ 491 $ 37,906 Foreign corporate — 11,314 197 11,511 U.S. government and agency 2,217 6,421 — 8,638 RMBS — 8,272 22 8,294 CMBS — 6,785 5 6,790 State and political subdivision — 4,640 — 4,640 ABS — 2,844 40 2,884 Foreign government — 1,832 — 1,832 Total fixed maturity securities 2,217 79,523 755 82,495 Equity securities 36 99 3 138 Short-term investments 2,782 460 — 3,242 Derivative assets: (1) Interest rate — 2,094 — 2,094 Foreign currency exchange rate — 219 1 220 Credit — 27 14 41 Equity market — 1,213 14 1,227 Total derivative assets — 3,553 29 3,582 Embedded derivatives within asset host contracts (2) — — 283 283 Separate account assets 86 111,880 3 111,969 Total assets $ 5,121 $ 195,515 $ 1,073 $ 201,709 Liabilities Derivative liabilities: (1) Interest rate $ — $ 200 $ — $ 200 Foreign currency exchange rate — 137 7 144 Equity market — 1,660 20 1,680 Total derivative liabilities — 1,997 27 2,024 Embedded derivatives within liability host contracts (2) — — 7,157 7,157 Total liabilities $ — $ 1,997 $ 7,184 $ 9,181 December 31, 2019 Fair Value Hierarchy Level 1 Level 2 Level 3 Total Estimated (In millions) Assets Fixed maturity securities: U.S. corporate $ — $ 30,831 $ 329 $ 31,160 Foreign corporate — 9,712 132 9,844 U.S. government and agency 1,636 5,760 — 7,396 RMBS — 9,074 44 9,118 CMBS — 5,755 — 5,755 State and political subdivision — 3,984 73 4,057 ABS — 1,882 73 1,955 Foreign government — 1,751 — 1,751 Total fixed maturity securities 1,636 68,749 651 71,036 Equity securities 14 125 8 147 Short-term investments 1,271 682 5 1,958 Derivative assets: (1) Interest rate — 1,778 — 1,778 Foreign currency exchange rate — 281 5 286 Credit — 25 11 36 Equity market — 850 71 921 Total derivative assets — 2,934 87 3,021 Embedded derivatives within asset host contracts (2) — — 217 217 Separate account assets 180 106,924 3 107,107 Total assets $ 3,101 $ 179,414 $ 971 $ 183,486 Liabilities Derivative liabilities: (1) Interest rate $ — $ 330 $ — $ 330 Foreign currency exchange rate — 43 — 43 Equity market — 2,093 71 2,164 Total derivative liabilities — 2,466 71 2,537 Embedded derivatives within liability host contracts (2) — — 4,248 4,248 Total liabilities $ — $ 2,466 $ 4,319 $ 6,785 _______________ (1) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets. (2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the consolidated balance sheets. |
Fair Value Inputs, Quantitative Information | Certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) were as follows at: December 31, 2020 December 31, 2019 Impact of Valuation Techniques Significant Range Range Embedded derivatives Direct, assumed and ceded guaranteed minimum benefits • Option pricing techniques • Mortality rates 0.03 % - 12.13 % 0.02 % - 11.31 % Decrease (1) • Lapse rates 0.25 % - 15.00 % 0.25 % - 16.00 % Decrease (2) • Utilization rates 0.00 % - 25.00 % 0.00 % - 25.00 % Increase (3) • Withdrawal rates 0.25 % - 10.00 % 0.25 % - 10.00 % (4) • Long-term equity volatilities 16.66 % - 22.21 % 16.24 % - 21.65 % Increase (5) • Nonperformance risk spread 0.47 % - 1.97 % 0.54 % - 1.99 % Decrease (6) _______________ (1) Mortality rates vary by age and by demographic characteristics such as gender. The range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement. (2) The range shown reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. (3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. (4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. |
Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation | The changes in assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3) were summarized as follows: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Fixed Maturity Securities Corporate (1) Structured Securities State and Equity Short-term Investments Net Derivatives (2) Net Embedded Derivatives (3) Separate Account Assets (4) (In millions) Balance, January 1, 2019 $ 732 $ 173 $ 74 $ 3 $ — $ (122) $ (1,998) $ 1 Total realized/unrealized gains (losses) included in net income (loss) (5) (6) — 1 1 — — (12) (1,192) — Total realized/unrealized gains (losses) included in AOCI 15 2 (1) — — (1) — — Purchases (7) 342 69 — 5 5 — — 3 Sales (7) (150) (25) (1) — — — — — Issuances (7) — — — — — — — — Settlements (7) — — — — — 155 (841) — Transfers into Level 3 (8) 24 42 — — — — — — Transfers out of Level 3 (8) (502) (145) — — — (4) — (1) Balance, December 31, 2019 461 117 73 8 5 16 (4,031) 3 Total realized/unrealized gains (losses) included in net income (loss) (5) (6) (6) — — — — 9 (2,221) — Total realized/unrealized gains (losses) included in AOCI (3) 1 — — — (9) — — Purchases (7) 409 58 — — — — — — Sales (7) (117) (5) — — (5) (14) — — Issuances (7) — — — — — — — — Settlements (7) — — — — — — (622) — Transfers into Level 3 (8) 186 11 — — — — — — Transfers out of Level 3 (8) (242) (115) (73) (5) — — — — Balance, December 31, 2020 $ 688 $ 67 $ — $ 3 $ — $ 2 $ (6,874) $ 3 Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2018 (9) $ (2) $ — $ 1 $ 1 $ — $ 148 $ 395 $ — Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2019 (9) $ — $ — $ 1 $ — $ — $ (10) $ (1,450) $ — Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2020 (9) $ (5) $ — $ — $ — $ — $ (4) $ (2,297) $ — Changes in unrealized gains (losses) included in OCI for the instruments still held as of December 31, 2020 $ (3) $ 1 $ — $ — $ — $ (9) $ — $ — Gains (Losses) Data for the year ended December 31, 2018: Total realized/unrealized gains (losses) included in net income (loss) (5) (6) $ 1 $ 2 $ 1 $ — $ — $ 152 $ 526 $ — Total realized/unrealized gains (losses) included in AOCI $ (33) $ (6) $ (1) $ — $ — $ 9 $ — $ — _______________ (1) Comprised of U.S. and foreign corporate securities. (2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward. (3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward. (4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses). (5) Amortization of premium/accretion of discount is included within net investment income. Changes in the allowance for credit losses and direct write-offs are charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). (6) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (7) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (8) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (9) Changes in unrealized gains (losses) included in net income (loss) for fixed maturities are reported in either net investment income or net investment gains (losses). Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses). |
Fair Value of Financial Instruments Carried at Other Than Fair Value | The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: December 31, 2020 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 15,808 $ — $ — $ 16,926 $ 16,926 Policy loans $ 1,291 $ — $ 512 $ 1,530 $ 2,042 Other invested assets $ 51 $ — $ 39 $ 12 $ 51 Premiums, reinsurance and other receivables $ 3,277 $ — $ 90 $ 3,975 $ 4,065 Liabilities Policyholder account balances $ 17,497 $ — $ — $ 19,100 $ 19,100 Long-term debt $ 3,436 $ — $ 3,858 $ — $ 3,858 Other liabilities $ 807 $ — $ 163 $ 644 $ 807 Separate account liabilities $ 1,334 $ — $ 1,334 $ — $ 1,334 December 31, 2019 Fair Value Hierarchy Carrying Level 1 Level 2 Level 3 Total (In millions) Assets Mortgage loans $ 15,753 $ — $ — $ 16,383 $ 16,383 Policy loans $ 1,292 $ — $ 516 $ 1,062 $ 1,578 Other invested assets $ 51 $ — $ 39 $ 12 $ 51 Premiums, reinsurance and other receivables $ 2,224 $ — $ 41 $ 2,593 $ 2,634 Liabilities Policyholder account balances $ 15,614 $ — $ — $ 15,710 $ 15,710 Long-term debt $ 4,365 $ — $ 3,334 $ 1,000 $ 4,334 Other liabilities $ 846 $ — $ 191 $ 655 $ 846 Separate account liabilities $ 1,189 $ — $ 1,189 $ — $ 1,189 |
Long-term Debt (Tables)
Long-term Debt (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt | Long-term debt outstanding was as follows at: December 31, 2020 2019 Stated Interest Rate Maturity Face Value Carrying Value Face Value Carrying Value (In millions) Senior notes (1) 3.700% 2027 $ 1,300 $ 1,294 $ 1,500 $ 1,492 Senior notes (1) 5.625% 2030 615 614 — — Senior notes (1) 4.700% 2047 1,150 1,134 1,500 1,478 Term loan LIBOR plus 1.5% 2024 — — 1,000 1,000 Junior subordinated debentures (1) 6.250% 2058 375 363 375 363 Other long-term debt (2) 7.028% 2030 31 31 32 32 Total long-term debt (3) $ 3,471 $ 3,436 $ 4,407 $ 4,365 _______________ (1) Interest on senior notes is payable semi-annually. Interest on junior subordinated debentures is payable quarterly subject to BHF’s right to defer interest payments in accordance with the terms of the debentures. (2) Represents non-recourse debt for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment companies. (3) Includes unamortized debt issuance costs, discounts and premiums, as applicable, totaling net $35 million and $42 million for the senior notes and junior subordinated debentures on a combined basis at December 31, 2020 and 2019, respectively. |
Equity (Tables)
Equity (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Equity [Abstract] | |
Preferred Stock Authorized, Issued and Outstanding | Preferred stock shares authorized, issued and outstanding were as follows at: December 31, 2020 2019 Shares Authorized Shares Issued Shares Outstanding Shares Authorized Shares Issued Shares Outstanding 6.600% Non-Cumulative Preferred Stock, Series A 17,000 17,000 17,000 17,000 17,000 17,000 6.750% Non-Cumulative Preferred Stock, Series B 16,100 16,100 16,100 — — — 5.375% Non-Cumulative Preferred Stock, Series C 23,000 23,000 23,000 — — — Not designated 99,943,900 — — 99,983,000 — — Total 100,000,000 56,100 56,100 100,000,000 17,000 17,000 |
Preferred Stock Dividends Declared | The declaration, record and payment dates, as well as per share and aggregate dividend amounts for BHF’s preferred stock by series for the years ended December 31, 2020 and 2019 were as follows: Series A Series B Declaration Date Record Date Payment Date Per Share Aggregate Per Share Aggregate (In millions, except per share data) November 16, 2020 December 10, 2020 December 28, 2020 $ 412.50 $ 7 $ 421.88 $ 6 August 17, 2020 September 10, 2020 September 25, 2020 412.50 7 595.31 10 May 15, 2020 June 10, 2020 June 25, 2020 412.50 7 — — February 14, 2020 March 10, 2020 March 25, 2020 412.50 7 — — $ 1,650.00 $ 28 $ 1,017.19 $ 16 November 15, 2019 December 10, 2019 December 26, 2019 $ 412.50 $ 7 $ — $ — August 15, 2019 September 10, 2019 September 25, 2019 412.50 7 — — May 15, 2019 June 10, 2019 June 25, 2019 412.50 7 — — $ 1,237.50 $ 21 $ — $ — |
Common Stock Outstanding Roll Forward | Changes in common shares outstanding were as follows: Years Ended December 31, 2020 2019 2018 Shares outstanding at beginning of year 106,027,301 117,532,336 119,773,106 Shares issued 354,652 199,853 674,912 Shares repurchased (1) (18,170,335) (11,704,888) (2,915,682) Shares outstanding at end of year 88,211,618 106,027,301 117,532,336 _______________ (1) Includes shares of common stock withheld with respect to tax withholding obligations associated with the vesting of share-based compensation awards under the Company’s publicly announced benefit plans or programs. |
Share-based Payment Arrangement, Cost by Plan [Table Text Block] | The following table presents total share-based compensation expense: Years Ended December 31, 2020 2019 2018 (In millions) Restricted stock units, Founders’ Grant $ — $ — $ 31 Restricted stock units $ 15 $ 15 $ 7 Stock options $ — $ 1 $ 1 Performance share units $ 5 $ 4 $ — Employee stock purchase plan $ 1 $ 1 $ 1 |
Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] | The following table presents a summary of PSU and RSU activity: RSUs PSUs Units Weighted Average Grant-Date Fair Value Units Weighted Average Grant-Date Fair Value Outstanding at January 1, 2020 588,729 $ 41.27 253,180 $ 41.21 Granted 494,596 $ 35.68 223,003 $ 35.84 Forfeited (50,251) $ 38.21 (22,212) $ 39.85 Paid (241,974) $ 41.90 — $ — Outstanding at December 31, 2020 791,100 $ 37.80 453,971 $ 38.64 Vested at December 31, 2020 — $ — — $ — |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | The following table presents the weighted average assumptions used to determine the grant-date fair value of stock options that BHF has granted: Year Ended December 31, 2018 (1) Risk-free rate of return 2.93% Expected volatility 25.00% Expected option life, years 5.8 years Weighted average exercise price of stock options granted $53.47 Weighted average fair value of stock options granted $12.54 _______________ (1) There were no stock options granted during the years ended December 31, 2020 and 2019. |
Schedules of statutory net income, capital and surplus and reserve strengthening by subsidiary including dividend restrictions | Statutory net income (loss) was as follows: Years Ended December 31, Company State of Domicile 2020 2019 2018 (In millions) Brighthouse Life Insurance Company Delaware $ (979) $ 1,074 $ (1,104) New England Life Insurance Company Massachusetts $ 105 $ 61 $ 130 Statutory capital and surplus was as follows at: December 31, Company 2020 2019 (In millions) Brighthouse Life Insurance Company $ 7,410 $ 8,746 New England Life Insurance Company $ 150 $ 116 The table below sets forth the dividends permitted to be paid by certain of the Company’s insurance companies without insurance regulatory approval and dividends paid: 2021 2020 2019 2018 Company Permitted Paid (2) Paid (2) Paid (2) (In millions) Brighthouse Life Insurance Company $ 733 $ 1,250 $ — $ — New England Life Insurance Company (3) $ 105 $ 61 $ 131 $ 400 ______________ (1) Reflects dividend amounts that may be paid during 2021 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2021, some or all of such dividends may require regulatory approval. (2) Reflects all amounts paid, including those requiring regulatory approval. (3) Dividends paid by NELICO in 2018, including a $65 million ordinary cash dividend and a $335 million extraordinary dividend comprised of $135 million of cash and a $200 million surplus note, were paid to its parent, BH Holdings, LLC. |
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Information regarding changes in the balances of each component of AOCI was as follows: Unrealized Unrealized Foreign Defined Benefit Plans Adjustment Total (In millions) Balance at December 31, 2017 $ 1,572 $ 154 $ (24) $ (26) $ 1,676 Cumulative effect of change in accounting principle and other, net of income tax (79) — — — (79) Balance, January 1, 2018 1,493 154 (24) (26) 1,597 OCI before reclassifications (1,346) 159 (4) 6 (1,185) Deferred income tax benefit (expense) 287 48 1 (1) 335 AOCI before reclassifications, net of income tax 434 361 (27) (21) 747 Amounts reclassified from AOCI 181 (134) — 1 48 Deferred income tax benefit (expense) (39) (40) — — (79) Amounts reclassified from AOCI, net of income tax 142 (174) — 1 (31) Balance at December 31, 2018 576 187 (27) (20) 716 OCI before reclassifications 3,285 40 12 (10) 3,327 Deferred income tax benefit (expense) (690) (8) — 2 (696) AOCI before reclassifications, net of income tax 3,171 219 (15) (28) 3,347 Amounts reclassified from AOCI (76) (59) — — (135) Deferred income tax benefit (expense) 16 12 — — 28 Amounts reclassified from AOCI, net of income tax (60) (47) — — (107) Balance at December 31, 2019 3,111 172 (15) (28) 3,240 OCI before reclassifications (2) 3,511 (52) 20 (14) 3,465 Deferred income tax benefit (expense) (737) 11 (13) 4 (735) AOCI before reclassifications, net of income tax 5,885 131 (8) (38) 5,970 Amounts reclassified from AOCI (303) (20) — 1 (322) Deferred income tax benefit (expense) 64 4 — — 68 Amounts reclassified from AOCI, net of income tax (239) (16) — 1 (254) Balance at December 31, 2020 $ 5,646 $ 115 $ (8) $ (37) $ 5,716 _______________ (1) See Note 6 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI. (2) Includes $3 million related to the adoption of ASU 2016-13 (see Note 1). |
Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Information regarding amounts reclassified out of each component of AOCI was as follows: AOCI Components Amounts Reclassified from AOCI Consolidated Statements of Operations Locations Years Ended December 31, 2020 2019 2018 (In millions) Net unrealized investment gains (losses): Net unrealized investment gains (losses) $ 318 $ 113 $ (180) Net investment gains (losses) Net unrealized investment gains (losses) — — 1 Net investment income Net unrealized investment gains (losses) (15) (37) (2) Net derivative gains (losses) Net unrealized investment gains (losses), before income tax 303 76 (181) Income tax (expense) benefit (64) (16) 39 Net unrealized investment gains (losses), net of income tax 239 60 (142) Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps 2 32 98 Net derivative gains (losses) Interest rate swaps 3 2 3 Net investment income Interest rate forwards — — 31 Net derivative gains (losses) Interest rate forwards — — 2 Net investment income Foreign currency swaps 15 25 — Net derivative gains (losses) Gains (losses) on cash flow hedges, before income tax 20 59 134 Income tax (expense) benefit (4) (12) 40 Gains (losses) on cash flow hedges, net of income tax 16 47 174 Defined benefit plans adjustment: Amortization of net actuarial gains (losses) (1) — (1) Amortization of defined benefit plan items, before income tax (1) — (1) Income tax (expense) benefit — — — Amortization of defined benefit plan items, net of income tax (1) — (1) Total reclassifications, net of income tax $ 254 $ 107 $ 31 |
Other Revenues and Other Expe_2
Other Revenues and Other Expenses (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Other Income and Expenses [Abstract] | |
Other Expenses | Information on other expenses was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Compensation $ 346 $ 333 $ 289 Contracted services and other labor costs 281 287 245 Transition services agreements 127 245 279 Establishment costs 112 118 239 Premium and other taxes, licenses and fees 44 48 68 Separate account fees 466 488 524 Volume related costs, excluding compensation, net of DAC capitalization 662 636 628 Interest expense on debt 184 191 158 Other 131 145 145 Total other expenses $ 2,353 $ 2,491 $ 2,575 |
Income Tax (Tables)
Income Tax (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Provision for income tax from continuing operations | The provision for income tax was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Current: Federal $ 30 $ (36) $ (166) State and local 6 4 — Subtotal 36 (32) (166) Deferred: Federal (399) (285) 285 Provision for income tax expense (benefit) $ (363) $ (317) $ 119 |
Income tax for continuing operations effective rate reconciliation | The reconciliation of the income tax provision at the statutory tax rate to the provision for income tax as reported was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Tax provision at statutory rate $ (298) $ (221) $ 207 Tax effect of: Excess loss account - Separation from MetLife — — (2) Dividends received deduction (42) (42) (44) Tax credits (25) (31) (25) Release of valuation allowance — — (11) Other, net 2 (23) (6) Provision for income tax expense (benefit) $ (363) $ (317) $ 119 Effective tax rate 26 % 30 % 12 % |
Components of deferred tax assets and liabilities | Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: December 31, 2020 2019 (In millions) Deferred income tax assets: Tax credit carryforwards $ 133 $ 106 Net operating loss carryforwards 1,486 1,087 Employee benefits 15 17 Intangibles 58 93 Investments, including derivatives — 260 Other — 15 Total deferred income tax assets 1,692 1,578 Deferred income tax liabilities: Policyholder liabilities and receivables 905 1,277 Net unrealized investment gains 1,532 871 DAC 720 785 Investments, including derivatives 154 — Other 1 — Total deferred income tax liabilities 3,312 2,933 Net deferred income tax asset (liability) $ (1,620) $ (1,355) |
Summary of Operating Loss Carryforwards [Table Text Block] | The following table sets forth the net operating loss carryforwards for tax purposes at December 31, 2020. Net Operating Loss Carryforwards (In millions) Expiration 2032-2037 $ 3,011 Indefinite 4,064 $ 7,075 |
Summary of Tax Credit Carryforwards | The following table sets forth the general business credits and foreign tax credits available for carryforward for tax purposes at December 31, 2020. Tax Credit Carryforwards General Business Credits Foreign Tax Credits (In millions) Expiration 2020-2024 $ — $ 18 2025-2029 — 70 2030-2034 — 28 2035-2039 17 — Indefinite — — $ 17 $ 116 |
Reconciliation of unrecognized tax benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: Years Ended December 31, 2020 2019 2018 (In millions) Balance at January 1, $ 35 $ 35 $ 23 Additions for tax positions of prior years — — 12 Reductions for tax positions of prior years — — — Additions for tax positions of current year — — — Reductions for tax positions of current year — — — Settlements with tax authorities — — — Balance at December 31, $ 35 $ 35 $ 35 Unrecognized tax benefits that, if recognized would impact the effective rate $ 35 $ 35 $ 35 |
Earnings Per Common Share (Tabl
Earnings Per Common Share (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |
Earnings Per Common Share | The calculation of earnings per common share was as follows: Years Ended December 31, 2020 2019 2018 (In millions, except share and per share data) Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders $ (1,105) $ (761) $ 865 Weighted average common shares outstanding — basic 95,350,822 112,508,650 119,386,280 Dilutive effect of share-based awards — — 441,198 Weighted average common shares outstanding — diluted 95,350,822 112,508,650 119,827,478 Earnings per common share: Basic $ (11.58) $ (6.76) $ 7.24 Diluted $ (11.58) $ (6.76) $ 7.21 |
Business, Basis of Presentati_3
Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) $ in Millions | Aug. 04, 2017 | Dec. 31, 2020USD ($)Segment | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
Number of segments | Segment | 3 | ||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Common stock, shares distributed, percentage | 80.80% | ||||
Common stock, shares retained by parent, percentage | 19.20% | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax | $ 5,716 | $ 3,240 | $ 716 | $ 1,676 | |
Retained earnings (deficit) | (534) | $ 585 | |||
Cumulative Effect, Adjustment | |||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||
Accumulated Other Comprehensive Income (Loss), Net of Tax | 3 | $ (79) | |||
Retained earnings (deficit) | $ 14 |
Segment Information (Operating
Segment Information (Operating Results) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | $ (1,419) | $ (1,052) | $ 989 |
Provision for income tax expense (benefit) | (363) | (317) | 119 |
Post-tax adjusted earnings | (1,056) | (735) | 870 |
Less: Net income (loss) attributable to noncontrolling interests | 5 | 5 | 5 |
Less: Preferred stock dividends | 44 | 21 | 0 |
Net investment gains (losses) | 278 | 112 | (207) |
Net derivative gains (losses) | (18) | (1,988) | 702 |
Other adjustments to net income (loss) | 413 | 389 | 397 |
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | (1,105) | (761) | 865 |
Annuities | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 1,820 | 1,809 | 1,536 |
Interest expense | 0 | 0 | 0 |
Life | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 460 | 436 | 449 |
Interest expense | 0 | 0 | 0 |
Run-off | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 1,269 | 1,265 | 1,310 |
Interest expense | 0 | 0 | 0 |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Interest revenue | 70 | 75 | 57 |
Interest expense | 184 | 191 | 158 |
Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | (372) | 670 | 1,030 |
Provision for income tax expense (benefit) | (143) | 45 | 133 |
Post-tax adjusted earnings | (229) | 625 | 897 |
Less: Net income (loss) attributable to noncontrolling interests | 5 | 5 | 5 |
Less: Preferred stock dividends | 44 | 21 | 0 |
Adjusted earnings | (278) | 599 | 892 |
Operating Segments | Annuities | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | 1,433 | 1,263 | 1,233 |
Provision for income tax expense (benefit) | 266 | 235 | 210 |
Post-tax adjusted earnings | 1,167 | 1,028 | 1,023 |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Less: Preferred stock dividends | 0 | 0 | 0 |
Adjusted earnings | 1,167 | 1,028 | 1,023 |
Operating Segments | Life | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | 182 | 288 | 285 |
Provision for income tax expense (benefit) | 34 | 57 | 57 |
Post-tax adjusted earnings | 148 | 231 | 228 |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Less: Preferred stock dividends | 0 | 0 | 0 |
Adjusted earnings | 148 | 231 | 228 |
Operating Segments | Run-off | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | (1,655) | (580) | (57) |
Provision for income tax expense (benefit) | (356) | (126) | (14) |
Post-tax adjusted earnings | (1,299) | (454) | (43) |
Less: Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 |
Less: Preferred stock dividends | 0 | 0 | 0 |
Adjusted earnings | (1,299) | (454) | (43) |
Operating Segments | Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Pre-tax adjusted earnings | (332) | (301) | (431) |
Provision for income tax expense (benefit) | (87) | (121) | (120) |
Post-tax adjusted earnings | (245) | (180) | (311) |
Less: Net income (loss) attributable to noncontrolling interests | 5 | 5 | 5 |
Less: Preferred stock dividends | 44 | 21 | 0 |
Adjusted earnings | (294) | (206) | (316) |
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Provision for income tax expense (benefit) | 220 | 362 | 14 |
Net investment gains (losses) | 278 | 112 | (207) |
Net derivative gains (losses) | (18) | (1,988) | 702 |
Other adjustments to net income (loss) | $ (1,307) | $ 154 | $ (536) |
Segment Information (Assets) (D
Segment Information (Assets) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Segment Reporting Information [Line Items] | ||
Total assets | $ 247,869 | $ 227,259 |
Annuities | ||
Segment Reporting Information [Line Items] | ||
Total assets | 172,233 | 156,965 |
Life | ||
Segment Reporting Information [Line Items] | ||
Total assets | 23,809 | 21,876 |
Run-off | ||
Segment Reporting Information [Line Items] | ||
Total assets | 38,366 | 35,112 |
Corporate & Other | ||
Segment Reporting Information [Line Items] | ||
Total assets | $ 13,461 | $ 13,306 |
Segment Information (Reconcilia
Segment Information (Reconciliation of Operating Revenues to Total Revenues) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Segment Reporting Information [Line Items] | |||
Total revenues | $ 8,503 | $ 6,554 | $ 8,965 |
Annuities | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 4,563 | 4,648 | 4,567 |
Life | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 1,334 | 1,328 | 1,389 |
Run-off | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 1,938 | 2,009 | 2,112 |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Total revenues | 156 | 176 | 152 |
Segment Reconciling Items | |||
Segment Reporting Information [Line Items] | |||
Total revenues | $ 512 | $ (1,607) | $ 745 |
Segment Information (Premiums,
Segment Information (Premiums, Universal Life and Investment-Type Product Policy Fees and Other Revenues by Major Product Group) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | $ 4,642 | $ 4,851 | $ 5,132 |
Annuity products | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | 3,010 | 3,106 | 3,304 |
Life insurance products | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | 1,619 | 1,709 | 1,827 |
Other products | |||
Segment Reporting Information [Line Items] | |||
Total premiums, universal life and investment-type product policy fees and other revenues | $ 13 | $ 36 | $ 1 |
Segment Information (Narrative)
Segment Information (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2020Segment | |
Segment Reporting [Abstract] | |
Number of segments | 3 |
Insurance (Insurance Liabilitie
Insurance (Insurance Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Insurance Liabilities [Line Items] | ||
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances | $ 102,367 | $ 88,568 |
Annuities | ||
Insurance Liabilities [Line Items] | ||
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances | 54,236 | 43,843 |
Life | ||
Insurance Liabilities [Line Items] | ||
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances | 9,327 | 8,960 |
Run-off | ||
Insurance Liabilities [Line Items] | ||
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances | 31,196 | 28,064 |
Corporate & Other | ||
Insurance Liabilities [Line Items] | ||
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances | $ 7,608 | $ 7,701 |
Insurance (Guarantees) (Details
Insurance (Guarantees) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Balance at January 1, | $ 10,447 | $ 9,357 | $ 8,380 | |
Incurred guaranteed benefits | 2,506 | 1,180 | 1,035 | |
Paid guaranteed benefits | (272) | (90) | (58) | |
Balance at December 31, | 12,681 | 10,447 | 9,357 | |
Variable Annuity Guarantees | Guaranteed Minimum Death Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Balance at January 1, | 1,620 | 1,567 | 1,439 | |
Incurred guaranteed benefits | 129 | 143 | 186 | |
Paid guaranteed benefits | (103) | (90) | (58) | |
Balance at December 31, | 1,646 | 1,620 | 1,567 | |
Variable Annuity Guarantees | Guaranteed Minimum Income Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Balance at January 1, | 3,237 | 3,074 | 2,709 | |
Incurred guaranteed benefits | 1,133 | 163 | 365 | |
Paid guaranteed benefits | 0 | 0 | 0 | |
Balance at December 31, | 4,370 | 3,237 | 3,074 | |
Universal and Variable Life Contracts | Secondary Guarantees | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Balance at January 1, | 5,590 | 4,716 | 4,232 | |
Incurred guaranteed benefits | 1,244 | 874 | 484 | |
Paid guaranteed benefits | (169) | 0 | 0 | |
Balance at December 31, | 6,665 | 5,590 | 4,716 | |
Net Ceded and Assumed Liabilities For Guarantees | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Paid guaranteed benefits | (140) | (88) | (56) | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 1,150 | 1,092 | 974 | $ 963 |
Liabilities for Guarantees on Long-Duration contracts reinsurance recoverable incurred benefits net | 198 | 206 | 67 | |
Net Ceded and Assumed Liabilities For Guarantees | Secondary Guarantees | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Paid guaranteed benefits | (39) | 0 | 0 | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 1,146 | 1,083 | 963 | 945 |
Liabilities for Guarantees on Long-Duration contracts reinsurance recoverable incurred benefits net | 102 | 120 | 18 | |
Net Ceded and Assumed Liabilities For Guarantees | Guaranteed Minimum Death Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Paid guaranteed benefits | (101) | (88) | (56) | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 4 | 9 | 11 | 18 |
Liabilities for Guarantees on Long-Duration contracts reinsurance recoverable incurred benefits net | 96 | 86 | 49 | |
Net Ceded and Assumed Liabilities For Guarantees | Guaranteed Minimum Income Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Paid guaranteed benefits | 0 | 0 | 0 | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 0 | 0 | 0 | 0 |
Liabilities for Guarantees on Long-Duration contracts reinsurance recoverable incurred benefits net | 0 | 0 | 0 | |
Net Liabilities For Guarantees | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Incurred guaranteed benefits | 2,308 | 974 | 968 | |
Paid guaranteed benefits | (132) | (2) | (2) | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 11,531 | 9,355 | 8,383 | 7,417 |
Net Liabilities For Guarantees | Secondary Guarantees | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Incurred guaranteed benefits | 1,142 | 754 | 466 | |
Paid guaranteed benefits | (130) | 0 | 0 | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 5,519 | 4,507 | 3,753 | 3,287 |
Net Liabilities For Guarantees | Guaranteed Minimum Death Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Incurred guaranteed benefits | 33 | 57 | 137 | |
Paid guaranteed benefits | (2) | (2) | (2) | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | 1,642 | 1,611 | 1,556 | 1,421 |
Net Liabilities For Guarantees | Guaranteed Minimum Income Benefit | ||||
Movement In Guaranteed Benefit Liability Gross Rollforward | ||||
Incurred guaranteed benefits | 1,133 | 163 | 365 | |
Paid guaranteed benefits | 0 | 0 | 0 | |
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Net | $ 4,370 | $ 3,237 | $ 3,074 | $ 2,709 |
Insurance (Guarantees Related t
Insurance (Guarantees Related to Annuity Contracts) (Details) - Variable Annuity Guarantees - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Guaranteed Death Benefits | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Total account value | $ 108,424 | $ 104,271 |
Separate account value | 103,315 | 99,385 |
Net amount at risk | $ 6,438 | $ 6,671 |
Average attained age of contractholders | 70 years | 68 years |
Guaranteed Annuitization Benefits | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Total account value | $ 60,674 | $ 59,859 |
Separate account value | 59,419 | 58,694 |
Net amount at risk | $ 6,692 | $ 4,750 |
Average attained age of contractholders | 70 years | 68 years |
Insurance (Guarantees Related_2
Insurance (Guarantees Related to Universal and Variable Life Contracts) (Details) - Secondary Guarantees [Member] - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Universal Life [Member] | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Net Amount At Risk By Product And Guarantee General And Separate Account Value | $ 5,772 | $ 5,957 |
Net Amount at Risk by Product and Guarantee, Net Amount at Risk | $ 69,083 | $ 71,124 |
Net Amount at Risk by Product and Guarantee, Weighted Average Attained Age | 67 years | 66 years |
Variable Life [Member] | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Net Amount At Risk By Product And Guarantee General And Separate Account Value | $ 3,926 | $ 3,526 |
Net Amount at Risk by Product and Guarantee, Net Amount at Risk | $ 19,909 | $ 21,325 |
Net Amount at Risk by Product and Guarantee, Weighted Average Attained Age | 51 years | 50 years |
Insurance (Fund Groupings) (Det
Insurance (Fund Groupings) (Details) - Variable Annuity and Variable Life - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Fair Value, Separate Account Investment [Line Items] | ||
Fund Groupings | $ 106,668 | $ 101,653 |
Balanced | ||
Fair Value, Separate Account Investment [Line Items] | ||
Fund Groupings | 64,736 | 64,134 |
Equity | ||
Fair Value, Separate Account Investment [Line Items] | ||
Fund Groupings | 32,811 | 29,036 |
Bond | ||
Fair Value, Separate Account Investment [Line Items] | ||
Fund Groupings | 9,105 | 8,467 |
Money Market | ||
Fair Value, Separate Account Investment [Line Items] | ||
Fund Groupings | $ 16 | $ 16 |
Insurance (Future Policy Benefi
Insurance (Future Policy Benefits - Narrative) (Details) | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Life Premiums as Percentage of Gross Premiums | 40.00% | 38.00% | 38.00% |
Participating Insurance, Percentage of Gross Insurance in Force | 3.00% | 3.00% | |
Minimum | |||
Liability for Policyholder Contract Deposits, Interest Rate | 1.00% | ||
Maximum | |||
Liability for Policyholder Contract Deposits, Interest Rate | 7.00% | ||
Nonparticipating Life Insurance Contract [Member] | Minimum | |||
Liability for Future Policy Benefits, Interest Rate | 3.00% | ||
Nonparticipating Life Insurance Contract [Member] | Maximum | |||
Liability for Future Policy Benefits, Interest Rate | 9.00% | ||
Fixed Annuity [Member] | Minimum | |||
Liability for Future Policy Benefits, Interest Rate | 0.00% | ||
Fixed Annuity [Member] | Maximum | |||
Liability for Future Policy Benefits, Interest Rate | 8.00% | ||
Participating Life Insurance Contract [Member] | Minimum | |||
Liability for Future Policy Benefits, Interest Rate | 4.00% | ||
Participating Life Insurance Contract [Member] | Maximum | |||
Liability for Future Policy Benefits, Interest Rate | 5.00% | ||
Insurance, Other [Member] | Minimum | |||
Liability for Future Policy Benefits, Interest Rate | 3.00% | ||
Insurance, Other [Member] | Maximum | |||
Liability for Future Policy Benefits, Interest Rate | 6.00% |
Insurance (Obligations Under Fu
Insurance (Obligations Under Funding Agreements - Narrative) (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Line of Credit Facility [Line Items] | ||
Federal Home Loan Bank Stock | $ 39,000,000 | $ 39,000,000 |
Federal Home Loan Bank, Advances, Branch of FHLB Bank, Amount of Advances | 595,000,000 | 595,000,000 |
Outstanding funding agreements to certain SPEs | 144,000,000 | $ 134,000,000 |
Farmer Mac Funding Agreements [Member] | ||
Line of Credit Facility [Line Items] | ||
Line of Credit Facility, Maximum Borrowing Capacity | 500,000,000 | |
Long-term Line of Credit | $ 0 |
Deferred Policy Acquisition C_3
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |||
Beginning Balance of DAC | $ 4,946 | $ 5,149 | $ 5,678 |
Capitalizations of DAC | 408 | 369 | 322 |
Net investment gains (losses) of DAC and net derivative gains (losses) | 95 | 204 | (384) |
Other expenses of DAC | (833) | (577) | (560) |
Total amortization of DAC | (738) | (373) | (944) |
Unrealized investment gains (losses) of DAC | (209) | (199) | 93 |
Ending Balance of DAC | 4,407 | 4,946 | 5,149 |
Beginning Balance of VOBA | 502 | 568 | 608 |
Net investment gains (losses) of VOBA and net derivative gains (losses) | 0 | (1) | (1) |
Other expenses of VOBA | (28) | (8) | (105) |
Total amortization of VOBA | (28) | (9) | (106) |
Unrealized investment gains (losses) of VOBA | 30 | (57) | 66 |
Ending Balance of VOBA | 504 | 502 | 568 |
Ending Balance of DAC and VOBA | $ 4,911 | $ 5,448 | $ 5,717 |
Deferred Policy Acquisition C_4
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA by Segment) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Segment Reporting Information [Line Items] | |||
DAC and VOBA | $ 4,911 | $ 5,448 | $ 5,717 |
Annuities | |||
Segment Reporting Information [Line Items] | |||
DAC and VOBA | 3,829 | 4,327 | |
Life | |||
Segment Reporting Information [Line Items] | |||
DAC and VOBA | 971 | 1,019 | |
Run-off | |||
Segment Reporting Information [Line Items] | |||
DAC and VOBA | 5 | 5 | |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
DAC and VOBA | $ 106 | $ 97 |
Deferred Policy Acquisition C_5
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DSI) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |||
Beginning Balance of DSI | $ 379 | $ 410 | $ 431 |
Capitalization of DSI | 2 | 2 | 2 |
Amortization of DSI | (71) | (38) | (41) |
Unrealized investment gains (losses) of DSI | 0 | 5 | 18 |
Ending Balance of DSI | $ 310 | $ 379 | $ 410 |
Deferred Policy Acquisition C_6
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Estimated Future Amortization - Narrative) (Details) $ in Millions | Dec. 31, 2020USD ($) |
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] | |
Present Value of Future Insurance Profits, Expected Amortization, Year One | $ 70 |
Present Value of Future Insurance Profits, Expected Amortization, Year Two | 61 |
Present Value of Future Insurance Profits, Expected Amortization, Year Three | 52 |
Present Value of Future Insurance Profits, Expected Amortization, Year Four | 45 |
Present Value of Future Insurance Profits, Expected Amortization, Year Five | $ 39 |
Reinsurance (Effects of Reinsur
Reinsurance (Effects of Reinsurance on Earnings) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Premiums: | |||
Direct premiums | $ 1,509 | $ 1,651 | $ 1,699 |
Reinsurance assumed | 10 | 10 | 11 |
Reinsurance ceded | (753) | (779) | (810) |
Net premiums | 766 | 882 | 900 |
Universal life and investment-type product policy fees [Abstract] | |||
Direct universal life and investment-type product policy fees | 4,022 | 4,048 | 4,296 |
Reinsurance assumed | 48 | 72 | 95 |
Reinsurance ceded | (607) | (540) | (556) |
Net universal life and investment-type product policy fees | 3,463 | 3,580 | 3,835 |
Other revenues | |||
Other Income Direct | 351 | 366 | 373 |
Commissions Fees And Other Income Assumed | 16 | 1 | 0 |
Other Income Ceded | 46 | 22 | 24 |
Other adjustments to net income (loss) | 413 | 389 | 397 |
Policyholder benefits and claims: | |||
Direct policyholder benefits and claims | 7,545 | 5,441 | 4,891 |
Reinsurance assumed | 103 | 36 | 32 |
Reinsurance ceded | (1,937) | (1,807) | (1,651) |
Net policyholder benefits and claims | $ 5,711 | $ 3,670 | $ 3,272 |
Reinsurance (Effects of Reins_2
Reinsurance (Effects of Reinsurance on Balance Sheet) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Assets | ||
Premiums and Other Receivables, Net | $ 16,158 | $ 14,760 |
Liabilities | ||
Liability for Future Policy Benefits, Life | 44,448 | 39,686 |
Policyholder account balances | 54,508 | 45,771 |
Other policy-related balances | 3,411 | 3,111 |
Other liabilities | 5,011 | 5,236 |
Direct Reinsurance [Member] | ||
Assets | ||
Premiums and Other Receivables, Net | 728 | 631 |
Liabilities | ||
Liability for Future Policy Benefits, Life | 44,329 | 39,581 |
Policyholder account balances | 51,451 | 43,154 |
Other policy-related balances | 1,723 | 1,447 |
Other liabilities | 3,832 | 4,106 |
Assumed Reinsurance | ||
Assets | ||
Premiums and Other Receivables, Net | 6 | 14 |
Liabilities | ||
Liability for Future Policy Benefits, Life | 119 | 105 |
Policyholder account balances | 3,057 | 2,617 |
Other policy-related balances | 1,688 | 1,664 |
Other liabilities | 31 | 32 |
Ceded Reinsurance [Member] | ||
Assets | ||
Premiums and Other Receivables, Net | 15,424 | 14,115 |
Liabilities | ||
Liability for Future Policy Benefits, Life | 0 | 0 |
Policyholder account balances | 0 | 0 |
Other policy-related balances | 0 | 0 |
Other liabilities | $ 1,148 | $ 1,098 |
Reinsurance Reinsurance (Effect
Reinsurance Reinsurance (Effects of Reinsurance on Earnings - Related Party) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Premiums: | |||
Reinsurance assumed | $ 10 | $ 10 | $ 11 |
Ceded Earned Premiums | (753) | (779) | (810) |
Premiums | 766 | 882 | 900 |
Universal life and investment-type product policy fees [Abstract] | |||
Assumed Insurance Commissions And Fees | 48 | 72 | 95 |
Ceded Insurance Commissions and Fees | (607) | (540) | (556) |
Insurance Commissions and Fees | 3,463 | 3,580 | 3,835 |
Other revenues | |||
Commissions Fees And Other Income Assumed | 16 | 1 | 0 |
Other Income Ceded | 46 | 22 | 24 |
Other adjustments to net income (loss) | 413 | 389 | 397 |
Policyholder Benefits and Claims Incurred [Abstract] | |||
Policyholder Benefits and Claims Incurred, Assumed | 103 | 36 | 32 |
Policyholder Benefits and Claims Incurred, Ceded | $ (1,937) | $ (1,807) | (1,651) |
Affiliated Entity | Assumed Reinsurance | |||
Premiums: | |||
Reinsurance assumed | 6 | ||
Universal life and investment-type product policy fees [Abstract] | |||
Assumed Insurance Commissions And Fees | 45 | ||
Other revenues | |||
Commissions Fees And Other Income Assumed | 0 | ||
Policyholder Benefits and Claims Incurred [Abstract] | |||
Policyholder Benefits and Claims Incurred, Assumed | 9 | ||
Affiliated Entity | Ceded Reinsurance [Member] | |||
Premiums: | |||
Ceded Earned Premiums | (201) | ||
Universal life and investment-type product policy fees [Abstract] | |||
Ceded Insurance Commissions and Fees | 1 | ||
Other revenues | |||
Other Income Ceded | 18 | ||
Policyholder Benefits and Claims Incurred [Abstract] | |||
Policyholder Benefits and Claims Incurred, Ceded | (178) | ||
Affiliated Entity | Reinsurance | |||
Premiums: | |||
Premiums | (195) | ||
Universal life and investment-type product policy fees [Abstract] | |||
Insurance Commissions and Fees | 46 | ||
Other revenues | |||
Other adjustments to net income (loss) | 18 | ||
Policyholder Benefits and Claims Incurred [Abstract] | |||
Policyholder Benefits and Claims Incurred, Assumed and Ceded | $ (169) |
Reinsurance (Reinsurance Introd
Reinsurance (Reinsurance Introduction - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Effects of Reinsurance [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 15,100 | $ 13,800 |
Mortality Risk on Case by Case Basis [Member] | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Amount Retained | $ 20 | |
Reinsurance Retention Policy, Excess Retention, Percentage | 100.00% | |
Participating Life Insurance Contract [Member] | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Excess Retention, Percentage | 90.00% | |
Quota Share Reinsurance for Certain Disability Business [Member] | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | |
Ceded Credit Risk, Secured [Member] | Accident and Health Insurance Product Line [Member] | ||
Effects of Reinsurance [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 6,700 |
Reinsurance (Reinsurance Recove
Reinsurance (Reinsurance Recoverables - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Ceded Credit Risk [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 15,100 | $ 13,800 |
Premiums, reinsurance and other, allowance for credit losses | 10 | 0 |
Five Largest Ceded Reinsurers [Member] | ||
Ceded Credit Risk [Line Items] | ||
Ceded Credit Risk, Reinsurance Recoverables, Net | $ 12,900 | $ 11,900 |
Ceded Credit Risk, Reinsurance Recoverables, Percentage | 85.00% | 86.00% |
Ceded Credit Risk, Unsecured [Member] | ||
Ceded Credit Risk [Line Items] | ||
Reinsurance Recoverables, Ceded | $ 5,900 | $ 5,700 |
Ceded Credit Risk, Unsecured [Member] | Five Largest Ceded Reinsurers [Member] | ||
Ceded Credit Risk [Line Items] | ||
Ceded Credit Risk, Reinsurance Recoverables, Net | $ 4,000 | $ 4,200 |
Reinsurance Reinsurance (Reinsu
Reinsurance Reinsurance (Reinsurance Deposit Part B - Narrative) (Details) - USD ($) $ in Billions | Dec. 31, 2020 | Dec. 31, 2019 |
Reinsurance Disclosures [Abstract] | ||
Deposit Contracts, Assets | $ 3.2 | $ 2.2 |
Deposit Contracts, Liabilities | $ 2.6 | $ 2.3 |
Reinsurance Reinsurance (Rein_2
Reinsurance Reinsurance (Reinsurance Related Party Narrative) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Affiliated Entity | Ceded Guaranteed Minimum Benefit [Member] | |
Effects of Reinsurance [Line Items] | |
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net | $ (1) |
Investments (Fixed Maturity Sec
Investments (Fixed Maturity Securities by Sector) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | $ 70,529 | $ 64,079 |
Fixed maturity securities, allowance for credit losses | 2 | 0 |
Fixed maturity securities, gross unrealized gains | 12,117 | 7,136 |
Fixed maturity securities, gross unrealized losses | 149 | 179 |
Fixed maturity securities, estimated fair value | 82,495 | 71,036 |
U.S. Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 32,608 | 28,375 |
Fixed maturity securities, allowance for credit losses | 2 | 0 |
Fixed maturity securities, gross unrealized gains | 5,370 | 2,852 |
Fixed maturity securities, gross unrealized losses | 70 | 67 |
Fixed maturity securities, estimated fair value | 37,906 | 31,160 |
Foreign Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 10,060 | 9,177 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 1,501 | 741 |
Fixed maturity securities, gross unrealized losses | 50 | 74 |
Fixed maturity securities, estimated fair value | 11,511 | 9,844 |
U.S. Government and Agency | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 6,007 | 5,529 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 2,637 | 1,869 |
Fixed maturity securities, gross unrealized losses | 6 | 2 |
Fixed maturity securities, estimated fair value | 8,638 | 7,396 |
RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 7,653 | 8,692 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 644 | 438 |
Fixed maturity securities, gross unrealized losses | 3 | 12 |
Fixed maturity securities, estimated fair value | 8,294 | 9,118 |
CMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 6,207 | 5,500 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 592 | 264 |
Fixed maturity securities, gross unrealized losses | 9 | 9 |
Fixed maturity securities, estimated fair value | 6,790 | 5,755 |
State and Political Subdivision | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 3,673 | 3,358 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 967 | 701 |
Fixed maturity securities, gross unrealized losses | 0 | 2 |
Fixed maturity securities, estimated fair value | 4,640 | 4,057 |
ABS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 2,834 | 1,945 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 60 | 21 |
Fixed maturity securities, gross unrealized losses | 10 | 11 |
Fixed maturity securities, estimated fair value | 2,884 | 1,955 |
Foreign Government | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, amortized cost | 1,487 | 1,503 |
Fixed maturity securities, allowance for credit losses | 0 | 0 |
Fixed maturity securities, gross unrealized gains | 346 | 250 |
Fixed maturity securities, gross unrealized losses | 1 | 2 |
Fixed maturity securities, estimated fair value | $ 1,832 | $ 1,751 |
Investments (Maturities of Fixe
Investments (Maturities of Fixed Maturity Securities) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Investments, Debt and Equity Securities [Abstract] | ||
Amortized cost, due in one year or less | $ 1,504 | |
Amortized cost, due after one year through five years | 7,304 | |
Amortized cost, due after five years through ten years | 14,562 | |
Amortized cost, due after ten years | 30,465 | |
Amortized cost, Structured Securities | 16,694 | |
Fixed maturity securities, amortized cost | 70,529 | $ 64,079 |
Estimated fair value, due in one year or less | 1,521 | |
Estimated fair value, due after one year through five years | 7,851 | |
Estimated fair value, due after five years through ten years | 16,339 | |
Estimated fair value, due after ten years | 38,816 | |
Estimated fair value, Structured Securities | 17,968 | |
Fixed maturity securities, estimated fair value | $ 82,495 | $ 71,036 |
Investments (Continuous Gross U
Investments (Continuous Gross Unrealized Losses for Fixed Maturity Securities by Sector) (Details) $ in Millions | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) |
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | $ 3,347 | $ 4,619 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | $ 84 | $ 79 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, number of securities | 667 | 720 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | $ 1,267 | $ 2,128 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | $ 65 | $ 100 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, number of securities | 244 | 302 |
U.S. Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | $ 1,737 | $ 2,017 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 57 | 44 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 185 | 326 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 13 | 23 |
Foreign Corporate | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 254 | 576 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 8 | 12 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 387 | 561 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 42 | 62 |
U.S. Government and Agency | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 236 | 40 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 6 | 2 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 0 | 0 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 0 | 0 |
RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 180 | 857 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 2 | 8 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 22 | 386 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 1 | 4 |
CMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 332 | 559 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 7 | 7 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 44 | 171 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 2 | 2 |
State and Political Subdivision | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 48 | 143 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 0 | 2 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 0 | 8 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 0 | 0 |
ABS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 506 | 362 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 3 | 2 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 629 | 676 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | 7 | 9 |
Foreign Government | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities in continuous unrealized loss position, less than 12 months, estimated fair value | 54 | 65 |
Fixed maturity securities in continuous unrealized loss position, less than 12 months, gross unrealized losses | 1 | 2 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, estimated fair value | 0 | 0 |
Fixed maturity securities in continuous unrealized loss position, 12 months or greater, gross unrealized losses | $ 0 | $ 0 |
Investments (Rollforward of the
Investments (Rollforward of the Allowance for Credit Losses for Fixed Maturity Securities by Sector (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | $ 0 |
Allowance on securities where credit losses were not previously recorded | 4 |
Reductions for securities sold | (1) |
Change in allowance on securities with an allowance recorded in a previous period | (1) |
Write-offs charged against allowance | (4) |
Fixed maturity securities, allowance for credit losses, end of year | 2 |
U.S. Corporate | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | 0 |
Allowance on securities where credit losses were not previously recorded | 3 |
Reductions for securities sold | (1) |
Change in allowance on securities with an allowance recorded in a previous period | 0 |
Write-offs charged against allowance | (3) |
Fixed maturity securities, allowance for credit losses, end of year | 2 |
Foreign Corporate | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | 0 |
Allowance on securities where credit losses were not previously recorded | 1 |
Reductions for securities sold | 0 |
Change in allowance on securities with an allowance recorded in a previous period | (1) |
Write-offs charged against allowance | (1) |
Fixed maturity securities, allowance for credit losses, end of year | 0 |
Cumulative Effect, Adjusted Balance | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | 4 |
Cumulative Effect, Adjusted Balance | U.S. Corporate | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | 3 |
Cumulative Effect, Adjusted Balance | Foreign Corporate | |
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] | |
Fixed maturity securities, allowance for credit losses, beginning of year | $ 1 |
Investments (Mortgage Loans by
Investments (Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 15,902 | $ 15,817 |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 100.60% | 100.40% |
Financing receivable, allowance for credit losses | $ (94) | $ (64) |
Financing receivable, allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | (0.60%) | (0.40%) |
Financing receivable, net of allowance for credit losses | $ 15,808 | $ 15,753 |
Financing receivable, after allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 100.00% | 100.00% |
Commercial | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 9,714 | $ 9,721 |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 61.40% | 61.70% |
Financing receivable, allowance for credit losses | $ (44) | $ (47) |
Agricultural | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 3,538 | $ 3,388 |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 22.40% | 21.50% |
Financing receivable, allowance for credit losses | $ (15) | $ (10) |
Residential | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 2,650 | $ 2,708 |
Financing receivable, before allowance for credit losses as a percentage of financing receivable, net of allowance for credit losses | 16.80% | 17.20% |
Financing receivable, allowance for credit losses | $ (35) | $ (7) |
Investments (Rollforward of t_2
Investments (Rollforward of the Allowance for Credit Losses for Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans $ in Millions | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | $ 64 |
Current period provision | 28 |
Financing receivable, allowance for credit losses, end of year | 94 |
Cumulative Effect, Adjustment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 2 |
Cumulative Effect, Adjusted Balance | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 66 |
Commercial | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 47 |
Current period provision | 17 |
Financing receivable, allowance for credit losses, end of year | 44 |
Commercial | Cumulative Effect, Adjustment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | (20) |
Commercial | Cumulative Effect, Adjusted Balance | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 27 |
Agricultural | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 10 |
Current period provision | (2) |
Financing receivable, allowance for credit losses, end of year | 15 |
Agricultural | Cumulative Effect, Adjustment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 7 |
Agricultural | Cumulative Effect, Adjusted Balance | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 17 |
Residential | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 7 |
Current period provision | 13 |
Financing receivable, allowance for credit losses, end of year | 35 |
Residential | Cumulative Effect, Adjustment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | 15 |
Residential | Cumulative Effect, Adjusted Balance | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Financing receivable, allowance for credit losses, beginning of year | $ 22 |
Investments (PCD Mortgage Loans
Investments (PCD Mortgage Loans) (Details) - Mortgage Loans $ in Millions | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Financing receivables purchased with credit deterioration, purchase price | $ 159 |
Financing receivables purchased with credit deterioration, allowance at acquisition date | 3 |
Financing receivables purchased with credit deterioration, discount or premium attributable to other factors | 2 |
Financing receivables purchased with credit deterioration, par value | $ 160 |
Investments (Credit Quality of
Investments (Credit Quality of Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | $ 1,383 | |
Financing receivable, originated in FY before latest FY | 2,971 | |
Financing receivable, originated two years before latest FY | 2,691 | |
Financing receivable, originated three years before latest FY | 1,436 | |
Financing receivable, originated four years before latest FY | 1,741 | |
Financing receivable, originated five or more years before latest FY | 5,680 | |
Financing receivable, before allowance for credit losses | 15,902 | $ 15,817 |
Commercial | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 517 | |
Financing receivable, originated in FY before latest FY | 1,977 | |
Financing receivable, originated two years before latest FY | 1,515 | |
Financing receivable, originated three years before latest FY | 881 | |
Financing receivable, originated four years before latest FY | 1,253 | |
Financing receivable, originated five or more years before latest FY | 3,571 | |
Financing receivable, before allowance for credit losses | $ 9,714 | $ 9,721 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 100.00% | 100.00% |
Commercial | Debt Service Coverage Ratio, Greater than 1.20x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 9,450 | $ 9,257 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 97.30% | 95.20% |
Commercial | Debt Service Coverage Ratio, 1.00x to 1.20x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 204 | $ 298 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 2.10% | 3.10% |
Commercial | Debt Service Coverage Ratio, Less than 1.00x | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 60 | $ 166 |
Financing receivable, before allowance for credit losses by debt service coverage ratio as a percentage of financing receivable, before allowance for credit losses | 0.60% | 1.70% |
Commercial | Loan-to-Value Ratio, Less than 65% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | $ 317 | |
Financing receivable, originated in FY before latest FY | 1,527 | |
Financing receivable, originated two years before latest FY | 1,004 | |
Financing receivable, originated three years before latest FY | 515 | |
Financing receivable, originated four years before latest FY | 1,109 | |
Financing receivable, originated five or more years before latest FY | 2,808 | |
Financing receivable, before allowance for credit losses | 7,280 | |
Commercial | Loan-to-Value Ratio, 65% to 75% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 200 | |
Financing receivable, originated in FY before latest FY | 450 | |
Financing receivable, originated two years before latest FY | 482 | |
Financing receivable, originated three years before latest FY | 322 | |
Financing receivable, originated four years before latest FY | 59 | |
Financing receivable, originated five or more years before latest FY | 521 | |
Financing receivable, before allowance for credit losses | 2,034 | |
Commercial | Loan-to-Value Ratio, 76% to 80% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | |
Financing receivable, originated in FY before latest FY | 0 | |
Financing receivable, originated two years before latest FY | 0 | |
Financing receivable, originated three years before latest FY | 44 | |
Financing receivable, originated four years before latest FY | 79 | |
Financing receivable, originated five or more years before latest FY | 8 | |
Financing receivable, before allowance for credit losses | 131 | |
Commercial | Loan-to-Value Ratio, Greater than 80% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 0 | |
Financing receivable, originated in FY before latest FY | 0 | |
Financing receivable, originated two years before latest FY | 29 | |
Financing receivable, originated three years before latest FY | 0 | |
Financing receivable, originated four years before latest FY | 6 | |
Financing receivable, originated five or more years before latest FY | 234 | |
Financing receivable, before allowance for credit losses | 269 | |
Agricultural | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 650 | |
Financing receivable, originated in FY before latest FY | 607 | |
Financing receivable, originated two years before latest FY | 759 | |
Financing receivable, originated three years before latest FY | 424 | |
Financing receivable, originated four years before latest FY | 417 | |
Financing receivable, originated five or more years before latest FY | 681 | |
Financing receivable, before allowance for credit losses | 3,538 | $ 3,388 |
Agricultural | Loan-to-Value Ratio, Less than 65% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 569 | |
Financing receivable, originated in FY before latest FY | 526 | |
Financing receivable, originated two years before latest FY | 749 | |
Financing receivable, originated three years before latest FY | 391 | |
Financing receivable, originated four years before latest FY | 417 | |
Financing receivable, originated five or more years before latest FY | 663 | |
Financing receivable, before allowance for credit losses | 3,315 | |
Agricultural | Loan-to-Value Ratio, 65% to 75% | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 81 | |
Financing receivable, originated in FY before latest FY | 81 | |
Financing receivable, originated two years before latest FY | 10 | |
Financing receivable, originated three years before latest FY | 33 | |
Financing receivable, originated four years before latest FY | 0 | |
Financing receivable, originated five or more years before latest FY | 18 | |
Financing receivable, before allowance for credit losses | 223 | |
Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 216 | |
Financing receivable, originated in FY before latest FY | 387 | |
Financing receivable, originated two years before latest FY | 417 | |
Financing receivable, originated three years before latest FY | 131 | |
Financing receivable, originated four years before latest FY | 71 | |
Financing receivable, originated five or more years before latest FY | 1,428 | |
Financing receivable, before allowance for credit losses | 2,650 | $ 2,708 |
Residential | Performing | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 214 | |
Financing receivable, originated in FY before latest FY | 381 | |
Financing receivable, originated two years before latest FY | 413 | |
Financing receivable, originated three years before latest FY | 131 | |
Financing receivable, originated four years before latest FY | 70 | |
Financing receivable, originated five or more years before latest FY | 1,375 | |
Financing receivable, before allowance for credit losses | 2,584 | |
Residential | Nonperforming | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated in current FY | 2 | |
Financing receivable, originated in FY before latest FY | 6 | |
Financing receivable, originated two years before latest FY | 4 | |
Financing receivable, originated three years before latest FY | 0 | |
Financing receivable, originated four years before latest FY | 1 | |
Financing receivable, originated five or more years before latest FY | 53 | |
Financing receivable, before allowance for credit losses | $ 66 |
Investments (Past Due Mortgage
Investments (Past Due Mortgage Loans by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 15,902 | $ 15,817 |
Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 15,827 | |
30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 9 | |
60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 24 | |
90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 27 | |
180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 15 | |
Commercial | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 9,714 | 9,721 |
Commercial | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 9,714 | |
Commercial | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Commercial | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Commercial | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Commercial | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Agricultural | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 3,538 | 3,388 |
Agricultural | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 3,538 | |
Agricultural | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Agricultural | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Agricultural | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Agricultural | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 0 | |
Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 2,650 | $ 2,708 |
Residential | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 2,575 | |
Residential | 30 to 59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 9 | |
Residential | 60 to 89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 24 | |
Residential | 90 to 179 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | 27 | |
Residential | 180 Days and Greater Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 15 |
Investments (Mortgage Loans in
Investments (Mortgage Loans in Nonaccrual Status by Portfolio Segment) (Details) - Mortgage Loans - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | $ 66 | $ 58 |
Commercial | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | 0 | 0 |
Agricultural | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | 0 | 21 |
Residential | ||
Financing Receivable, Nonaccrual [Line Items] | ||
Financing receivable in nonaccrual status | $ 66 | $ 37 |
Investments (Net Unrealized Inv
Investments (Net Unrealized Investment Gains (Losses)) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss | |||
Fixed maturity securities | $ 11,968 | $ 6,957 | $ 1,691 |
Derivatives | 173 | 245 | 264 |
Other | (16) | (13) | (13) |
Subtotal | 12,125 | 7,189 | 1,942 |
Amounts allocated from: Future policy benefits | (4,313) | (2,692) | (886) |
Amounts allocated from: DAC, VOBA and DSI | (520) | (341) | (90) |
Subtotal | (4,833) | (3,033) | (976) |
Deferred income tax benefit (expense) | (1,531) | (873) | (203) |
Net unrealized investment gains (losses) | $ 5,761 | $ 3,283 | $ 763 |
Investments (Changes in Net Unr
Investments (Changes in Net Unrealized Investment Gains (Losses)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Unrealized investment gains (losses), beginning of year | $ 3,283 | $ 763 | $ 1,726 |
Unrealized investment gains (losses) during the year | 4,936 | 5,247 | (3,057) |
Unrealized investment gains (losses) relating to: Future policy benefits | (1,621) | (1,806) | 1,740 |
Unrealized investment gains (losses) relating to: DAC, VOBA and DSI | (179) | (251) | 177 |
Unrealized investment gains (losses) relating to: Deferred income tax benefit (expense) | (658) | (670) | 256 |
Unrealized investment gains (losses), end of year | 5,761 | 3,283 | 763 |
Change in net unrealized investment gains (losses) | 2,478 | 2,520 | (884) |
Cumulative Effect, Adjustment | |||
Unrealized investment gains (losses), beginning of year | 0 | 0 | (79) |
Unrealized investment gains (losses), end of year | 0 | 0 | |
Cumulative Effect, Adjusted Balance | |||
Unrealized investment gains (losses), beginning of year | $ 3,283 | 763 | 1,647 |
Unrealized investment gains (losses), end of year | $ 3,283 | $ 763 |
Investments (Securities Lending
Investments (Securities Lending) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 3,674 | $ 3,074 |
Reinvestment portfolio — estimated fair value | 3,830 | 3,174 |
Amortized cost | ||
Securities Financing Transaction [Line Items] | ||
Securities on loan | 2,373 | 2,031 |
Estimated fair value | ||
Securities Financing Transaction [Line Items] | ||
Securities on loan | $ 3,603 | $ 2,996 |
Investments (Securities Lendi_2
Investments (Securities Lending Remaining Tenor) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 3,674 | $ 3,074 |
U.S. Government and Agency | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 3,674 | 3,074 |
U.S. Government and Agency | Remaining Tenor of Securities Lending Agreements: Open | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 937 | 1,279 |
U.S. Government and Agency | Remaining Tenor of Securities Lending Agreements: 1 Month or Less | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | 2,300 | 1,094 |
U.S. Government and Agency | Remaining Tenor of Securities Lending Agreements: 1 to 6 Months | ||
Securities Financing Transaction [Line Items] | ||
Cash collateral received from counterparties | $ 437 | $ 701 |
Investments (Invested Assets on
Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Investments, Debt and Equity Securities [Abstract] | ||
Invested assets on deposit (regulatory deposits) | $ 10,135 | $ 9,349 |
Invested assets held in trust (reinsurance agreements) | 5,717 | 4,561 |
Invested assets pledged as collateral | 5,595 | 3,641 |
Total invested assets on deposit, held in trust and pledged as collateral | $ 21,447 | $ 17,551 |
Investments (Variable Interest
Investments (Variable Interest Entities) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Variable Interest Entity [Line Items] | ||
Carrying amount | $ 247,869 | $ 227,259 |
VIE, Not Primary Beneficiary | ||
Variable Interest Entity [Line Items] | ||
Carrying amount | 15,984 | 15,001 |
Maximum exposure to loss | 16,159 | 15,534 |
VIE, Not Primary Beneficiary | Fixed maturity securities | ||
Variable Interest Entity [Line Items] | ||
Carrying amount | 13,665 | 13,094 |
Maximum exposure to loss | 12,581 | 12,454 |
VIE, Not Primary Beneficiary | Limited partnerships and LLCs | ||
Variable Interest Entity [Line Items] | ||
Carrying amount | 2,319 | 1,907 |
Maximum exposure to loss | $ 3,578 | $ 3,080 |
Investments (Net Investment Inc
Investments (Net Investment Income) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Net Investment Income [Line Items] | |||
Gross investment income | $ 3,771 | $ 3,782 | $ 3,534 |
Less: Investment expenses | 170 | 203 | 196 |
Net investment income | 3,601 | 3,579 | 3,338 |
Fixed maturity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 2,700 | 2,673 | 2,565 |
Equity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 6 | 8 | 7 |
Mortgage loans | |||
Net Investment Income [Line Items] | |||
Gross investment income | 666 | 680 | 543 |
Policy loans | |||
Net Investment Income [Line Items] | |||
Gross investment income | 56 | 67 | 85 |
Limited partnerships and LLCs | |||
Net Investment Income [Line Items] | |||
Gross investment income | 240 | 220 | 258 |
Cash, cash equivalents and short-term investments | |||
Net Investment Income [Line Items] | |||
Gross investment income | 49 | 93 | 35 |
Other | |||
Net Investment Income [Line Items] | |||
Gross investment income | $ 54 | $ 41 | $ 41 |
Investments (Components of Net
Investments (Components of Net Investment Gains (Losses)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Investments, Debt and Equity Securities [Abstract] | |||
Net investment gains (losses), fixed maturity securities | $ 297 | $ 106 | $ (180) |
Net investment gains (losses), equity securities | 0 | 17 | (16) |
Net investment gains (losses), mortgage loans | (27) | (10) | (13) |
Net investment gains (losses), limited partnerships and LLCs | (3) | 7 | 40 |
Net investment gains (losses), other | 11 | (8) | (38) |
Net investment gains (losses) | $ 278 | $ 112 | $ (207) |
Investments (Sales or Disposals
Investments (Sales or Disposals of Fixed Maturity Securities) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Investments, Debt and Equity Securities [Abstract] | |||
Proceeds from sales or disposals of fixed maturity securities | $ 3,218 | $ 9,259 | $ 11,251 |
Fixed maturity securities, gross investment gains | 390 | 257 | 102 |
Fixed maturity securities, gross investment losses | (78) | (151) | (282) |
Fixed maturity securities, net investment gains (losses) | $ 312 | $ 106 | $ (180) |
Investments (Fixed Maturity S_2
Investments (Fixed Maturity Securities - Narrative) (Details) $ in Millions | 12 Months Ended | |
Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, estimated fair value | $ 82,495 | $ 71,036 |
Fixed maturity securities, allowance for credit losses | $ 2 | 0 |
Fixed maturity securities with allowance for credit losses, number of securities | 6 | |
Fixed maturity securities, total write-offs | $ 13 | |
Fixed maturity securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Accrued interest receivable | 514 | |
Non-Income Producing | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fixed maturity securities, estimated fair value | $ 5 | $ 0 |
Investments (Mortgage Loans - N
Investments (Mortgage Loans - Narrative) (Details) - Mortgage Loans - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivables purchased from third parties | $ 815 | $ 962 |
Accrued interest receivable | 89 | |
Financing receivable, before allowance for credit losses | 15,902 | $ 15,817 |
COVID-19 Pandemic financial receivable in nonaccrual status | 38 | |
Financing receivables in nonaccrual status, investment income | 2 | |
COVID-19 Pandemic Financial Asset Past Due | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 38 | |
Minimum | Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses by performance status as a percentage of financing receivables, before allowance for credit losses | 99.00% | 99.00% |
Residential | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 2,650 | $ 2,708 |
Financing receivables in nonaccrual status with no allowance for credit losses | 7 | |
Residential | Performing | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Financing receivable, before allowance for credit losses | $ 2,584 |
Investments (Other Invested Ass
Investments (Other Invested Assets - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Derivative [Line Items] | ||
Leveraged leases, net of allowance for credit losses | $ 50 | $ 64 |
Leveraged leases, allowance for credit losses | $ 13 | $ 0 |
Leveraged leases by performance status as a percentage of leveraged leases | 100.00% | 100.00% |
Minimum | ||
Derivative [Line Items] | ||
Percentage of other invested assets comprised of freestanding derivatives with positive estimated fair values | 95.00% |
Investments (Securities Lendi_3
Investments (Securities Lending - Narrative) (Details) $ in Millions | Dec. 31, 2020USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Cash collateral on deposit from counterparties | $ 920 |
Percentage of reinvestment portfolio invested in liquid assets | 63.00% |
Investments (Invested Assets _2
Investments (Invested Assets on Deposit, Held in Trust and Pledged as Collateral - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Restricted Cash and Cash Equivalents Items [Line Items] | ||
Invested assets on deposit (regulatory deposits) | $ 10,135 | $ 9,349 |
Invested assets held in trust (reinsurance agreements) | 5,717 | 4,561 |
Restricted Cash and Cash Equivalents | ||
Restricted Cash and Cash Equivalents Items [Line Items] | ||
Invested assets on deposit (regulatory deposits) | 60 | 69 |
Invested assets held in trust (reinsurance agreements) | $ 101 | $ 124 |
Investments (Collectively Signi
Investments (Collectively Significant Equity Method Investments - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Schedule of Equity Method Investments [Line Items] | |||
Carrying value of investments accounted for under the equity method | $ 2,800 | ||
Total assets | 247,869 | $ 227,259 | |
Total liabilities | 229,781 | 211,022 | |
Net income (loss) | (1,061) | (740) | $ 865 |
Nonconsolidated Equity Method Investment | |||
Schedule of Equity Method Investments [Line Items] | |||
Unfunded commitments | 1,500 | ||
Total assets | 504,000 | 404,000 | |
Total liabilities | 63,000 | 52,800 | |
Net income (loss) | $ 37,700 | $ 33,300 | $ 33,300 |
Investments (Net Investment I_2
Investments (Net Investment Income - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Net Investment Income [Line Items] | |||
Net investment income | $ 3,601 | $ 3,579 | $ 3,338 |
Other limited partnership interests | |||
Net Investment Income [Line Items] | |||
Net investment income | $ 225 | $ 181 | $ 211 |
Investments (Related Party Inve
Investments (Related Party Investment Transactions - Narrative) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Related Party Transaction [Line Items] | |
Related party investment administrative service charges | $ 186 |
MetLife Investment Management, LLC | |
Related Party Transaction [Line Items] | |
Related party investment administrative service charges | $ 50 |
Derivatives (Primary Risks Mana
Derivatives (Primary Risks Managed by Derivatives) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | $ 92,617 | $ 113,472 |
Derivative assets | 3,865 | 3,238 |
Derivative liabilities | 9,181 | 6,785 |
Embedded Derivative, Fair Value of Embedded Derivative Asset | 283 | 217 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 7,157 | 4,248 |
Derivatives Designated as Hedging Instruments | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 3,102 | 3,185 |
Derivative assets | 200 | 212 |
Derivative liabilities | 112 | 27 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 89,515 | 110,287 |
Derivative assets | 3,382 | 2,809 |
Derivative liabilities | 1,912 | 2,510 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate swaps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 2,295 | 7,559 |
Derivative assets | 463 | 878 |
Derivative liabilities | 0 | 29 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate caps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 2,350 | 3,350 |
Derivative assets | 2 | 2 |
Derivative liabilities | 0 | 0 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate options | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 25,980 | 29,750 |
Derivative assets | 712 | 782 |
Derivative liabilities | 122 | 187 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate forwards | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 8,086 | 5,418 |
Derivative assets | 851 | 94 |
Derivative liabilities | 78 | 114 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Foreign currency swaps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 1,000 | 1,051 |
Derivative assets | 86 | 96 |
Derivative liabilities | 32 | 15 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Foreign currency forwards | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 201 | 138 |
Derivative assets | 0 | 0 |
Derivative liabilities | 0 | 1 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Credit default swaps — purchased | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 18 | 18 |
Derivative assets | 0 | 0 |
Derivative liabilities | 0 | 0 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Credit default swaps — written | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 1,755 | 1,635 |
Derivative assets | 41 | 36 |
Derivative liabilities | 0 | 0 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Credit Default Swaption | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 100 | 0 |
Derivative assets | 0 | 0 |
Derivative liabilities | 0 | 0 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity index options | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 31,576 | 51,509 |
Derivative assets | 1,071 | 850 |
Derivative liabilities | 838 | 1,728 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity variance swaps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 1,098 | 2,136 |
Derivative assets | 13 | 69 |
Derivative liabilities | 20 | 69 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity total return swaps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 15,056 | 7,723 |
Derivative assets | 143 | 2 |
Derivative liabilities | 822 | 367 |
Ceded guaranteed minimum income benefits | ||
Derivatives, Fair Value [Line Items] | ||
Embedded Derivative, Fair Value of Embedded Derivative Asset | 283 | 217 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 0 | 0 |
Direct guaranteed minimum benefits | ||
Derivatives, Fair Value [Line Items] | ||
Embedded Derivative, Fair Value of Embedded Derivative Asset | 0 | 0 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 2,920 | 1,656 |
Assumed index-linked annuities | ||
Derivatives, Fair Value [Line Items] | ||
Embedded Derivative, Fair Value of Embedded Derivative Asset | 0 | 0 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 382 | 339 |
Direct index-linked annuities | ||
Derivatives, Fair Value [Line Items] | ||
Embedded Derivative, Fair Value of Embedded Derivative Asset | 0 | 0 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 3,855 | 2,253 |
Cash Flow Hedging | Derivatives Designated as Hedging Instruments | Interest rate forwards | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 290 | 420 |
Derivative assets | 66 | 22 |
Derivative liabilities | 0 | 0 |
Cash Flow Hedging | Derivatives Designated as Hedging Instruments | Foreign currency swaps | ||
Derivatives, Fair Value [Line Items] | ||
Derivative, Notional Amount | 2,812 | 2,765 |
Derivative assets | 134 | 190 |
Derivative liabilities | $ 112 | $ 27 |
Derivatives Derivatives (Deriva
Derivatives Derivatives (Derivatives Pertaining to Hedged Items) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | $ (14) | $ (32) | $ 2 |
Amount of Gains (Losses) Deferred in AOCI | (52) | 40 | 159 |
Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (7) | (3) | (8) |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 12 | ||
Amount of Gains (Losses) Deferred in AOCI | 0 | ||
Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (7) | (29) | (2) |
Amount of Gains (Losses) Deferred in AOCI | (52) | 40 | 159 |
Net Derivative Gains (Losses) | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (4) | (1,956) | 700 |
Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (21) | (2,013) | 583 |
Net Derivative Gains (Losses) | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (12) | ||
Net Derivative Gains (Losses) | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 17 | 57 | 129 |
Net Investment Income | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 40 | 36 | 33 |
Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Net Investment Income | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 1 | ||
Net Investment Income | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 40 | 36 | 32 |
Policyholder Benefits and Claims | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | (8) |
Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | (8) |
Policyholder Benefits and Claims | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | ||
Policyholder Benefits and Claims | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Interest rate derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Interest rate derivatives | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 12 | ||
Amount of Gains (Losses) Deferred in AOCI | 0 | ||
Interest rate derivatives | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | (1) |
Amount of Gains (Losses) Deferred in AOCI | 77 | 25 | (5) |
Interest rate derivatives | Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 3,565 | 1,589 | (658) |
Interest rate derivatives | Net Derivative Gains (Losses) | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (12) | ||
Interest rate derivatives | Net Derivative Gains (Losses) | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 2 | 32 | 129 |
Interest rate derivatives | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Interest rate derivatives | Net Investment Income | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 1 | ||
Interest rate derivatives | Net Investment Income | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 3 | 2 | 5 |
Interest rate derivatives | Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Interest rate derivatives | Policyholder Benefits and Claims | Fair Value Hedges | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | ||
Interest rate derivatives | Policyholder Benefits and Claims | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Foreign currency exchange rate derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (7) | (3) | (8) |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Foreign currency exchange rate derivatives | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | (7) | (29) | (1) |
Amount of Gains (Losses) Deferred in AOCI | (129) | 15 | 164 |
Foreign currency exchange rate derivatives | Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (16) | 22 | 82 |
Foreign currency exchange rate derivatives | Net Derivative Gains (Losses) | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 15 | 25 | 0 |
Foreign currency exchange rate derivatives | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Foreign currency exchange rate derivatives | Net Investment Income | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 37 | 34 | 27 |
Foreign currency exchange rate derivatives | Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Foreign currency exchange rate derivatives | Policyholder Benefits and Claims | Cash Flow Hedging | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Credit derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Credit derivatives | Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 18 | 44 | (7) |
Credit derivatives | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Credit derivatives | Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Equity derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Equity derivatives | Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (1,367) | (2,476) | 632 |
Equity derivatives | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Equity derivatives | Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Net Embedded Derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net Derivative Gains (Losses) Recognized for Hedged Items | 0 | 0 | 0 |
Amount of Gains (Losses) Deferred in AOCI | 0 | 0 | 0 |
Net Embedded Derivatives | Net Derivative Gains (Losses) | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | (2,221) | (1,192) | 534 |
Net Embedded Derivatives | Net Investment Income | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | 0 | 0 | 0 |
Net Embedded Derivatives | Policyholder Benefits and Claims | Derivatives Not Designated or Not Qualifying as Hedging Instruments | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Derivative, Gain (Loss) on Derivative, Net | $ 0 | $ 0 | $ (8) |
Derivatives (Credit Derivatives
Derivatives (Credit Derivatives) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Credit Derivatives [Line Items] | ||
Credit Risk Derivatives, at Fair Value, Net | $ 41 | $ 36 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 1,755 | $ 1,635 |
Weighted Average Years to Maturity (2) | 4 years 3 months 18 days | 4 years 1 month 6 days |
Credit Default Swap | Aaa/Aa/A | ||
Credit Derivatives [Line Items] | ||
Credit Risk Derivatives, at Fair Value, Net | $ 15 | $ 11 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 683 | $ 615 |
Weighted Average Years to Maturity (2) | 2 years 10 months 24 days | 2 years 6 months |
Credit Default Swap | Baa | ||
Credit Derivatives [Line Items] | ||
Credit Risk Derivatives, at Fair Value, Net | $ 26 | $ 25 |
Maximum Amount of Future Payments under Credit Default Swaps | $ 1,072 | $ 1,020 |
Weighted Average Years to Maturity (2) | 5 years 2 months 12 days | 5 years 1 month 6 days |
Derivatives (Estimated Fair Val
Derivatives (Estimated Fair Value of Derivatives Assets and Liabilities after Master Netting Agreements and Cash Collateral) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Offsetting Derivative Assets [Abstract] | ||
Derivative Asset, Fair Value, Amount Not Offset Against Collateral | $ 3,588 | $ 3,062 |
Derivative Asset, Not Offset, Policy Election Deduction | (1,342) | (1,458) |
Derivative Asset, Collateral, Obligation to Return Cash, Offset | (1,340) | (1,115) |
Derivative Asset, Fair Value, Amount Offset Against Collateral | 906 | 489 |
Derivative Asset, Collateral, Obligation to Return Securities, Offset | (840) | (488) |
Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election | 66 | 1 |
Offsetting Derivative Liabilities [Abstract] | ||
Derivative Liability, Fair Value, Amount Not Offset Against Collateral | 2,010 | 2,522 |
Derivative Liability, Not Offset, Policy Election Deduction | (1,342) | (1,458) |
Derivative Liability, Collateral, Right to Reclaim Cash, Offset | 0 | 0 |
Derivative Liability, Fair Value, Amount Offset Against Collateral | 668 | 1,064 |
Derivative Liability, Collateral, Right to Reclaim Securities, Offset | (630) | (1,061) |
Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election | $ 38 | $ 3 |
Derivatives (Credit Risk on Fre
Derivatives (Credit Risk on Freestanding Derivatives) (Details) - Derivatives Subject To Credit-Contingent Provisions - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Credit Derivatives [Line Items] | ||
Estimated fair value of derivatives in a net liability position (1) | $ 668 | $ 1,064 |
Fixed maturity securities | ||
Credit Derivatives [Line Items] | ||
Estimated Fair Value of Collateral Provided (2): | $ 1,205 | $ 1,473 |
Derivatives (Narrative) (Detail
Derivatives (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax | $ 173 | $ 245 |
Maximum Length of Time Hedged in Cash Flow Hedge | 3 years | 4 years |
Fair Value (Recurring Fair Valu
Fair Value (Recurring Fair Value Measurements) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | $ 82,495 | $ 71,036 |
Available-for-sale Securities, Equity Securities | 138 | 147 |
Short-term investments | 3,242 | 1,958 |
Derivative assets | 3,865 | 3,238 |
Net embedded derivatives within asset host contracts | 283 | 217 |
Separate Account Asset | 111,969 | 107,107 |
Liabilities [Abstract] | ||
Derivative liabilities | 9,181 | 6,785 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 7,157 | 4,248 |
Recurring | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 82,495 | 71,036 |
Available-for-sale Securities, Equity Securities | 138 | 147 |
Short-term investments | 3,242 | 1,958 |
Derivative assets | 3,582 | 3,021 |
Net embedded derivatives within asset host contracts | 283 | 217 |
Separate Account Asset | 111,969 | 107,107 |
Total assets | 201,709 | 183,486 |
Liabilities [Abstract] | ||
Derivative liabilities | 2,024 | 2,537 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 7,157 | 4,248 |
Total liabilities | 9,181 | 6,785 |
Recurring | Interest rate | ||
Assets [Abstract] | ||
Derivative assets | 2,094 | 1,778 |
Liabilities [Abstract] | ||
Derivative liabilities | 200 | 330 |
Recurring | Foreign currency exchange rate | ||
Assets [Abstract] | ||
Derivative assets | 220 | 286 |
Liabilities [Abstract] | ||
Derivative liabilities | 144 | 43 |
Recurring | Credit | ||
Assets [Abstract] | ||
Derivative assets | 41 | 36 |
Recurring | Equity market | ||
Assets [Abstract] | ||
Derivative assets | 1,227 | 921 |
Liabilities [Abstract] | ||
Derivative liabilities | 1,680 | 2,164 |
Recurring | U.S. Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 37,906 | 31,160 |
Recurring | Foreign Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 11,511 | 9,844 |
Recurring | RMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 8,294 | 9,118 |
Recurring | U.S. government and agency | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 8,638 | 7,396 |
Recurring | CMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 6,790 | 5,755 |
Recurring | State and Political Subdivision | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 4,640 | 4,057 |
Recurring | ABS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 2,884 | 1,955 |
Recurring | Foreign Government | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 1,832 | 1,751 |
Recurring | Level 1 | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 2,217 | 1,636 |
Available-for-sale Securities, Equity Securities | 36 | 14 |
Short-term investments | 2,782 | 1,271 |
Derivative assets | 0 | 0 |
Net embedded derivatives within asset host contracts | 0 | 0 |
Separate Account Asset | 86 | 180 |
Total assets | 5,121 | 3,101 |
Liabilities [Abstract] | ||
Derivative liabilities | 0 | 0 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 0 | 0 |
Total liabilities | 0 | 0 |
Recurring | Level 1 | Interest rate | ||
Assets [Abstract] | ||
Derivative assets | 0 | 0 |
Liabilities [Abstract] | ||
Derivative liabilities | 0 | 0 |
Recurring | Level 1 | Foreign currency exchange rate | ||
Assets [Abstract] | ||
Derivative assets | 0 | 0 |
Liabilities [Abstract] | ||
Derivative liabilities | 0 | 0 |
Recurring | Level 1 | Credit | ||
Assets [Abstract] | ||
Derivative assets | 0 | 0 |
Recurring | Level 1 | Equity market | ||
Assets [Abstract] | ||
Derivative assets | 0 | 0 |
Liabilities [Abstract] | ||
Derivative liabilities | 0 | 0 |
Recurring | Level 1 | U.S. Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | Foreign Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | RMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | U.S. government and agency | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 2,217 | 1,636 |
Recurring | Level 1 | CMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | State and Political Subdivision | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | ABS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 1 | Foreign Government | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 2 | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 79,523 | 68,749 |
Available-for-sale Securities, Equity Securities | 99 | 125 |
Short-term investments | 460 | 682 |
Derivative assets | 3,553 | 2,934 |
Net embedded derivatives within asset host contracts | 0 | 0 |
Separate Account Asset | 111,880 | 106,924 |
Total assets | 195,515 | 179,414 |
Liabilities [Abstract] | ||
Derivative liabilities | 1,997 | 2,466 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 0 | 0 |
Total liabilities | 1,997 | 2,466 |
Recurring | Level 2 | Interest rate | ||
Assets [Abstract] | ||
Derivative assets | 2,094 | 1,778 |
Liabilities [Abstract] | ||
Derivative liabilities | 200 | 330 |
Recurring | Level 2 | Foreign currency exchange rate | ||
Assets [Abstract] | ||
Derivative assets | 219 | 281 |
Liabilities [Abstract] | ||
Derivative liabilities | 137 | 43 |
Recurring | Level 2 | Credit | ||
Assets [Abstract] | ||
Derivative assets | 27 | 25 |
Recurring | Level 2 | Equity market | ||
Assets [Abstract] | ||
Derivative assets | 1,213 | 850 |
Liabilities [Abstract] | ||
Derivative liabilities | 1,660 | 2,093 |
Recurring | Level 2 | U.S. Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 37,415 | 30,831 |
Recurring | Level 2 | Foreign Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 11,314 | 9,712 |
Recurring | Level 2 | RMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 8,272 | 9,074 |
Recurring | Level 2 | U.S. government and agency | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 6,421 | 5,760 |
Recurring | Level 2 | CMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 6,785 | 5,755 |
Recurring | Level 2 | State and Political Subdivision | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 4,640 | 3,984 |
Recurring | Level 2 | ABS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 2,844 | 1,882 |
Recurring | Level 2 | Foreign Government | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 1,832 | 1,751 |
Recurring | Level 3 | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 755 | 651 |
Available-for-sale Securities, Equity Securities | 3 | 8 |
Short-term investments | 0 | 5 |
Derivative assets | 29 | 87 |
Net embedded derivatives within asset host contracts | 283 | 217 |
Separate Account Asset | 3 | 3 |
Total assets | 1,073 | 971 |
Liabilities [Abstract] | ||
Derivative liabilities | 27 | 71 |
Embedded Derivative, Fair Value of Embedded Derivative Liability | 7,157 | 4,248 |
Total liabilities | 7,184 | 4,319 |
Recurring | Level 3 | Interest rate | ||
Assets [Abstract] | ||
Derivative assets | 0 | 0 |
Liabilities [Abstract] | ||
Derivative liabilities | 0 | 0 |
Recurring | Level 3 | Foreign currency exchange rate | ||
Assets [Abstract] | ||
Derivative assets | 1 | 5 |
Liabilities [Abstract] | ||
Derivative liabilities | 7 | 0 |
Recurring | Level 3 | Credit | ||
Assets [Abstract] | ||
Derivative assets | 14 | 11 |
Recurring | Level 3 | Equity market | ||
Assets [Abstract] | ||
Derivative assets | 14 | 71 |
Liabilities [Abstract] | ||
Derivative liabilities | 20 | 71 |
Recurring | Level 3 | U.S. Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 491 | 329 |
Recurring | Level 3 | Foreign Corporate | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 197 | 132 |
Recurring | Level 3 | RMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 22 | 44 |
Recurring | Level 3 | U.S. government and agency | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 0 |
Recurring | Level 3 | CMBS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 5 | 0 |
Recurring | Level 3 | State and Political Subdivision | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 0 | 73 |
Recurring | Level 3 | ABS | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | 40 | 73 |
Recurring | Level 3 | Foreign Government | ||
Assets [Abstract] | ||
Fixed maturity securities, estimated fair value | $ 0 | $ 0 |
Fair Value (Quantitative Inform
Fair Value (Quantitative Information) (Details) - Fair Value, Inputs, Level 3 [Member] | Dec. 31, 2020 | Dec. 31, 2019 |
Measurement Input, Mortality Rate [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.0003 | 0.0002 |
Measurement Input, Mortality Rate [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.1213 | 0.1131 |
Measurement Input, Lapse Rate [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.0025 | 0.0025 |
Measurement Input, Lapse Rate [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.1500 | 0.1600 |
Measurement Input, Utilization Rate [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0 | 0 |
Measurement Input, Utilization Rate [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.2500 | 0.2500 |
Measurement Input, Withdrawal Rate [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.0025 | 0.0025 |
Measurement Input, Withdrawal Rate [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.1000 | 0.1000 |
Measurement Input, Long Term Equity Volatilities [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.1666 | 0.1624 |
Measurement Input, Long Term Equity Volatilities [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.2221 | 0.2165 |
Measurement Input, Entity Credit Risk [Member] | Minimum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.0047 | 0.0054 |
Measurement Input, Entity Credit Risk [Member] | Maximum | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Embedded Derivative Liability, Measurement Input | 0.0197 | 0.0199 |
Fair Value (Unobservable Input
Fair Value (Unobservable Input Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Net Derivatives | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | $ (9) | ||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Balance at January 1, | 16 | $ (122) | |
Total realized/unrealized gains (losses) included in net income (loss) | 9 | (12) | $ 152 |
Total realized/unrealized gains (losses) included in AOCI | (9) | (1) | 9 |
Purchases | 0 | 0 | |
Sales | (14) | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 155 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | (4) | |
Balance at December 31, | 2 | 16 | (122) |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (4) | (10) | 148 |
Net Embedded Derivatives | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0 | ||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
Balance at January 1, | (4,031) | (1,998) | |
Total realized/unrealized gains (losses) included in net income (loss) | (2,221) | (1,192) | 526 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases | 0 | 0 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | (622) | (841) | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Balance at December 31, | (6,874) | (4,031) | (1,998) |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (2,297) | (1,450) | 395 |
U.S. corporate and foreign corporate | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 461 | 732 | |
Total realized/unrealized gains (losses) included in net income (loss) | (6) | 0 | 1 |
Total realized/unrealized gains (losses) included in AOCI | (3) | 15 | (33) |
Purchases | 409 | 342 | |
Sales | (117) | (150) | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 186 | 24 | |
Transfers out of Level 3 | (242) | (502) | |
Balance at December 31, | 688 | 461 | 732 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | (5) | 0 | (2) |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | (3) | ||
Structured securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 117 | 173 | |
Total realized/unrealized gains (losses) included in net income (loss) | 0 | 1 | 2 |
Total realized/unrealized gains (losses) included in AOCI | 1 | 2 | (6) |
Purchases | 58 | 69 | |
Sales | (5) | (25) | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 11 | 42 | |
Transfers out of Level 3 | (115) | (145) | |
Balance at December 31, | 67 | 117 | 173 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 0 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 1 | ||
State and Political Subdivision | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 73 | 74 | |
Total realized/unrealized gains (losses) included in net income (loss) | 0 | 1 | 1 |
Total realized/unrealized gains (losses) included in AOCI | 0 | (1) | (1) |
Purchases | 0 | 0 | |
Sales | 0 | (1) | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | (73) | 0 | |
Balance at December 31, | 0 | 73 | 74 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 1 | 1 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0 | ||
Equity securities | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 8 | 3 | |
Total realized/unrealized gains (losses) included in net income (loss) | 0 | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases | 0 | 5 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | (5) | 0 | |
Balance at December 31, | 3 | 8 | 3 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 1 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0 | ||
Short-term investments | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 5 | 0 | |
Total realized/unrealized gains (losses) included in net income (loss) | 0 | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases | 0 | 5 | |
Sales | (5) | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | 0 | |
Balance at December 31, | 0 | 5 | 0 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | 0 | 0 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0 | ||
Separate account assets | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance at January 1, | 3 | 1 | |
Total realized/unrealized gains (losses) included in net income (loss) | 0 | 0 | 0 |
Total realized/unrealized gains (losses) included in AOCI | 0 | 0 | 0 |
Purchases | 0 | 3 | |
Sales | 0 | 0 | |
Issuances | 0 | 0 | |
Settlements | 0 | 0 | |
Transfers into Level 3 | 0 | 0 | |
Transfers out of Level 3 | 0 | (1) | |
Balance at December 31, | 3 | 3 | 1 |
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period | 0 | $ 0 | $ 0 |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | $ 0 |
Fair Value (Financial Instrumen
Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Assets | ||
Policy loans | $ 1,291 | $ 1,292 |
Liabilities | ||
Separate Account, Liability | 111,969 | 107,107 |
Reported Value Measurement [Member] | ||
Assets | ||
Mortgage loans | 15,808 | 15,753 |
Policy loans | 1,291 | 1,292 |
Other Investments Fair Value Disclosure | 51 | 51 |
Premiums, reinsurance and other receivables | 3,277 | 2,224 |
Liabilities | ||
Policyholder account balances | 17,497 | 15,614 |
Long-term debt | 3,436 | 4,365 |
Other liabilities | 807 | 846 |
Separate Account, Liability | 1,334 | 1,189 |
Estimate of Fair Value Measurement [Member] | ||
Assets | ||
Mortgage loans | 16,926 | 16,383 |
Policy loans | 2,042 | 1,578 |
Other Investments Fair Value Disclosure | 51 | 51 |
Premiums, reinsurance and other receivables | 4,065 | 2,634 |
Liabilities | ||
Policyholder account balances | 19,100 | 15,710 |
Long-term debt | 3,858 | 4,334 |
Other liabilities | 807 | 846 |
Separate Account, Liability | 1,334 | 1,189 |
Estimate of Fair Value Measurement [Member] | Level 1 | ||
Assets | ||
Mortgage loans | 0 | 0 |
Policy loans | 0 | 0 |
Other Investments Fair Value Disclosure | 0 | 0 |
Premiums, reinsurance and other receivables | 0 | 0 |
Liabilities | ||
Policyholder account balances | 0 | 0 |
Long-term debt | 0 | 0 |
Other liabilities | 0 | 0 |
Separate Account, Liability | 0 | 0 |
Estimate of Fair Value Measurement [Member] | Level 2 | ||
Assets | ||
Mortgage loans | 0 | 0 |
Policy loans | 512 | 516 |
Other Investments Fair Value Disclosure | 39 | 39 |
Premiums, reinsurance and other receivables | 90 | 41 |
Liabilities | ||
Policyholder account balances | 0 | 0 |
Long-term debt | 3,858 | 3,334 |
Other liabilities | 163 | 191 |
Separate Account, Liability | 1,334 | 1,189 |
Estimate of Fair Value Measurement [Member] | Level 3 | ||
Assets | ||
Mortgage loans | 16,926 | 16,383 |
Policy loans | 1,530 | 1,062 |
Other Investments Fair Value Disclosure | 12 | 12 |
Premiums, reinsurance and other receivables | 3,975 | 2,593 |
Liabilities | ||
Policyholder account balances | 19,100 | 15,710 |
Long-term debt | 0 | 1,000 |
Other liabilities | 644 | 655 |
Separate Account, Liability | $ 0 | $ 0 |
Long-term Debt (Details)
Long-term Debt (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2019 | Dec. 31, 2020 | Jun. 30, 2020 | Sep. 30, 2018 | |
Debt Instrument [Line Items] | ||||
Debt instrument, face value | $ 4,407 | $ 3,471 | ||
Debt instrument, carrying value | $ 4,365 | 3,436 | ||
Term Loan Due 2024 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, basis spread on variable rate debt | 1.50% | |||
Debt instrument, face value | $ 1,000 | 0 | ||
Debt instrument, carrying value | $ 1,000 | $ 0 | ||
Senior Notes Due 2027 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 3.70% | 3.70% | ||
Debt instrument, face value | $ 1,500 | $ 1,300 | ||
Debt instrument, carrying value | $ 1,492 | $ 1,294 | ||
Senior Notes Due 2047 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 4.70% | 4.70% | ||
Debt instrument, face value | $ 1,500 | $ 1,150 | ||
Debt instrument, carrying value | $ 1,478 | $ 1,134 | ||
Junior Subordinated Debentures Due 2058 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 6.25% | 6.25% | 6.25% | |
Debt instrument, face value | $ 375 | $ 375 | $ 375 | |
Debt instrument, carrying value | $ 363 | $ 363 | ||
Non-recourse Debt Due 2030 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 7.028% | 7.028% | ||
Debt instrument, face value | $ 32 | $ 31 | ||
Debt instrument, carrying value | 32 | $ 31 | ||
Senior Notes Due 2030 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 5.625% | 5.625% | ||
Debt instrument, face value | 0 | $ 615 | $ 615 | |
Debt instrument, carrying value | $ 0 | $ 614 |
Long-term Debt (Narrative) (Det
Long-term Debt (Narrative) (Details) - USD ($) $ in Millions | Feb. 01, 2019 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Nov. 20, 2020 | Jun. 11, 2020 | May 07, 2019 | Sep. 30, 2018 | Apr. 28, 2017 |
Debt Instrument [Line Items] | |||||||||||
Debt instrument, unamortized debt issuance costs and debt discount | $ 35 | $ 35 | $ 42 | ||||||||
Long-term debt maturities, year one | 2 | 2 | |||||||||
Long-term debt maturities, year two | 2 | 2 | |||||||||
Long-term debt maturities, year three | 2 | 2 | |||||||||
Long-term debt maturities, year four | 2 | 2 | |||||||||
Long-term debt maturities, year five | 3 | 3 | |||||||||
Long-term debt maturities, after year five | 3,500 | 3,500 | |||||||||
Interest expense on long-term debt | 184 | 191 | $ 158 | ||||||||
Debt instrument, face value | 3,471 | 3,471 | 4,407 | ||||||||
Debt instrument, premium paid in excess of debt principal upon repurchase | 37 | ||||||||||
Debt instrument, unamortized debt issuance costs written off | 6 | ||||||||||
Long-term debt issued | 615 | 1,000 | 375 | ||||||||
Long-term debt repaid | 1,552 | 602 | 9 | ||||||||
BHF Revolving Credit Facility Due 2024 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Maximum borrowing capacity | 1,000 | 1,000 | $ 1,000 | ||||||||
Credit facilities, outstanding balance | 0 | 0 | |||||||||
Credit facilities, letters of credit outstanding | 0 | 0 | |||||||||
BHF Revolving Credit Facility Due 2021 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Maximum borrowing capacity | $ 2,000 | ||||||||||
BHF Term Loan Due 2024 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, face value | 0 | 0 | 1,000 | ||||||||
Maximum borrowing capacity | $ 1,000 | 1,000 | 1,000 | ||||||||
Long-term debt issued | 1,000 | ||||||||||
BHF Term Loan Due 2019 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Maximum borrowing capacity | 600 | ||||||||||
Long-term debt repaid | $ 600 | ||||||||||
BRCD Reinsurance Financing Arrangement | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Maximum borrowing capacity | 12,000 | 12,000 | $ 12,000 | $ 10,000 | |||||||
Credit facilities, outstanding balance | 0 | 0 | |||||||||
Credit facilities, remaining borrowing capacity | 10,900 | 10,900 | |||||||||
Credit facilities, commitment fee amount | 30 | 41 | $ 44 | ||||||||
BLIC Repurchase Facility | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Maximum borrowing capacity | 2,000 | 2,000 | $ 2,000 | ||||||||
Credit facilities, outstanding balance | 0 | 0 | |||||||||
Senior Notes Due 2030 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, face value | $ 615 | $ 615 | $ 615 | 0 | |||||||
Debt instrument, stated interest rate | 5.625% | 5.625% | 5.625% | ||||||||
Proceeds from debt issued, net of issuance costs | $ 614 | ||||||||||
Senior Notes Due 2027 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, face value | $ 1,300 | $ 1,300 | $ 1,500 | ||||||||
Debt instrument, stated interest rate | 3.70% | 3.70% | 3.70% | ||||||||
Debt instrument, principal amount repurchased | $ 200 | $ 200 | |||||||||
Senior Notes Due 2047 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, face value | $ 1,150 | $ 1,150 | $ 1,500 | ||||||||
Debt instrument, stated interest rate | 4.70% | 4.70% | 4.70% | ||||||||
Debt instrument, principal amount repurchased | $ 350 | $ 350 | |||||||||
Junior Subordinated Debentures Due 2058 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt instrument, face value | $ 375 | $ 375 | $ 375 | $ 375 | |||||||
Debt instrument, stated interest rate | 6.25% | 6.25% | 6.25% | 6.25% | |||||||
Debt issuance costs capitalized | $ 14 |
Equity (Preferred Stock) (Detai
Equity (Preferred Stock) (Details) - shares | Mar. 25, 2019 | Nov. 30, 2020 | May 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 |
Class of Stock [Line Items] | |||||
Preferred Stock, shares authorized | 100,000,000 | 100,000,000 | |||
Preferred stock, shares issued | 56,100 | 17,000 | |||
Preferred stock, shares outstanding | 56,100 | 17,000 | |||
Series A Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred stock, annual dividend rate | 6.60% | 6.60% | 6.60% | ||
Preferred Stock, shares authorized | 17,000 | 17,000 | |||
Preferred stock, shares issued | 17,000 | 17,000 | 17,000 | ||
Preferred stock, shares outstanding | 17,000 | 17,000 | |||
Series B Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred stock, annual dividend rate | 6.75% | 6.75% | |||
Preferred Stock, shares authorized | 16,100 | 0 | |||
Preferred stock, shares issued | 16,100 | 16,100 | 0 | ||
Preferred stock, shares outstanding | 16,100 | 0 | |||
Series C Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred stock, annual dividend rate | 5.375% | 5.375% | |||
Preferred Stock, shares authorized | 23,000 | 0 | |||
Preferred stock, shares issued | 23,000 | 23,000 | 0 | ||
Preferred stock, shares outstanding | 23,000 | 0 | |||
Not Designated Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred Stock, shares authorized | 99,943,900 | 99,983,000 | |||
Preferred stock, shares issued | 0 | 0 | |||
Preferred stock, shares outstanding | 0 | 0 |
Equity (Preferred Stock Dividen
Equity (Preferred Stock Dividends) (Details) - USD ($) $ / shares in Units, $ in Millions | Nov. 16, 2020 | Aug. 17, 2020 | May 15, 2020 | Feb. 14, 2020 | Nov. 15, 2019 | Aug. 15, 2019 | May 15, 2019 | Dec. 31, 2020 | Dec. 31, 2019 |
Class of Stock [Line Items] | |||||||||
Preferred stock, aggregate dividends declared | $ 44 | $ 21 | |||||||
Series A Preferred Stock | |||||||||
Class of Stock [Line Items] | |||||||||
Preferred stock, dividends declared per share | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 1,650 | $ 1,237.50 |
Preferred stock, aggregate dividends declared | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 28 | $ 21 |
Series B Preferred Stock | |||||||||
Class of Stock [Line Items] | |||||||||
Preferred stock, dividends declared per share | $ 421.88 | $ 595.31 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 1,017.19 | $ 0 |
Preferred stock, aggregate dividends declared | $ 6 | $ 10 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 16 | $ 0 |
Equity (Common Stock) (Details)
Equity (Common Stock) (Details) - shares | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Common stock, shares outstanding at beginning of period | 106,027,301 | 117,532,336 | 119,773,106 |
Common stock, shares issued | 354,652 | 199,853 | 674,912 |
Common stock, shares repurchased | (18,170,335) | (11,704,888) | (2,915,682) |
Common stock, shares outstanding at end of period | 88,211,618 | 106,027,301 | 117,532,336 |
Equity (Share-Based Compensatio
Equity (Share-Based Compensation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Restricted Stock Units (RSUs), Founders' Grant | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Expense | $ 0 | $ 0 | $ 31 |
Other Share Based | Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Expense | 15 | 15 | 7 |
Other Share Based | Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Expense | 0 | 1 | 1 |
Other Share Based | Performance Shares units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Expense | 5 | 4 | 0 |
Other Share Based | Employee Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Expense | $ 1 | $ 1 | $ 1 |
Equity (Performance Share Units
Equity (Performance Share Units) (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 9,121 | |
Restricted Stock Units (RSUs) | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 791,100 | 588,729 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 37.80 | $ 41.27 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 494,596 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 35.68 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 50,251 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 38.21 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | 241,974 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 41.90 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share | $ 0 | |
Performance Shares units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 453,971 | 253,180 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 38.64 | $ 41.21 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 223,003 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 35.84 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 22,212 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 39.85 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share | $ 0 |
Equity (Stock Options) (Details
Equity (Stock Options) (Details) - Stock Options | 12 Months Ended |
Dec. 31, 2018$ / shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | 2.93% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 25.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 5 years 9 months 18 days |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 53.47 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 12.54 |
Equity (Statutory Net Income_Lo
Equity (Statutory Net Income/Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Brighthouse Life Insurance Company | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Net Income Amount | $ (979) | $ 1,074 | $ (1,104) |
New England Life Insurance Company [Member] | |||
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Net Income Amount | $ 105 | $ 61 | $ 130 |
Equity (Statutory Capital and S
Equity (Statutory Capital and Surplus) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Minimum | ||
Statutory Accounting Practices [Line Items] | ||
Description of Regulatory Capital Requirements under Insurance Regulations | in excess of 400% | in excess of 400% |
Brighthouse Life Insurance Company | ||
Statutory Accounting Practices [Line Items] | ||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 7,410 | $ 8,746 |
New England Life Insurance Company [Member] | ||
Statutory Accounting Practices [Line Items] | ||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 150 | $ 116 |
Equity (Dividend Restrictions)
Equity (Dividend Restrictions) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2021 | |
Brighthouse Life Insurance Company | ||||
Statutory Accounting Practices [Line Items] | ||||
Payments of Dividends | $ 1,250 | $ 0 | $ 0 | |
Brighthouse Life Insurance Company | Scenario, Forecast | ||||
Statutory Accounting Practices [Line Items] | ||||
Permitted w/o Approval | $ 733 | |||
New England Life Insurance Company [Member] | ||||
Statutory Accounting Practices [Line Items] | ||||
Payments of Dividends | $ 61 | $ 131 | $ 400 | |
New England Life Insurance Company [Member] | Scenario, Forecast | ||||
Statutory Accounting Practices [Line Items] | ||||
Permitted w/o Approval | $ 105 |
Equity (Components of Accumulat
Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | $ 3,240 | $ 716 | $ 1,676 |
OCI before reclassifications | 3,465 | 3,327 | (1,185) |
Deferred income tax benefit (expense) | (735) | (696) | 335 |
AOCI before reclassifications, net of income tax | 5,970 | 3,347 | 747 |
Amounts reclassified from AOCI | (322) | (135) | 48 |
Deferred income tax benefit (expense) | 68 | 28 | (79) |
Amounts reclassified from AOCI, net of income tax | (254) | (107) | (31) |
Balance end of period | 5,716 | 3,240 | 716 |
Cumulative Effect, Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (79) | ||
Balance end of period | 3 | ||
Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 1,597 | ||
Unrealized Investment Gains (Losses), Net of Related Offsets | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 3,111 | 576 | 1,572 |
OCI before reclassifications | 3,511 | 3,285 | (1,346) |
Deferred income tax benefit (expense) | (737) | (690) | 287 |
AOCI before reclassifications, net of income tax | 5,885 | 3,171 | 434 |
Amounts reclassified from AOCI | (303) | (76) | 181 |
Deferred income tax benefit (expense) | 64 | 16 | (39) |
Amounts reclassified from AOCI, net of income tax | (239) | (60) | 142 |
Balance end of period | 5,646 | 3,111 | 576 |
Unrealized Investment Gains (Losses), Net of Related Offsets | Cumulative Effect, Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (79) | ||
Unrealized Investment Gains (Losses), Net of Related Offsets | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 1,493 | ||
Unrealized Gains (Losses) on Derivatives | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 172 | 187 | 154 |
OCI before reclassifications | (52) | 40 | 159 |
Deferred income tax benefit (expense) | 11 | (8) | 48 |
AOCI before reclassifications, net of income tax | 131 | 219 | 361 |
Amounts reclassified from AOCI | (20) | (59) | (134) |
Deferred income tax benefit (expense) | 4 | 12 | (40) |
Amounts reclassified from AOCI, net of income tax | (16) | (47) | (174) |
Balance end of period | 115 | 172 | 187 |
Unrealized Gains (Losses) on Derivatives | Cumulative Effect, Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 0 | ||
Unrealized Gains (Losses) on Derivatives | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 154 | ||
Foreign Currency Translation Adjustments | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (15) | (27) | (24) |
OCI before reclassifications | 20 | 12 | (4) |
Deferred income tax benefit (expense) | (13) | 0 | 1 |
AOCI before reclassifications, net of income tax | (8) | (15) | (27) |
Amounts reclassified from AOCI | 0 | 0 | 0 |
Deferred income tax benefit (expense) | 0 | 0 | 0 |
Amounts reclassified from AOCI, net of income tax | 0 | 0 | 0 |
Balance end of period | (8) | (15) | (27) |
Foreign Currency Translation Adjustments | Cumulative Effect, Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 0 | ||
Foreign Currency Translation Adjustments | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (24) | ||
Defined Benefit Plans Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | (28) | (20) | (26) |
OCI before reclassifications | (14) | (10) | 6 |
Deferred income tax benefit (expense) | 4 | 2 | (1) |
AOCI before reclassifications, net of income tax | (38) | (28) | (21) |
Amounts reclassified from AOCI | 1 | 0 | 1 |
Deferred income tax benefit (expense) | 0 | 0 | 0 |
Amounts reclassified from AOCI, net of income tax | 1 | 0 | 1 |
Balance end of period | $ (37) | $ (28) | (20) |
Defined Benefit Plans Adjustment | Cumulative Effect, Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | 0 | ||
Defined Benefit Plans Adjustment | Cumulative Effect, Adjusted Balance | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance beginning of period | $ (26) |
Equity (Reclassifications Out o
Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment gains (losses) | $ 278 | $ 112 | $ (207) |
Net investment income | 3,601 | 3,579 | 3,338 |
Net derivative gains (losses) | (18) | (1,988) | 702 |
Income (loss) before provision for income tax | (1,419) | (1,052) | 989 |
Provision for income tax expense (benefit) | 363 | 317 | (119) |
Net income (loss) | (1,105) | (761) | 865 |
Reclassification out of Accumulated Other Comprehensive Income | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net income (loss) | 254 | 107 | 31 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Investment Gains (Losses), Net of Related Offsets | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment gains (losses) | 318 | 113 | (180) |
Net investment income | 0 | 0 | 1 |
Net derivative gains (losses) | (15) | (37) | (2) |
Income (loss) before provision for income tax | 303 | 76 | (181) |
Provision for income tax expense (benefit) | (64) | (16) | 39 |
Net income (loss) | 239 | 60 | (142) |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Income (loss) before provision for income tax | 20 | 59 | 134 |
Provision for income tax expense (benefit) | (4) | (12) | 40 |
Net income (loss) | 16 | 47 | 174 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Interest rate swaps | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment income | 3 | 2 | 3 |
Net derivative gains (losses) | 2 | 32 | 98 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Interest rate forwards | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net investment income | 0 | 0 | 2 |
Net derivative gains (losses) | 0 | 0 | 31 |
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Foreign currency swaps | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Net derivative gains (losses) | 15 | 25 | 0 |
Reclassification out of Accumulated Other Comprehensive Income | Defined Benefit Plans Adjustment | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Amortization of net actuarial gains (losses) | (1) | 0 | (1) |
Income (loss) before provision for income tax | (1) | 0 | (1) |
Provision for income tax expense (benefit) | 0 | 0 | 0 |
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax | $ (1) | $ 0 | $ (1) |
Equity (Preferred Stock & Commo
Equity (Preferred Stock & Common Stock - Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | Mar. 25, 2019 | Nov. 30, 2020 | May 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Feb. 06, 2020 | May 03, 2019 | Aug. 05, 2018 |
Class of Stock [Line Items] | |||||||||
Preferred stock, shares issued | 56,100 | 17,000 | |||||||
Preferred stock, stated amount per share | $ 25,000 | ||||||||
Preferred stock, proceeds from issuance, net of issuance costs | $ 948 | $ 412 | $ 0 | ||||||
Stock repurchase program, aggregate amount repurchased | $ 473 | $ 442 | $ 105 | ||||||
Authorization Under 10b5-1 Plan | |||||||||
Class of Stock [Line Items] | |||||||||
Stock repurchase program, authorized repurchase amount | $ 500 | $ 400 | $ 200 | ||||||
Stock repurchase program, shares repurchased | 18,097,084 | 11,658,208 | 2,628,167 | ||||||
Stock repurchase program, aggregate amount repurchased | $ 473 | $ 442 | $ 105 | ||||||
Stock repurchase program, remaining authorized repurchase amount | $ 80 | ||||||||
Series C Preferred Stock | |||||||||
Class of Stock [Line Items] | |||||||||
Preferred stock, annual dividend rate | 5.375% | 5.375% | |||||||
Preferred stock, shares issued | 23,000 | 23,000 | 0 | ||||||
Preferred stock, stated amount per share | $ 25,000 | ||||||||
Preferred stock, proceeds from issuance, net of issuance costs | $ 558 | ||||||||
Preferred stock, issuance costs | $ 17 | ||||||||
Series B Preferred Stock | |||||||||
Class of Stock [Line Items] | |||||||||
Preferred stock, annual dividend rate | 6.75% | 6.75% | |||||||
Preferred stock, shares issued | 16,100 | 16,100 | 0 | ||||||
Preferred stock, stated amount per share | $ 25,000 | ||||||||
Preferred stock, proceeds from issuance, net of issuance costs | $ 390 | ||||||||
Preferred stock, issuance costs | $ 13 | ||||||||
Series A Preferred Stock | |||||||||
Class of Stock [Line Items] | |||||||||
Preferred stock, annual dividend rate | 6.60% | 6.60% | 6.60% | ||||||
Preferred stock, shares issued | 17,000 | 17,000 | 17,000 | ||||||
Preferred stock, stated amount per share | $ 25,000 | ||||||||
Preferred stock, proceeds from issuance, net of issuance costs | $ 412 | ||||||||
Preferred stock, issuance costs | $ 13 |
Equity (Share-Based Compensat_2
Equity (Share-Based Compensation (Narrative) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 6,747,990 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | (9,121) | ||
Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 242,560 | ||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 53.47 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 0 | |
Employee Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | 15.00% | ||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | 117,950 | 68,897 | 38,898 |
Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased | $ 8.34 | $ 6.99 | $ 6.40 |
Other Share Based | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ 17,000,000 | $ 24,000,000 | $ 13,000,000 |
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Performance Factor | 150.00% |
Equity (Statutory Equity and In
Equity (Statutory Equity and Income - Narrative) (Details) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Minimum | ||
Statutory Accounting Practices [Line Items] | ||
Description of Regulatory Capital Requirements under Insurance Regulations | in excess of 400% | in excess of 400% |
Equity (Captive Equity and Inco
Equity (Captive Equity and Income - Narrative) (Details) - Brighthouse Reinsurance Company of Delaware - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Statutory Accounting Practices [Line Items] | |||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 8,000 | $ 9,000 | |
Statutory Accounting Practices, Statutory Net Income Amount | 145 | (316) | $ (1,100) |
Statutory Accounting Practices, Prescribed Practice, Amount | $ 624 | $ 572 |
Equity (Dividend Restrictions -
Equity (Dividend Restrictions - Narrative) (Details) - New England Life Insurance Company [Member] $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Statutory Accounting Practices [Line Items] | |
Payments of Capital Distribution | $ 335 |
Cash [Member] | |
Statutory Accounting Practices [Line Items] | |
Payments of Ordinary Dividends | 65 |
Payments of Capital Distribution | 135 |
Debt [Member] | |
Statutory Accounting Practices [Line Items] | |
Payments of Capital Distribution | $ 200 |
Equity (Captive Dividend Restri
Equity (Captive Dividend Restriction - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Investments [Member] | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | $ 423 | ||
Accounts Receivable [Member] | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | 177 | ||
Brighthouse Reinsurance Company of Delaware | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | $ 0 | $ 0 | |
Preferred Stock [Member] | Brighthouse Reinsurance Company of Delaware | |||
Statutory Accounting Practices [Line Items] | |||
Payments of Dividends | $ 1 | $ 1 | $ 2 |
Equity (Accumulated Other Compr
Equity (Accumulated Other Comprehensive Income - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax | $ 5,716 | $ 3,240 | $ 716 | $ 1,676 |
Cumulative Effect, Adjustment | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Accumulated Other Comprehensive Income (Loss), Net of Tax | $ 3 | $ (79) |
Other Revenues and Other Expe_3
Other Revenues and Other Expenses (Other Expenses) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Other Income and Expenses [Abstract] | |||
Compensation | $ 346 | $ 333 | $ 289 |
Contracted services and other labor costs | 281 | 287 | 245 |
Transition services agreements | 127 | 245 | 279 |
Establishment costs | 112 | 118 | 239 |
Premium and other taxes, licenses and fees | 44 | 48 | 68 |
Separate account fees | 466 | 488 | 524 |
Volume related costs, excluding compensation, net of DAC capitalization | 662 | 636 | 628 |
Interest expense on debt | 184 | 191 | 158 |
Other | 131 | 145 | 145 |
Operating Expenses, Total | $ 2,353 | $ 2,491 | $ 2,575 |
Other Revenues and Other Expe_4
Other Revenues and Other Expenses (Other Revenues - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Distribution Service [Member] | |||
Revenue from Contract with Customer, Including Assessed Tax | $ 325 | $ 336 | $ 360 |
Employee Benefit Plans (Employe
Employee Benefit Plans (Employee Benefit Plans - Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Contribution Plan, Employer Discretionary Contribution Amount | $ 17 | $ 15 | $ 14 |
Defined Contribution Plan, Cost | 7 | 6 | $ 3 |
Assets for Plan Benefits, Defined Benefit Plan | 8 | 7 | |
Other Deferred Compensation Arrangements, Liability, Current and Noncurrent | 65 | 72 | |
MetLife, Inc. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Accounts Payable | 197 | 193 | |
Qualified Plan [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Accumulated Benefit Obligation | 182 | 164 | |
Nonqualified Plan [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Accumulated Benefit Obligation | $ 111 | $ 106 |
Income Tax (Provision for Incom
Income Tax (Provision for Income Tax) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Current: | |||
Federal | $ 30 | $ (36) | $ (166) |
State and local | 6 | 4 | 0 |
Subtotal | 36 | (32) | (166) |
Deferred: | |||
Federal | (399) | (285) | 285 |
Current and Deferred: | |||
Provision for income tax expense (benefit) | $ (363) | $ (317) | $ 119 |
Income Tax (Rate Reconciliation
Income Tax (Rate Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Income tax expense benefit continuing operations income tax reconciliation | |||
Tax provision at statutory rate | $ (298) | $ (221) | $ 207 |
Adjustments To Additional Paid In Capital, Capital Contribution | 0 | 0 | (2) |
Dividends received deduction | (42) | (42) | (44) |
Tax credits | (25) | (31) | (25) |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | 0 | 0 | (11) |
Other, net | 2 | (23) | (6) |
Provision for income tax expense (benefit) | $ (363) | $ (317) | $ 119 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 26.00% | 30.00% | 12.00% |
Income Tax (Net Deferred Income
Income Tax (Net Deferred Income Tax Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Deferred income tax assets: | ||
Tax credit carryforwards | $ 133 | $ 106 |
Net operating loss carryforwards | 1,486 | 1,087 |
Employee benefits | 15 | 17 |
Intangibles | 58 | 93 |
Investments, including derivatives | 0 | 260 |
Other | 0 | 15 |
Total deferred income tax assets | 1,692 | 1,578 |
Deferred income tax liabilities: | ||
Policyholder liabilities and receivables | 905 | 1,277 |
Net unrealized investment gains | 1,532 | 871 |
DAC | 720 | 785 |
Investments, including derivatives | 154 | 0 |
Other | 1 | 0 |
Total deferred income tax liabilities | 3,312 | 2,933 |
Deferred tax assets and liabilities [Abstract] | ||
Net deferred income tax asset (liability) | $ (1,620) | $ (1,355) |
Income Tax (Net Operating Loss
Income Tax (Net Operating Loss Carryforwards) (Details) $ in Millions | Dec. 31, 2020USD ($) |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | $ 7,075 |
Expiration Period Fourth Four Years By Deferred Tax Asset [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | 3,011 |
Expiration Period For Indefinite Number Of Years By Deferred Tax Asset [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforwards | $ 4,064 |
Income Tax (Tax Credit Carryfor
Income Tax (Tax Credit Carryforwards) (Details) $ in Millions | Dec. 31, 2020USD ($) |
Foreign Tax Authority | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | $ 116 |
Foreign Tax Authority | 2020-2024 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 18 |
Foreign Tax Authority | 2025-2029 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 70 |
Foreign Tax Authority | 2030-2034 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 28 |
Foreign Tax Authority | 2035-2039 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
Foreign Tax Authority | Indefinite | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 17 |
General business tax credit carryforward | 2020-2024 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | 2025-2029 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | 2030-2034 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 0 |
General business tax credit carryforward | 2035-2039 | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | 17 |
General business tax credit carryforward | Indefinite | |
Tax Credit Carryforward [Line Items] | |
Tax credit carryforwards | $ 0 |
Income Tax (Reconciliation of U
Income Tax (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Reconciliation of Unrecognized Tax Benefits | |||
Balance at January 1, | $ 35 | $ 35 | $ 23 |
Additions for tax positions of prior years | 0 | 0 | 12 |
Reductions for tax positions of prior years | 0 | 0 | 0 |
Additions for tax positions of current year | 0 | 0 | 0 |
Reductions for tax positions of current year | 0 | 0 | 0 |
Settlements with tax authorities | 0 | 0 | 0 |
Balance at December 31, | 35 | 35 | 35 |
Unrecognized tax benefits that, if recognized would impact the effective rate | $ 35 | $ 35 | $ 35 |
Income Tax (Narrative) (Details
Income Tax (Narrative) (Details) - USD ($) | Nov. 30, 2018 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Income Tax Examination, Penalties Expense | $ 0 | $ 0 | $ 0 | |
Percent of cash savings included in tax receivable agreement | 86.00% | |||
Accrued Income Taxes | $ 126,000,000 | 0 | ||
MetLife, Inc. | ||||
Related Party Transaction, Amounts of Transaction | $ 909,000,000 | |||
Accrued Income Taxes | 136,000,000 | 130,000,000 | ||
Income tax paid by Brighthouse Financial, Inc. | 0 | 3,000,000 | ||
Taxes Payable | $ 328,000,000 | $ 328,000,000 |
Earnings Per Common Share (Deta
Earnings Per Common Share (Details) - USD ($) $ / shares in Units, $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Earnings Per Share [Abstract] | |||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $ (1,105) | $ (761) | $ 865 |
Weighted average common shares outstanding - basic | 95,350,822 | 112,508,650 | 119,386,280 |
Dilutive effect of share-based awards | 0 | 0 | 441,198 |
Weighted average common shares outstanding - diluted | 95,350,822 | 112,508,650 | 119,827,478 |
Earnings per common share - basic | $ (11.58) | $ (6.76) | $ 7.24 |
Earnings per common share - diluted | $ (11.58) | $ (6.76) | $ 7.21 |
Antidilutive stock options excluded from the computation of earnings per common share | 217,990 |
Contingencies, Commitments an_2
Contingencies, Commitments and Guarantees (Contingencies - Narrative) (Details) - Maximum $ in Millions | Dec. 31, 2020USD ($) |
Loss Contingencies [Line Items] | |
Aggregate reasonably possible losses in excess of amounts accrued for loss contingency matters as to which an estimate can be made | $ 10 |
Non-litigation loss [Member] | |
Loss Contingencies [Line Items] | |
Aggregate reasonably possible losses in excess of amounts accrued for loss contingency matters as to which an estimate can be made | $ 125 |
Contingencies, Commitments an_3
Contingencies, Commitments and Guarantees (Commitments Off Balance Sheet - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Loan Origination Commitments [Member] | ||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||
Off-balance sheet commitments | $ 210 | $ 206 |
Commitments to Extend Credit [Member] | ||
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | ||
Off-balance sheet commitments | $ 1,700 | $ 1,800 |
Contingencies, Commitments an_4
Contingencies, Commitments and Guarantees Contingencies, Commitments and Guarantees (Guarantees - Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 |
Loss Contingencies [Line Items] | ||
Guarantor Obligations, Maximum Exposure, Undiscounted | $ 118 | |
Guarantor Obligations, Current Carrying Value | 1 | $ 1 |
Minimum | ||
Loss Contingencies [Line Items] | ||
Indemnities And Guarantees Contractual Limitation Range | 1 | |
Maximum | ||
Loss Contingencies [Line Items] | ||
Indemnities And Guarantees Contractual Limitation Range | $ 112 |
Related Party Transactions (Nar
Related Party Transactions (Narrative) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Related Party Transaction [Line Items] | |
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | $ 186 |
All Services and Transactions Except Broker Dealer Activities [Member] | |
Related Party Transaction [Line Items] | |
Revenue from Related Parties | (182) |
Related Party Transaction, Expenses from Transactions with Related Party | $ 133 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions | Nov. 16, 2020 | Aug. 17, 2020 | May 15, 2020 | Feb. 14, 2020 | Nov. 15, 2019 | Aug. 15, 2019 | May 15, 2019 | Feb. 16, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Feb. 10, 2021 | Feb. 06, 2020 | May 03, 2019 | Aug. 05, 2018 |
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, aggregate dividends declared | $ 44 | $ 21 | ||||||||||||
Series A Preferred Stock | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, dividends declared per share | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 412.50 | $ 1,650 | $ 1,237.50 | |||||
Preferred stock, aggregate dividends declared | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 7 | $ 28 | $ 21 | |||||
Series B Preferred Stock | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, dividends declared per share | $ 421.88 | $ 595.31 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 1,017.19 | $ 0 | |||||
Preferred stock, aggregate dividends declared | $ 6 | $ 10 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 16 | $ 0 | |||||
Authorization Under 10b5-1 Plan | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Stock repurchase program, authorized repurchase amount | $ 500 | $ 400 | $ 200 | |||||||||||
Subsequent Event | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, aggregate dividends declared | $ 25 | |||||||||||||
Subsequent Event | Series A Preferred Stock | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, dividends declared per share | $ 412.50 | |||||||||||||
Subsequent Event | Series B Preferred Stock | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, dividends declared per share | 421.88 | |||||||||||||
Subsequent Event | Series C Preferred Stock | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Preferred stock, dividends declared per share | $ 466.58 | |||||||||||||
Subsequent Event | Authorization Under 10b5-1 Plan | ||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||
Stock repurchase program, authorized repurchase amount | $ 200 |
Consolidated Summary of Inves_2
Consolidated Summary of Investments - Other Than Investments in Related Parties (Details) $ in Millions | Dec. 31, 2020USD ($) |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | $ 97,559 |
Amount at Which Shown on Balance Sheet | 109,531 |
U.S. government and agency | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 6,007 |
Estimated Fair Value | 8,638 |
Amount at Which Shown on Balance Sheet | 8,638 |
State and political subdivision | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,673 |
Estimated Fair Value | 4,640 |
Amount at Which Shown on Balance Sheet | 4,640 |
Public utilities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,699 |
Estimated Fair Value | 4,489 |
Amount at Which Shown on Balance Sheet | 4,489 |
Foreign government | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 1,487 |
Estimated Fair Value | 1,832 |
Amount at Which Shown on Balance Sheet | 1,832 |
All other corporate bonds | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 38,696 |
Estimated Fair Value | 44,630 |
Amount at Which Shown on Balance Sheet | 44,630 |
Total bonds | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 53,562 |
Estimated Fair Value | 64,229 |
Amount at Which Shown on Balance Sheet | 64,229 |
Mortgage-backed and asset-backed securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 16,694 |
Estimated Fair Value | 17,968 |
Amount at Which Shown on Balance Sheet | 17,968 |
Redeemable preferred stock | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 273 |
Estimated Fair Value | 298 |
Amount at Which Shown on Balance Sheet | 298 |
Total fixed maturity securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 70,529 |
Estimated Fair Value | 82,495 |
Amount at Which Shown on Balance Sheet | 82,495 |
Non-redeemable preferred stock | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 98 |
Estimated Fair Value | 99 |
Amount at Which Shown on Balance Sheet | 99 |
Industrial, miscellaneous and all other | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 34 |
Estimated Fair Value | 37 |
Amount at Which Shown on Balance Sheet | 37 |
Public utilities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 0 |
Estimated Fair Value | 2 |
Amount at Which Shown on Balance Sheet | 2 |
Total equity securities | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 132 |
Estimated Fair Value | 138 |
Amount at Which Shown on Balance Sheet | 138 |
Mortgage loans | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 15,808 |
Amount at Which Shown on Balance Sheet | 15,808 |
Policy loans | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 1,291 |
Amount at Which Shown on Balance Sheet | 1,291 |
Limited partnerships and LLCs | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 2,810 |
Amount at Which Shown on Balance Sheet | 2,810 |
Short-term investments | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,242 |
Amount at Which Shown on Balance Sheet | 3,242 |
Other invested assets | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] | |
Amortized Cost | 3,747 |
Amount at Which Shown on Balance Sheet | $ 3,747 |
Condensed Financial Informati_2
Condensed Financial Information (Parent Company) (Condensed Balance Sheets) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Investments: | ||||
Debt Securities, Available-for-sale | $ 82,495 | $ 71,036 | ||
Short-term investments | 3,242 | 1,958 | ||
Total investments | 109,531 | 95,782 | ||
Cash and Cash Equivalents | 4,108 | 2,877 | ||
Accrued Investment Income Receivable | 676 | 684 | ||
Premiums and Other Receivables, Net | 16,158 | 14,760 | ||
Current income tax recoverable | 0 | 17 | ||
Other Assets | 516 | 584 | ||
Total assets | 247,869 | 227,259 | ||
Liabilities | ||||
Other liabilities | 5,011 | 5,236 | ||
Total liabilities | 229,781 | 211,022 | ||
Stockholders’ Equity | ||||
Preferred Stock, Value, Issued | 0 | 0 | ||
Common Stock, Value, Issued | 1 | 1 | ||
Additional paid-in capital | 13,878 | 12,908 | ||
Retained earnings (deficit) | $ (534) | $ 585 | ||
Treasury stock, shares | 32,790,905 | 14,620,570 | ||
Treasury Stock, Value | $ (1,038) | $ (562) | ||
Accumulated other comprehensive income (loss) | 5,716 | 3,240 | $ 716 | $ 1,676 |
Total Brighthouse Financial, Inc.’s stockholders’ equity | 18,023 | 16,172 | ||
Total liabilities and equity | 247,869 | 227,259 | ||
Parent Company | ||||
Investments: | ||||
Debt Securities, Available-for-sale | 47 | 44 | ||
Short-term investments | 1,333 | 459 | ||
Investment in subsidiary | 20,326 | 20,222 | ||
Total investments | 21,706 | 20,725 | ||
Cash and Cash Equivalents | 262 | 212 | $ 461 | $ 326 |
Premiums and Other Receivables, Net | 197 | 199 | ||
Current income tax recoverable | 62 | 36 | ||
Deferred Income Tax Assets, Net | 1 | 8 | ||
Other Assets | 4 | 7 | ||
Total assets | 22,232 | 21,187 | ||
Liabilities | ||||
Long-term and short-term debt | 3,858 | 4,676 | ||
Other liabilities | 351 | 339 | ||
Total liabilities | 4,209 | 5,015 | ||
Stockholders’ Equity | ||||
Preferred Stock, Value, Issued | 0 | 0 | ||
Common Stock, Value, Issued | 1 | 1 | ||
Additional paid-in capital | 13,878 | 12,908 | ||
Retained earnings (deficit) | $ (534) | $ 585 | ||
Treasury stock, shares | 32,790,905 | 14,620,570 | ||
Treasury Stock, Value | $ (1,038) | $ (562) | ||
Accumulated other comprehensive income (loss) | 5,716 | 3,240 | ||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 18,023 | 16,172 | ||
Total liabilities and equity | $ 22,232 | $ 21,187 |
Condensed Financial Informati_3
Condensed Financial Information (Parent Company) (Condensed Balance Sheets Insets) (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Condensed Balance Sheet Statements, Captions [Line Items] | ||||
Amortized cost of fixed maturity securities available-for-sale | $ 70,529,000,000 | $ 64,079,000,000 | ||
Fixed maturity securities, allowance for credit losses | $ 2,000,000 | $ 0 | ||
Preferred stock, par value | $ 0.01 | $ 0.01 | ||
Preferred stock, aggregate liquidation preference | $ 1,403,000,000 | $ 425,000,000 | ||
Common stock, par value | $ 0.01 | $ 0.01 | ||
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 | ||
Common stock, shares issued | 121,002,523 | 120,647,871 | ||
Common stock, shares outstanding | 88,211,618 | 106,027,301 | 117,532,336 | 119,773,106 |
Treasury stock, shares | 32,790,905 | 14,620,570 | ||
Parent Company | ||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||
Amortized cost of fixed maturity securities available-for-sale | $ 45,000,000 | $ 44,000,000 | ||
Fixed maturity securities, allowance for credit losses | $ 0 | $ 0 | ||
Preferred stock, par value | $ 0.01 | $ 0.01 | ||
Preferred stock, aggregate liquidation preference | $ 1,403 | $ 425 | ||
Common stock, par value | $ 0.01 | $ 0.01 | ||
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 | ||
Common stock, shares issued | 121,002,523 | 120,647,871 | ||
Common stock, shares outstanding | 88,211,618 | 106,027,301 | ||
Treasury stock, shares | 32,790,905 | 14,620,570 |
Condensed Financial Informati_4
Condensed Financial Information (Parent Company) (Condensed Statements of Operations) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Condensed Income Statements, Captions [Line Items] | |||
Net investment income | $ 3,601 | $ 3,579 | $ 3,338 |
Other revenues | 413 | 389 | 397 |
Net investment gains (losses) | 278 | 112 | (207) |
Net derivative gains (losses) | (18) | (1,988) | 702 |
Total revenues | 8,503 | 6,554 | 8,965 |
Expenses | |||
Other expenses | 2,353 | 2,491 | 2,575 |
Total expenses | 9,922 | 7,606 | 7,976 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (1,419) | (1,052) | 989 |
Provision for income tax expense (benefit) | (363) | (317) | 119 |
Income (loss) before equity in earnings (losses) of subsidiaries | (175) | (138) | (138) |
Net income (loss) attributable to Brighthouse Financial, Inc. | (1,061) | (740) | 865 |
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | (1,105) | (761) | 865 |
Comprehensive income (loss) | 1,415 | 1,784 | (16) |
Net Income (Loss) Attributable to Noncontrolling Interest | 5 | 5 | 5 |
Parent Company | |||
Condensed Income Statements, Captions [Line Items] | |||
Net investment income | 7 | 20 | 10 |
Other revenues | 19 | 24 | 5 |
Net derivative gains (losses) | 8 | 0 | 0 |
Total revenues | 34 | 44 | 15 |
Expenses | |||
Debt repayment costs | 43 | 0 | 0 |
Other expenses | 211 | 219 | 183 |
Total expenses | 254 | 219 | 183 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (220) | (175) | (168) |
Provision for income tax expense (benefit) | (45) | (37) | (30) |
Income (Loss) from Subsidiaries, Net of Tax | (886) | (602) | 1,003 |
Net income (loss) attributable to Brighthouse Financial, Inc. | (1,061) | (740) | 865 |
Dividends, Preferred Stock | 44 | 21 | 0 |
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | (1,105) | (761) | 865 |
Comprehensive income (loss) | $ 1,415 | $ 1,784 | $ (16) |
Condensed Financial Informati_5
Condensed Financial Information (Parent Company) (Condensed Statements of Cash Flows) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Cash flows from operating activities | |||
Net income (loss) | $ (1,061) | $ (740) | $ 865 |
Other, net | 75 | 75 | 114 |
Net cash provided by (used in) operating activities | 888 | 1,828 | 3,062 |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 8,459 | 14,146 | 15,819 |
Purchases of fixed maturity securities | (14,401) | (16,915) | (16,460) |
Net change in short-term investments | (1,271) | (1,942) | 312 |
Net cash provided by (used in) investing activities | (5,843) | (7,341) | (4,538) |
Cash flows from financing activities | |||
Treasury stock acquired in connection with share repurchases | (473) | (442) | (105) |
Preferred stock issued, net of issuance costs | 948 | 412 | 0 |
Dividends on preferred stock | (44) | (21) | 0 |
Other, net | (46) | (56) | (68) |
Net cash provided by (used in) financing activities | 6,186 | 4,245 | 3,764 |
Cash and cash equivalents, beginning of year | 2,877 | ||
Cash and cash equivalents, end of year | 4,108 | 2,877 | |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 186 | 187 | 159 |
Net cash paid (received) for income tax | (100) | 16 | (895) |
Parent Company | |||
Cash flows from operating activities | |||
Net income (loss) | (1,061) | (740) | 865 |
Equity in (earnings) losses of subsidiaries | 886 | 602 | (1,003) |
Distributions from subsidiary | 1,468 | 195 | 52 |
Other, net | 68 | (16) | 7 |
Net cash provided by (used in) operating activities | 1,361 | 41 | (79) |
Cash flows from investing activities | |||
Sales, maturities and repayments of fixed maturity securities | 11 | 194 | 3 |
Purchases of fixed maturity securities | (12) | (4) | 0 |
Capital contributions to subsidiary | 0 | (412) | (208) |
Net change in short-term investments | (873) | (455) | 0 |
Net cash provided by (used in) investing activities | (874) | (677) | (205) |
Cash flows from financing activities | |||
Long-term and short-term debt issued | 1,764 | 2,156 | 893 |
Long-term and short-term debt repaid | (2,590) | (1,716) | (351) |
Treasury stock acquired in connection with share repurchases | (473) | (442) | (105) |
Preferred stock issued, net of issuance costs | 948 | 412 | 0 |
Dividends on preferred stock | (44) | (21) | 0 |
Other, net | (42) | (2) | (18) |
Net cash provided by (used in) financing activities | (437) | 387 | 419 |
Change in cash and cash equivalents | 50 | (249) | 135 |
Cash and cash equivalents, beginning of year | 212 | 461 | 326 |
Cash and cash equivalents, end of year | 262 | 212 | 461 |
Supplemental disclosures of cash flow information | |||
Net cash paid (received) for interest | 184 | 187 | 158 |
Cash received from MetLife, Inc. for income tax | 0 | 0 | (7) |
Income tax paid (received) by Brighthouse Financial, Inc. | (25) | (4) | 1 |
Net cash paid (received) for income tax | $ (25) | $ (4) | $ (6) |
Condensed Financial Informati_6
Condensed Financial Information (Parent Company) (Investment in Subsidiary Footnote) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Brighthouse Life Insurance Company | |||
Condensed Financial Statements, Captions [Line Items] | |||
Distributions from BH Holdings | $ 1,300 | ||
Parent Company | |||
Condensed Financial Statements, Captions [Line Items] | |||
Capital contributions to BH Holdings | 0 | $ (412) | $ (208) |
Distributions from BH Holdings | $ 1,468 | $ 195 | $ 52 |
Condensed Financial Informati_7
Condensed Financial Information (Parent Company) (Long-term and Short-term Debt Footnote) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | ||||
Sep. 30, 2018 | Jun. 30, 2018 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Jun. 30, 2020 | |
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, carrying value | $ 3,436 | $ 4,365 | ||||
Debt instrument, unamortized debt issuance costs and debt discount | 35 | 42 | ||||
Long-term debt maturities, year one | 2 | |||||
Long-term debt maturities, year two | 2 | |||||
Long-term debt maturities, year three | 2 | |||||
Long-term debt maturities, year four | 2 | |||||
Long-term debt maturities, year five | 3 | |||||
Long-term debt maturities, after year five | 3,500 | |||||
Interest expense on long-term debt | 184 | $ 191 | $ 158 | |||
Term Loan Due 2024 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, basis spread on variable rate debt | 1.50% | |||||
Debt instrument, carrying value | $ 0 | $ 1,000 | ||||
Senior Notes Due 2027 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 3.70% | 3.70% | ||||
Debt instrument, carrying value | $ 1,294 | $ 1,492 | ||||
Senior Notes Due 2030 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 5.625% | 5.625% | ||||
Debt instrument, carrying value | $ 614 | $ 0 | ||||
Senior Notes Due 2047 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 4.70% | 4.70% | ||||
Debt instrument, carrying value | $ 1,134 | $ 1,478 | ||||
Junior Subordinated Debentures Due 2058 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 6.25% | 6.25% | 6.25% | |||
Debt instrument, carrying value | $ 363 | $ 363 | ||||
Parent Company | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, carrying value | 3,405 | 4,333 | ||||
Short-term debt outstanding | 453 | 343 | ||||
Long-term and short-term debt outstanding | 3,858 | 4,676 | ||||
Debt instrument, unamortized debt issuance costs and debt discount | 35 | 42 | ||||
Long-term debt maturities, year one | 453 | |||||
Long-term debt maturities, year two | 0 | |||||
Long-term debt maturities, year three | 0 | |||||
Long-term debt maturities, year four | 0 | |||||
Long-term debt maturities, year five | 0 | |||||
Long-term debt maturities, after year five | 3,400 | |||||
Interest expense on long-term debt | 183 | 191 | 157 | |||
Parent Company | Term Loan Due 2024 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, carrying value | 0 | 1,000 | ||||
Parent Company | Short-term Intercompany Loans | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Short-term intercompany debt issued | 1,200 | 1,200 | 478 | |||
Short-term intercompany debt repaid | $ 1,000 | $ 1,100 | $ 311 | |||
Weighted average interest rate | 0.05% | 0.95% | 1.80% | |||
Parent Company | Intercompany Liquidity Facilities | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Short-term intercompany debt issued | $ 40 | $ 0 | $ 0 | |||
Short-term intercompany debt repaid | $ 40 | $ 0 | 0 | |||
Parent Company | Senior Notes Due 2027 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 3.70% | |||||
Debt instrument, carrying value | $ 1,294 | 1,492 | ||||
Parent Company | Senior Notes Due 2030 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 5.625% | |||||
Debt instrument, carrying value | $ 614 | 0 | ||||
Parent Company | Senior Notes Due 2047 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 4.70% | |||||
Debt instrument, carrying value | $ 1,134 | 1,478 | ||||
Parent Company | Junior Subordinated Debentures Due 2058 | ||||||
Condensed Financial Statements, Captions [Line Items] | ||||||
Debt instrument, stated interest rate | 6.25% | |||||
Debt instrument, carrying value | $ 363 | $ 363 |
Consolidated Supplementary In_2
Consolidated Supplementary Insurance Information (Balance Sheet Items) (Details) - USD ($) $ in Millions | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | $ 4,911 | $ 5,448 | $ 5,717 |
Future Policy Benefits and Other Policy-Related Balances | 47,859 | 42,797 | |
Policyholder account balances | 54,508 | 45,771 | |
Unearned Premiums | 15 | 19 | |
Unearned Revenue | 620 | 574 | |
Annuities | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 3,829 | 4,327 | |
Future Policy Benefits and Other Policy-Related Balances | 10,452 | 9,073 | |
Policyholder account balances | 43,784 | 34,770 | |
Unearned Premiums | 0 | 0 | |
Unearned Revenue | 86 | 88 | |
Life | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 971 | 1,019 | |
Future Policy Benefits and Other Policy-Related Balances | 6,242 | 5,832 | |
Policyholder account balances | 3,085 | 3,128 | |
Unearned Premiums | 10 | 13 | |
Unearned Revenue | 350 | 335 | |
Run-off | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 5 | 5 | |
Future Policy Benefits and Other Policy-Related Balances | 23,558 | 20,192 | |
Policyholder account balances | 7,638 | 7,872 | |
Unearned Premiums | 0 | 0 | |
Unearned Revenue | 184 | 151 | |
Corporate & Other | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
DAC and VOBA | 106 | 97 | |
Future Policy Benefits and Other Policy-Related Balances | 7,607 | 7,700 | |
Policyholder account balances | 1 | 1 | |
Unearned Premiums | 5 | 6 | |
Unearned Revenue | $ 0 | $ 0 |
Consolidated Supplementary In_3
Consolidated Supplementary Insurance Information (Income Statement Items) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | $ 4,229 | $ 4,462 | $ 4,735 |
Net Investment Income (1) | 3,601 | 3,579 | 3,338 |
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances | 6,803 | 4,733 | 4,351 |
Amortization of DAC and VOBA | 766 | 382 | 1,050 |
Other Expenses | 2,353 | 2,491 | 2,575 |
Corporate & Other | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 84 | 85 | 85 |
Net Investment Income (1) | 70 | 75 | 57 |
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances | 60 | 59 | 64 |
Amortization of DAC and VOBA | (9) | 14 | 16 |
Other Expenses | 437 | 404 | 503 |
Annuities | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 2,656 | 2,788 | 2,947 |
Net Investment Income (1) | 1,809 | 1,797 | 1,522 |
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances | 2,452 | 1,414 | 1,597 |
Amortization of DAC and VOBA | 668 | 363 | 944 |
Other Expenses | 1,554 | 1,676 | 1,629 |
Life | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 848 | 871 | 927 |
Net Investment Income (1) | 459 | 434 | 447 |
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances | 869 | 824 | 768 |
Amortization of DAC and VOBA | 107 | 5 | 90 |
Other Expenses | 176 | 211 | 241 |
Run-off | |||
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
Premiums and Universal Life and Investment-Type Product Policy Fees | 641 | 718 | 776 |
Net Investment Income (1) | 1,263 | 1,273 | 1,312 |
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances | 3,422 | 2,436 | 1,922 |
Amortization of DAC and VOBA | 0 | 0 | 0 |
Other Expenses | $ 186 | $ 200 | $ 202 |
Consolidated Reinsurance (Detai
Consolidated Reinsurance (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||
Gross Amount | $ 541,463 | $ 568,120 | $ 597,694 |
Ceded | 164,336 | 175,728 | 191,083 |
Assumed | 7,293 | 7,153 | 7,458 |
Net Amount | $ 384,420 | $ 399,545 | $ 414,069 |
% Amount Assumed to Net | 1.90% | 1.80% | 1.80% |
Consolidated Reinsurance | |||
Gross Amount | $ 1,509 | $ 1,651 | $ 1,699 |
Ceded | 753 | 779 | 810 |
Assumed | 10 | 10 | 11 |
Net premiums | $ 766 | $ 882 | $ 900 |
% Amount Assumed to Net | 1.30% | 1.10% | 1.20% |
Life insurance (1) | |||
Consolidated Reinsurance | |||
Gross Amount | $ 1,289 | $ 1,424 | $ 1,468 |
Ceded | 538 | 556 | 580 |
Assumed | 10 | 10 | 11 |
Net premiums | $ 761 | $ 878 | $ 899 |
% Amount Assumed to Net | 1.30% | 1.10% | 1.20% |
Accident and Health Insurance Product Line [Member] | |||
Consolidated Reinsurance | |||
Gross Amount | $ 220 | $ 227 | $ 231 |
Ceded | 215 | 223 | 230 |
Assumed | 0 | 0 | 0 |
Net premiums | $ 5 | $ 4 | $ 1 |
% Amount Assumed to Net | 0.00% | 0.00% | 0.00% |
Affiliated Entity | Life insurance (1) | |||
Consolidated Reinsurance | |||
Ceded | $ 201 | ||
Assumed | $ 6 |